id	sid	tid	token	lemma	pos
amwa-13	1	1	72	72	NUM
amwa-13	1	2	amwa	amwa	PROPN
amwa-13	1	3	journal	journal	PROPN
amwa-13	1	4	/	/	SYM
amwa-13	1	5	v36	v36	PROPN
amwa-13	1	6	n2	n2	PROPN
amwa-13	1	7	/	/	SYM
amwa-13	1	8	2021	2021	NUM
amwa-13	1	9	/	/	SYM
amwa-13	1	10	amwa.org	amwa.org	PROPN
amwa-13	1	11	f	f	X
amwa-13	1	12	e	e	PROPN
amwa-13	1	13	a	a	PROPN
amwa-13	1	14	t	t	NOUN
amwa-13	1	15	u	u	NOUN
amwa-13	1	16	r	r	NOUN
amwa-13	1	17	e	e	PROPN
amwa-13	1	18	science	science	NOUN
amwa-13	1	19	series	series	PROPN
amwa-13	1	20	abstract	abstract	PROPN
amwa-13	1	21	coronavirus	coronavirus	NOUN
amwa-13	1	22	disease	disease	NOUN
amwa-13	1	23	2019	2019	NUM
amwa-13	1	24	(	(	PUNCT
amwa-13	1	25	covid-19	covid-19	PROPN
amwa-13	1	26	)	)	PUNCT
amwa-13	1	27	,	,	PUNCT
amwa-13	1	28	caused	cause	VERB
amwa-13	1	29	by	by	ADP
amwa-13	1	30	the	the	DET
amwa-13	1	31	severe	severe	ADJ
amwa-13	1	32	acute	acute	ADJ
amwa-13	1	33	respiratory	respiratory	ADJ
amwa-13	1	34	syndrome	syndrome	NOUN
amwa-13	1	35	coronavirus	coronavirus	NOUN
amwa-13	1	36	2	2	NUM
amwa-13	1	37	(	(	PUNCT
amwa-13	1	38	sars	sar	NOUN
amwa-13	1	39	-	-	PUNCT
amwa-13	1	40	cov-2	cov-2	NOUN
amwa-13	1	41	)	)	PUNCT
amwa-13	1	42	,	,	PUNCT
amwa-13	1	43	has	have	VERB
amwa-13	1	44	far	far	ADV
amwa-13	1	45	-	-	PUNCT
amwa-13	1	46	reaching	reach	VERB
amwa-13	1	47	impacts	impact	NOUN
amwa-13	1	48	on	on	ADP
amwa-13	1	49	human	human	ADJ
amwa-13	1	50	health	health	NOUN
amwa-13	1	51	.	.	PUNCT
amwa-13	2	1	first	first	ADV
amwa-13	2	2	identified	identify	VERB
amwa-13	2	3	as	as	ADP
amwa-13	2	4	a	a	DET
amwa-13	2	5	disease	disease	NOUN
amwa-13	2	6	of	of	ADP
amwa-13	2	7	the	the	DET
amwa-13	2	8	respiratory	respiratory	ADJ
amwa-13	2	9	system	system	NOUN
amwa-13	2	10	,	,	PUNCT
amwa-13	2	11	covid-19	covid-19	PROPN
amwa-13	2	12	also	also	ADV
amwa-13	2	13	causes	cause	VERB
amwa-13	2	14	gastrointestinal	gastrointestinal	ADJ
amwa-13	2	15	,	,	PUNCT
amwa-13	2	16	renal	renal	ADJ
amwa-13	2	17	,	,	PUNCT
amwa-13	2	18	neurological	neurological	ADJ
amwa-13	2	19	,	,	PUNCT
amwa-13	2	20	and/or	and/or	CCONJ
amwa-13	2	21	cardiovascular	cardiovascular	ADJ
amwa-13	2	22	symptoms	symptom	NOUN
amwa-13	2	23	.	.	PUNCT
amwa-13	3	1	this	this	DET
amwa-13	3	2	article	article	NOUN
amwa-13	3	3	elucidates	elucidate	VERB
amwa-13	3	4	biological	biological	ADJ
amwa-13	3	5	relationships	relationship	NOUN
amwa-13	3	6	between	between	ADP
amwa-13	3	7	covid19	covid19	NOUN
amwa-13	3	8	and	and	CCONJ
amwa-13	3	9	the	the	DET
amwa-13	3	10	cardiovascular	cardiovascular	ADJ
amwa-13	3	11	system	system	NOUN
amwa-13	3	12	.	.	PUNCT
amwa-13	4	1	it	it	PRON
amwa-13	4	2	postulates	postulate	VERB
amwa-13	4	3	molecular	molecular	ADJ
amwa-13	4	4	and	and	CCONJ
amwa-13	4	5	physiological	physiological	ADJ
amwa-13	4	6	mechanisms	mechanism	NOUN
amwa-13	4	7	behind	behind	ADP
amwa-13	4	8	covid-19	covid-19	PROPN
amwa-13	4	9	–	–	PUNCT
amwa-13	4	10	related	relate	VERB
amwa-13	4	11	cardiovascular	cardiovascular	ADJ
amwa-13	4	12	ailments	ailment	NOUN
amwa-13	4	13	and	and	CCONJ
amwa-13	4	14	examines	examine	VERB
amwa-13	4	15	intersections	intersection	NOUN
amwa-13	4	16	among	among	ADP
amwa-13	4	17	the	the	DET
amwa-13	4	18	cardiovascular	cardiovascular	ADJ
amwa-13	4	19	system	system	NOUN
amwa-13	4	20	,	,	PUNCT
amwa-13	4	21	sars	sar	NOUN
amwa-13	4	22	-	-	PUNCT
amwa-13	4	23	cov-2	cov-2	NOUN
amwa-13	4	24	,	,	PUNCT
amwa-13	4	25	covid-19	covid-19	PROPN
amwa-13	4	26	,	,	PUNCT
amwa-13	4	27	and	and	CCONJ
amwa-13	4	28	certain	certain	ADJ
amwa-13	4	29	medications	medication	NOUN
amwa-13	4	30	.	.	PUNCT
amwa-13	5	1	new	new	ADJ
amwa-13	5	2	scientific	scientific	ADJ
amwa-13	5	3	information	information	NOUN
amwa-13	5	4	on	on	ADP
amwa-13	5	5	covid-19	covid-19	PROPN
amwa-13	5	6	and	and	CCONJ
amwa-13	5	7	the	the	DET
amwa-13	5	8	cardiovascular	cardiovascular	ADJ
amwa-13	5	9	system	system	NOUN
amwa-13	5	10	accumulates	accumulate	VERB
amwa-13	5	11	weekly	weekly	ADV
amwa-13	5	12	.	.	PUNCT
amwa-13	6	1	in	in	ADP
amwa-13	6	2	recognition	recognition	NOUN
amwa-13	6	3	of	of	ADP
amwa-13	6	4	such	such	ADJ
amwa-13	6	5	rapidity	rapidity	NOUN
amwa-13	6	6	,	,	PUNCT
amwa-13	6	7	this	this	DET
amwa-13	6	8	paper	paper	NOUN
amwa-13	6	9	offers	offer	VERB
amwa-13	6	10	a	a	DET
amwa-13	6	11	framework	framework	NOUN
amwa-13	6	12	in	in	ADP
amwa-13	6	13	which	which	PRON
amwa-13	6	14	the	the	DET
amwa-13	6	15	reader	reader	NOUN
amwa-13	6	16	will	will	AUX
amwa-13	6	17	be	be	AUX
amwa-13	6	18	able	able	ADJ
amwa-13	6	19	to	to	PART
amwa-13	6	20	place	place	VERB
amwa-13	6	21	the	the	DET
amwa-13	6	22	growing	grow	VERB
amwa-13	6	23	and	and	CCONJ
amwa-13	6	24	evolving	evolve	VERB
amwa-13	6	25	field	field	NOUN
amwa-13	6	26	of	of	ADP
amwa-13	6	27	knowledge	knowledge	NOUN
amwa-13	6	28	.	.	PUNCT
amwa-13	7	1	effects	effect	NOUN
amwa-13	7	2	of	of	ADP
amwa-13	7	3	severe	severe	ADJ
amwa-13	7	4	acute	acute	ADJ
amwa-13	7	5	respiratory	respiratory	ADJ
amwa-13	7	6	syndrome	syndrome	NOUN
amwa-13	7	7	coronavirus	coronavirus	NOUN
amwa-13	7	8	2	2	NUM
amwa-13	7	9	infection	infection	NOUN
amwa-13	7	10	on	on	ADP
amwa-13	7	11	the	the	DET
amwa-13	7	12	cardiovascular	cardiovascular	ADJ
amwa-13	7	13	system	system	NOUN
amwa-13	7	14	severe	severe	ADJ
amwa-13	7	15	acute	acute	ADJ
amwa-13	7	16	respiratory	respiratory	ADJ
amwa-13	7	17	syndrome	syndrome	NOUN
amwa-13	7	18	coronavirus	coronavirus	NOUN
amwa-13	7	19	2	2	NUM
amwa-13	7	20	(	(	PUNCT
amwa-13	7	21	sars	sar	NOUN
amwa-13	7	22	-	-	PUNCT
amwa-13	7	23	cov-2	cov-2	NOUN
amwa-13	7	24	)	)	PUNCT
amwa-13	7	25	infects	infect	VERB
amwa-13	7	26	cells	cell	NOUN
amwa-13	7	27	through	through	ADP
amwa-13	7	28	an	an	DET
amwa-13	7	29	interaction	interaction	NOUN
amwa-13	7	30	between	between	ADP
amwa-13	7	31	the	the	DET
amwa-13	7	32	virus	virus	NOUN
amwa-13	7	33	’s	’s	PART
amwa-13	7	34	spike	spike	NOUN
amwa-13	7	35	(	(	PUNCT
amwa-13	7	36	s	s	NOUN
amwa-13	7	37	)	)	PUNCT
amwa-13	7	38	protein	protein	NOUN
amwa-13	7	39	and	and	CCONJ
amwa-13	7	40	angiotensin	angiotensin	NOUN
amwa-13	7	41	-	-	PUNCT
amwa-13	7	42	converting	convert	VERB
amwa-13	7	43	enzyme	enzyme	NOUN
amwa-13	7	44	(	(	PUNCT
amwa-13	7	45	ace	ace	NOUN
amwa-13	7	46	)	)	PUNCT
amwa-13	7	47	2	2	NUM
amwa-13	7	48	in	in	ADP
amwa-13	7	49	host	host	NOUN
amwa-13	7	50	cells.1	cells.1	PROPN
amwa-13	7	51	-	-	SYM
amwa-13	7	52	5	5	NUM
amwa-13	7	53	within	within	ADP
amwa-13	7	54	the	the	DET
amwa-13	7	55	cardiovascular	cardiovascular	ADJ
amwa-13	7	56	system	system	NOUN
amwa-13	7	57	,	,	PUNCT
amwa-13	7	58	ace2	ace2	PROPN
amwa-13	7	59	is	be	AUX
amwa-13	7	60	reportedly	reportedly	ADV
amwa-13	7	61	located	locate	VERB
amwa-13	7	62	on	on	ADP
amwa-13	7	63	heart	heart	NOUN
amwa-13	7	64	muscle	muscle	NOUN
amwa-13	7	65	cells,6	cells,6	ADJ
amwa-13	7	66	-	-	PUNCT
amwa-13	7	67	11	11	NUM
amwa-13	7	68	endothelial	endothelial	ADJ
amwa-13	7	69	cells	cell	NOUN
amwa-13	7	70	(	(	PUNCT
amwa-13	7	71	ecs	ec	NOUN
amwa-13	7	72	)	)	PUNCT
amwa-13	7	73	that	that	PRON
amwa-13	7	74	line	line	VERB
amwa-13	7	75	the	the	DET
amwa-13	7	76	interior	interior	NOUN
amwa-13	7	77	of	of	ADP
amwa-13	7	78	blood	blood	NOUN
amwa-13	7	79	vessels	vessel	NOUN
amwa-13	7	80	and	and	CCONJ
amwa-13	7	81	regulate	regulate	VERB
amwa-13	7	82	blood	blood	NOUN
amwa-13	7	83	clotting	clotting	NOUN
amwa-13	7	84	and	and	CCONJ
amwa-13	7	85	blood	blood	NOUN
amwa-13	7	86	pressure,12,13	pressure,12,13	NOUN
amwa-13	7	87	pericytes	pericyte	NOUN
amwa-13	7	88	that	that	PRON
amwa-13	7	89	surround	surround	VERB
amwa-13	7	90	and	and	CCONJ
amwa-13	7	91	aid	aid	VERB
amwa-13	7	92	ecs,6	ecs,6	ADJ
amwa-13	7	93	-	-	PUNCT
amwa-13	7	94	8	8	NUM
amwa-13	7	95	and	and	CCONJ
amwa-13	7	96	arterial	arterial	ADJ
amwa-13	7	97	smooth	smooth	ADJ
amwa-13	7	98	muscle	muscle	NOUN
amwa-13	7	99	cells	cell	NOUN
amwa-13	7	100	(	(	PUNCT
amwa-13	7	101	smcs	smcs	ADJ
amwa-13	7	102	)	)	PUNCT
amwa-13	7	103	that	that	PRON
amwa-13	7	104	control	control	VERB
amwa-13	7	105	vascular	vascular	ADJ
amwa-13	7	106	diameter	diameter	NOUN
amwa-13	7	107	and	and	CCONJ
amwa-13	7	108	thereby	thereby	ADV
amwa-13	7	109	blood	blood	NOUN
amwa-13	7	110	pressure	pressure	NOUN
amwa-13	7	111	and	and	CCONJ
amwa-13	7	112	flow.7,12,13	flow.7,12,13	VERB
amwa-13	7	113	sars	sar	NOUN
amwa-13	7	114	-	-	PUNCT
amwa-13	7	115	cov-2	cov-2	NOUN
amwa-13	7	116	infection	infection	NOUN
amwa-13	7	117	of	of	ADP
amwa-13	7	118	these	these	DET
amwa-13	7	119	cells	cell	NOUN
amwa-13	7	120	hinders	hinder	VERB
amwa-13	7	121	their	their	PRON
amwa-13	7	122	health	health	NOUN
amwa-13	7	123	-	-	PUNCT
amwa-13	7	124	promoting	promote	VERB
amwa-13	7	125	work	work	NOUN
amwa-13	7	126	.	.	PUNCT
amwa-13	8	1	cardiovascular	cardiovascular	ADJ
amwa-13	8	2	health	health	NOUN
amwa-13	8	3	is	be	AUX
amwa-13	8	4	also	also	ADV
amwa-13	8	5	threatened	threaten	VERB
amwa-13	8	6	when	when	SCONJ
amwa-13	8	7	sars	sar	NOUN
amwa-13	8	8	-	-	PUNCT
amwa-13	8	9	cov-2	cov-2	PART
amwa-13	8	10	invades	invade	VERB
amwa-13	8	11	noncardiac	noncardiac	ADJ
amwa-13	8	12	areas	area	NOUN
amwa-13	8	13	and	and	CCONJ
amwa-13	8	14	triggers	trigger	VERB
amwa-13	8	15	immune	immune	ADJ
amwa-13	8	16	responses	response	NOUN
amwa-13	8	17	.	.	PUNCT
amwa-13	9	1	to	to	PART
amwa-13	9	2	fight	fight	VERB
amwa-13	9	3	the	the	DET
amwa-13	9	4	“	"	PUNCT
amwa-13	9	5	intruder	intruder	NOUN
amwa-13	9	6	,	,	PUNCT
amwa-13	9	7	”	"	PUNCT
amwa-13	9	8	local	local	ADJ
amwa-13	9	9	white	white	ADJ
amwa-13	9	10	blood	blood	NOUN
amwa-13	9	11	cells	cell	NOUN
amwa-13	9	12	activate	activate	VERB
amwa-13	9	13	,	,	PUNCT
amwa-13	9	14	recruit	recruit	VERB
amwa-13	9	15	other	other	ADJ
amwa-13	9	16	white	white	ADJ
amwa-13	9	17	blood	blood	NOUN
amwa-13	9	18	cells	cell	NOUN
amwa-13	9	19	,	,	PUNCT
amwa-13	9	20	and	and	CCONJ
amwa-13	9	21	produce	produce	VERB
amwa-13	9	22	pro	pro	ADJ
amwa-13	9	23	-	-	ADJ
amwa-13	9	24	inflammatory	inflammatory	ADJ
amwa-13	9	25	chemicals	chemical	NOUN
amwa-13	9	26	,	,	PUNCT
amwa-13	9	27	which	which	PRON
amwa-13	9	28	increases	increase	VERB
amwa-13	9	29	inflammation	inflammation	NOUN
amwa-13	9	30	.	.	PUNCT
amwa-13	10	1	interestingly	interestingly	ADV
amwa-13	10	2	,	,	PUNCT
amwa-13	10	3	a	a	DET
amwa-13	10	4	source	source	NOUN
amwa-13	10	5	of	of	ADP
amwa-13	10	6	these	these	DET
amwa-13	10	7	chemicals	chemical	NOUN
amwa-13	10	8	may	may	AUX
amwa-13	10	9	be	be	AUX
amwa-13	10	10	direct	direct	ADJ
amwa-13	10	11	sars	sar	NOUN
amwa-13	10	12	-	-	PUNCT
amwa-13	10	13	cov-2	cov-2	PART
amwa-13	10	14	infection	infection	NOUN
amwa-13	10	15	of	of	ADP
amwa-13	10	16	macrophages	macrophage	NOUN
amwa-13	10	17	—	—	PUNCT
amwa-13	10	18	a	a	DET
amwa-13	10	19	type	type	NOUN
amwa-13	10	20	of	of	ADP
amwa-13	10	21	white	white	ADJ
amwa-13	10	22	blood	blood	NOUN
amwa-13	10	23	cell	cell	NOUN
amwa-13	10	24	that	that	PRON
amwa-13	10	25	expresses	express	VERB
amwa-13	10	26	ace2.14	ace2.14	PROPN
amwa-13	10	27	as	as	SCONJ
amwa-13	10	28	the	the	DET
amwa-13	10	29	immune	immune	ADJ
amwa-13	10	30	system	system	NOUN
amwa-13	10	31	battles	battle	VERB
amwa-13	10	32	the	the	DET
amwa-13	10	33	virus	virus	NOUN
amwa-13	10	34	,	,	PUNCT
amwa-13	10	35	the	the	DET
amwa-13	10	36	affected	affected	ADJ
amwa-13	10	37	body	body	NOUN
amwa-13	10	38	organ	organ	NOUN
amwa-13	10	39	may	may	AUX
amwa-13	10	40	(	(	PUNCT
amwa-13	10	41	temporarily	temporarily	ADV
amwa-13	10	42	)	)	PUNCT
amwa-13	10	43	malfunction	malfunction	NOUN
amwa-13	10	44	.	.	PUNCT
amwa-13	11	1	these	these	DET
amwa-13	11	2	malfunctions	malfunction	NOUN
amwa-13	11	3	and	and	CCONJ
amwa-13	11	4	the	the	DET
amwa-13	11	5	pro	pro	ADJ
amwa-13	11	6	-	-	ADJ
amwa-13	11	7	inflammatory	inflammatory	ADJ
amwa-13	11	8	chemicals	chemical	NOUN
amwa-13	11	9	released	release	VERB
amwa-13	11	10	into	into	ADP
amwa-13	11	11	the	the	DET
amwa-13	11	12	blood	blood	NOUN
amwa-13	11	13	may	may	AUX
amwa-13	11	14	elicit	elicit	VERB
amwa-13	11	15	negative	negative	ADJ
amwa-13	11	16	effects	effect	NOUN
amwa-13	11	17	on	on	ADP
amwa-13	11	18	blood	blood	NOUN
amwa-13	11	19	vessels	vessel	NOUN
amwa-13	11	20	and	and	CCONJ
amwa-13	11	21	the	the	DET
amwa-13	11	22	heart.15	heart.15	NOUN
amwa-13	11	23	cardiovascular	cardiovascular	ADJ
amwa-13	11	24	conditions	condition	NOUN
amwa-13	11	25	induced	induce	VERB
amwa-13	11	26	by	by	ADP
amwa-13	11	27	these	these	DET
amwa-13	11	28	direct	direct	ADJ
amwa-13	11	29	and	and	CCONJ
amwa-13	11	30	indirect	indirect	ADJ
amwa-13	11	31	effects	effect	NOUN
amwa-13	11	32	of	of	ADP
amwa-13	11	33	sars	sar	NOUN
amwa-13	11	34	-	-	PUNCT
amwa-13	11	35	cov-2	cov-2	PART
amwa-13	11	36	infection	infection	NOUN
amwa-13	11	37	include	include	VERB
amwa-13	11	38	myocarditis	myocarditis	PROPN
amwa-13	11	39	(	(	PUNCT
amwa-13	11	40	inflamed	inflame	VERB
amwa-13	11	41	heart	heart	NOUN
amwa-13	11	42	tissue	tissue	NOUN
amwa-13	11	43	)	)	PUNCT
amwa-13	11	44	,	,	PUNCT
amwa-13	11	45	blood	blood	NOUN
amwa-13	11	46	pressure	pressure	NOUN
amwa-13	11	47	irregularities	irregularity	NOUN
amwa-13	11	48	,	,	PUNCT
amwa-13	11	49	abnormal	abnormal	ADJ
amwa-13	11	50	blood	blood	NOUN
amwa-13	11	51	clot	clot	NOUN
amwa-13	11	52	(	(	PUNCT
amwa-13	11	53	thrombus	thrombus	NOUN
amwa-13	11	54	)	)	PUNCT
amwa-13	11	55	formation	formation	NOUN
amwa-13	11	56	,	,	PUNCT
amwa-13	11	57	hypoxia	hypoxia	NOUN
amwa-13	11	58	,	,	PUNCT
amwa-13	11	59	arteriosclerotic	arteriosclerotic	ADJ
amwa-13	11	60	heart	heart	NOUN
amwa-13	11	61	disease	disease	NOUN
amwa-13	11	62	(	(	PUNCT
amwa-13	11	63	ashd	ashd	NOUN
amwa-13	11	64	)	)	PUNCT
amwa-13	11	65	,	,	PUNCT
amwa-13	11	66	myocardial	myocardial	ADJ
amwa-13	11	67	infarctions	infarction	NOUN
amwa-13	11	68	(	(	PUNCT
amwa-13	11	69	mis	mis	X
amwa-13	11	70	;	;	PUNCT
amwa-13	11	71	heart	heart	NOUN
amwa-13	11	72	attacks	attack	NOUN
amwa-13	11	73	)	)	PUNCT
amwa-13	11	74	,	,	PUNCT
amwa-13	11	75	arrhythmias	arrhythmia	NOUN
amwa-13	11	76	,	,	PUNCT
amwa-13	11	77	and	and	CCONJ
amwa-13	11	78	heart	heart	NOUN
amwa-13	11	79	failure	failure	NOUN
amwa-13	11	80	(	(	PUNCT
amwa-13	11	81	figure	figure	NOUN
amwa-13	11	82	1).16	1).16	NUM
amwa-13	11	83	-	-	SYM
amwa-13	11	84	29	29	NUM
amwa-13	11	85	if	if	SCONJ
amwa-13	11	86	left	leave	VERB
amwa-13	11	87	unchecked	unchecked	ADJ
amwa-13	11	88	or	or	CCONJ
amwa-13	11	89	if	if	SCONJ
amwa-13	11	90	severe	severe	ADJ
amwa-13	11	91	enough	enough	ADV
amwa-13	11	92	,	,	PUNCT
amwa-13	11	93	these	these	DET
amwa-13	11	94	ailments	ailment	NOUN
amwa-13	11	95	could	could	AUX
amwa-13	11	96	be	be	AUX
amwa-13	11	97	fatal	fatal	ADJ
amwa-13	11	98	.	.	PUNCT
amwa-13	12	1	myocarditis	myocarditis	ADJ
amwa-13	12	2	myocarditis	myocarditis	ADJ
amwa-13	12	3	compromises	compromise	NOUN
amwa-13	12	4	contractility	contractility	NOUN
amwa-13	12	5	of	of	ADP
amwa-13	12	6	the	the	DET
amwa-13	12	7	heart	heart	NOUN
amwa-13	12	8	muscle	muscle	NOUN
amwa-13	12	9	.	.	PUNCT
amwa-13	13	1	as	as	ADP
amwa-13	13	2	a	a	DET
amwa-13	13	3	result	result	NOUN
amwa-13	13	4	,	,	PUNCT
amwa-13	13	5	the	the	DET
amwa-13	13	6	heart	heart	NOUN
amwa-13	13	7	compensates	compensate	VERB
amwa-13	13	8	in	in	ADP
amwa-13	13	9	order	order	NOUN
amwa-13	13	10	to	to	PART
amwa-13	13	11	insure	insure	VERB
amwa-13	13	12	proper	proper	ADJ
amwa-13	13	13	delivery	delivery	NOUN
amwa-13	13	14	of	of	ADP
amwa-13	13	15	blood	blood	NOUN
amwa-13	13	16	(	(	PUNCT
amwa-13	13	17	and	and	CCONJ
amwa-13	13	18	o2	o2	PROPN
amwa-13	13	19	)	)	PUNCT
amwa-13	13	20	to	to	ADP
amwa-13	13	21	the	the	DET
amwa-13	13	22	body	body	NOUN
amwa-13	13	23	.	.	PUNCT
amwa-13	14	1	compensation	compensation	NOUN
amwa-13	14	2	occurs	occur	VERB
amwa-13	14	3	by	by	ADP
amwa-13	14	4	one	one	NUM
amwa-13	14	5	of	of	ADP
amwa-13	14	6	at	at	ADV
amwa-13	14	7	least	least	ADJ
amwa-13	14	8	2	2	NUM
amwa-13	14	9	methods	method	NOUN
amwa-13	14	10	:	:	PUNCT
amwa-13	14	11	(	(	PUNCT
amwa-13	14	12	1	1	X
amwa-13	14	13	)	)	PUNCT
amwa-13	14	14	thickening	thickening	NOUN
amwa-13	14	15	of	of	ADP
amwa-13	14	16	the	the	DET
amwa-13	14	17	heart	heart	NOUN
amwa-13	14	18	muscle	muscle	NOUN
amwa-13	14	19	layer	layer	NOUN
amwa-13	14	20	(	(	PUNCT
amwa-13	14	21	hypertrophy	hypertrophy	NOUN
amwa-13	14	22	)	)	PUNCT
amwa-13	14	23	,	,	PUNCT
amwa-13	14	24	and	and	CCONJ
amwa-13	14	25	(	(	PUNCT
amwa-13	14	26	2	2	X
amwa-13	14	27	)	)	PUNCT
amwa-13	14	28	heart	heart	NOUN
amwa-13	14	29	rate	rate	NOUN
amwa-13	14	30	elevation	elevation	NOUN
amwa-13	14	31	(	(	PUNCT
amwa-13	14	32	tachycardia	tachycardia	NOUN
amwa-13	14	33	)	)	PUNCT
amwa-13	14	34	.	.	PUNCT
amwa-13	15	1	both	both	DET
amwa-13	15	2	choices	choice	NOUN
amwa-13	15	3	could	could	AUX
amwa-13	15	4	progressively	progressively	ADV
amwa-13	15	5	worsen	worsen	VERB
amwa-13	15	6	the	the	DET
amwa-13	15	7	heart	heart	NOUN
amwa-13	15	8	’s	’s	PART
amwa-13	15	9	already	already	ADV
amwa-13	15	10	precarious	precarious	ADJ
amwa-13	15	11	condition	condition	NOUN
amwa-13	15	12	.	.	PUNCT
amwa-13	16	1	blood	blood	NOUN
amwa-13	16	2	pressure	pressure	NOUN
amwa-13	16	3	irregularities	irregularity	NOUN
amwa-13	16	4	some	some	DET
amwa-13	16	5	patients	patient	NOUN
amwa-13	16	6	with	with	ADP
amwa-13	16	7	coronavirus	coronavirus	NOUN
amwa-13	16	8	disease	disease	NOUN
amwa-13	16	9	2019	2019	NUM
amwa-13	16	10	(	(	PUNCT
amwa-13	16	11	covid-19	covid-19	PROPN
amwa-13	16	12	)	)	PUNCT
amwa-13	16	13	present	present	NOUN
amwa-13	16	14	with	with	ADP
amwa-13	16	15	hypertension.19	hypertension.19	PROPN
amwa-13	16	16	the	the	DET
amwa-13	16	17	causal	causal	PROPN
amwa-13	16	18	link	link	NOUN
amwa-13	16	19	between	between	ADP
amwa-13	16	20	this	this	DET
amwa-13	16	21	elevated	elevated	ADJ
amwa-13	16	22	blood	blood	NOUN
amwa-13	16	23	pressure	pressure	NOUN
amwa-13	16	24	and	and	CCONJ
amwa-13	16	25	sars	sar	NOUN
amwa-13	16	26	-	-	PUNCT
amwa-13	16	27	cov-2	cov-2	NUM
amwa-13	16	28	may	may	AUX
amwa-13	16	29	be	be	AUX
amwa-13	16	30	ace2	ace2	NOUN
amwa-13	16	31	.	.	PUNCT
amwa-13	17	1	besides	besides	SCONJ
amwa-13	17	2	being	be	AUX
amwa-13	17	3	the	the	DET
amwa-13	17	4	binding	bind	VERB
amwa-13	17	5	target	target	NOUN
amwa-13	17	6	of	of	ADP
amwa-13	17	7	sars	sar	NOUN
amwa-13	17	8	-	-	PUNCT
amwa-13	17	9	cov-2	cov-2	NOUN
amwa-13	17	10	’s	’s	NOUN
amwa-13	17	11	s	s	PART
amwa-13	17	12	protein	protein	NOUN
amwa-13	17	13	,	,	PUNCT
amwa-13	17	14	ace2	ace2	PROPN
amwa-13	17	15	is	be	AUX
amwa-13	17	16	part	part	NOUN
amwa-13	17	17	of	of	ADP
amwa-13	17	18	the	the	DET
amwa-13	17	19	renin	renin	ADJ
amwa-13	17	20	–	–	PUNCT
amwa-13	17	21	angiotensin	angiotensin	NOUN
amwa-13	17	22	system	system	NOUN
amwa-13	17	23	(	(	PUNCT
amwa-13	17	24	ras	ras	NOUN
amwa-13	17	25	)	)	PUNCT
amwa-13	17	26	pathway	pathway	NOUN
amwa-13	17	27	(	(	PUNCT
amwa-13	17	28	figure	figure	NOUN
amwa-13	17	29	2	2	NUM
amwa-13	17	30	)	)	PUNCT
amwa-13	17	31	.	.	PUNCT
amwa-13	18	1	the	the	DET
amwa-13	18	2	ras	ras	PROPN
amwa-13	18	3	pathway	pathway	NOUN
amwa-13	18	4	controls	control	VERB
amwa-13	18	5	smc	smc	PROPN
amwa-13	18	6	contraction	contraction	NOUN
amwa-13	18	7	and	and	CCONJ
amwa-13	18	8	relaxation	relaxation	NOUN
amwa-13	18	9	and	and	CCONJ
amwa-13	18	10	thereby	thereby	ADV
amwa-13	18	11	influences	influence	VERB
amwa-13	18	12	blood	blood	NOUN
amwa-13	18	13	pressure	pressure	NOUN
amwa-13	18	14	.	.	PUNCT
amwa-13	19	1	smc	smc	PROPN
amwa-13	19	2	contraction	contraction	PROPN
amwa-13	19	3	narrows	narrow	VERB
amwa-13	19	4	vessels	vessel	NOUN
amwa-13	19	5	’	'	PUNCT
amwa-13	19	6	diameter	diameter	NOUN
amwa-13	19	7	(	(	PUNCT
amwa-13	19	8	vasoconstriction	vasoconstriction	NOUN
amwa-13	19	9	)	)	PUNCT
amwa-13	19	10	and	and	CCONJ
amwa-13	19	11	raises	raise	VERB
amwa-13	19	12	blood	blood	NOUN
amwa-13	19	13	pressure	pressure	NOUN
amwa-13	19	14	.	.	PUNCT
amwa-13	20	1	smc	smc	PROPN
amwa-13	20	2	relaxation	relaxation	NOUN
amwa-13	20	3	widens	widen	VERB
amwa-13	20	4	vessels	vessel	NOUN
amwa-13	20	5	’	'	PUNCT
amwa-13	20	6	diameter	diameter	NOUN
amwa-13	20	7	(	(	PUNCT
amwa-13	20	8	vasodilation	vasodilation	NOUN
amwa-13	20	9	)	)	PUNCT
amwa-13	20	10	and	and	CCONJ
amwa-13	20	11	lowers	lower	VERB
amwa-13	20	12	blood	blood	NOUN
amwa-13	20	13	pressure	pressure	NOUN
amwa-13	20	14	.	.	PUNCT
amwa-13	21	1	smc	smc	PROPN
amwa-13	21	2	contraction	contraction	PROPN
amwa-13	21	3	and	and	CCONJ
amwa-13	21	4	relaxation	relaxation	NOUN
amwa-13	21	5	are	be	AUX
amwa-13	21	6	controlled	control	VERB
amwa-13	21	7	by	by	ADP
amwa-13	21	8	the	the	DET
amwa-13	21	9	ras	ras	PROPN
amwa-13	21	10	pathway	pathway	NOUN
amwa-13	21	11	’s	’s	PART
amwa-13	21	12	angiotensin	angiotensin	PROPN
amwa-13	21	13	ii	ii	PROPN
amwa-13	21	14	and	and	CCONJ
amwa-13	21	15	angiotensin	angiotensin	NOUN
amwa-13	21	16	(	(	PUNCT
amwa-13	21	17	1	1	NUM
amwa-13	21	18	-	-	SYM
amwa-13	21	19	7	7	NUM
amwa-13	21	20	)	)	PUNCT
amwa-13	21	21	,	,	PUNCT
amwa-13	21	22	respectively	respectively	ADV
amwa-13	21	23	.	.	PUNCT
amwa-13	22	1	ace1	ace1	PROPN
amwa-13	22	2	converts	convert	VERB
amwa-13	22	3	relatively	relatively	ADV
amwa-13	22	4	inactive	inactive	ADJ
amwa-13	22	5	angiotensin	angiotensin	NOUN
amwa-13	22	6	i	i	PRON
amwa-13	22	7	into	into	ADP
amwa-13	22	8	angiotensin	angiotensin	PROPN
amwa-13	22	9	ii	ii	PROPN
amwa-13	22	10	,	,	PUNCT
amwa-13	22	11	a	a	DET
amwa-13	22	12	highly	highly	ADV
amwa-13	22	13	active	active	ADJ
amwa-13	22	14	vasoconstrictor	vasoconstrictor	NOUN
amwa-13	22	15	.	.	PUNCT
amwa-13	23	1	ace2	ace2	PROPN
amwa-13	23	2	converts	convert	VERB
amwa-13	23	3	angiotensin	angiotensin	PROPN
amwa-13	23	4	ii	ii	PROPN
amwa-13	23	5	into	into	ADP
amwa-13	23	6	angiotensin	angiotensin	NOUN
amwa-13	23	7	(	(	PUNCT
amwa-13	23	8	1	1	NUM
amwa-13	23	9	-	-	SYM
amwa-13	23	10	7	7	NUM
amwa-13	23	11	)	)	PUNCT
amwa-13	23	12	,	,	PUNCT
amwa-13	23	13	a	a	DET
amwa-13	23	14	vasodilator	vasodilator	NOUN
amwa-13	23	15	(	(	PUNCT
amwa-13	23	16	figure	figure	NOUN
amwa-13	23	17	2).30	2).30	NUM
amwa-13	23	18	ace2	ace2	NOUN
amwa-13	23	19	levels	level	NOUN
amwa-13	23	20	likely	likely	ADV
amwa-13	23	21	decline	decline	VERB
amwa-13	23	22	in	in	ADP
amwa-13	23	23	sars	sar	NOUN
amwa-13	23	24	-	-	PUNCT
amwa-13	23	25	cov-2	cov-2	NOUN
amwa-13	23	26	–	–	PUNCT
amwa-13	23	27	infected	infect	VERB
amwa-13	23	28	jennifer	jennifer	PROPN
amwa-13	23	29	l.	l.	PROPN
amwa-13	23	30	busch	busch	PROPN
amwa-13	23	31	,	,	PUNCT
amwa-13	23	32	phd	phd	NOUN
amwa-13	23	33	/	/	SYM
amwa-13	23	34	associate	associate	NOUN
amwa-13	23	35	professor	professor	NOUN
amwa-13	23	36	of	of	ADP
amwa-13	23	37	biology	biology	NOUN
amwa-13	23	38	,	,	PUNCT
amwa-13	23	39	wheaton	wheaton	PROPN
amwa-13	23	40	college	college	PROPN
amwa-13	23	41	,	,	PUNCT
amwa-13	23	42	wheaton	wheaton	PROPN
amwa-13	23	43	,	,	PUNCT
amwa-13	23	44	il	il	PROPN
amwa-13	23	45	intersections	intersection	NOUN
amwa-13	23	46	of	of	ADP
amwa-13	23	47	severe	severe	ADJ
amwa-13	23	48	acute	acute	ADJ
amwa-13	23	49	respiratory	respiratory	ADJ
amwa-13	23	50	syndrome	syndrome	NOUN
amwa-13	23	51	coronavirus	coronavirus	NOUN
amwa-13	23	52	2	2	NUM
amwa-13	23	53	,	,	PUNCT
amwa-13	23	54	coronavirus	coronavirus	NOUN
amwa-13	23	55	disease	disease	NOUN
amwa-13	23	56	2019	2019	NUM
amwa-13	23	57	,	,	PUNCT
amwa-13	23	58	and	and	CCONJ
amwa-13	24	1	the	the	DET
amwa-13	24	2	cardiovascular	cardiovascular	ADJ
amwa-13	24	3	system	system	NOUN
amwa-13	24	4	amwa	amwa	PROPN
amwa-13	24	5	journal	journal	PROPN
amwa-13	24	6	/	/	SYM
amwa-13	24	7	v36	v36	PROPN
amwa-13	24	8	n2	n2	PROPN
amwa-13	24	9	/	/	SYM
amwa-13	24	10	2021	2021	NUM
amwa-13	24	11	/	/	SYM
amwa-13	24	12	amwa.org	amwa.org	PROPN
amwa-13	24	13	73	73	NUM
amwa-13	24	14	figure	figure	NOUN
amwa-13	24	15	1	1	NUM
amwa-13	24	16	.	.	PUNCT
amwa-13	24	17	confirmed	confirm	VERB
amwa-13	24	18	and	and	CCONJ
amwa-13	24	19	plausible	plausible	ADJ
amwa-13	24	20	mechanisms	mechanism	NOUN
amwa-13	24	21	by	by	ADP
amwa-13	24	22	which	which	PRON
amwa-13	24	23	severe	severe	ADJ
amwa-13	24	24	acute	acute	ADJ
amwa-13	24	25	respiratory	respiratory	ADJ
amwa-13	24	26	syndrome	syndrome	NOUN
amwa-13	24	27	coronavirus	coronavirus	NOUN
amwa-13	24	28	2	2	NUM
amwa-13	24	29	(	(	PUNCT
amwa-13	24	30	sars	sar	NOUN
amwa-13	24	31	-	-	PUNCT
amwa-13	24	32	cov-2	cov-2	NOUN
amwa-13	24	33	)	)	PUNCT
amwa-13	24	34	infection	infection	NOUN
amwa-13	24	35	causes	cause	VERB
amwa-13	24	36	cardiovascular	cardiovascular	ADJ
amwa-13	24	37	symptoms	symptom	NOUN
amwa-13	24	38	.	.	PUNCT
amwa-13	25	1	several	several	ADJ
amwa-13	25	2	cell	cell	NOUN
amwa-13	25	3	types	type	NOUN
amwa-13	25	4	and	and	CCONJ
amwa-13	25	5	organs	organ	NOUN
amwa-13	25	6	(	(	PUNCT
amwa-13	25	7	indicated	indicate	VERB
amwa-13	25	8	by	by	ADP
amwa-13	25	9	the	the	DET
amwa-13	25	10	spiked	spiked	ADJ
amwa-13	25	11	star	star	NOUN
amwa-13	25	12	symbol	symbol	NOUN
amwa-13	25	13	)	)	PUNCT
amwa-13	25	14	are	be	AUX
amwa-13	25	15	reported	report	VERB
amwa-13	25	16	targets	target	NOUN
amwa-13	25	17	for	for	ADP
amwa-13	25	18	sars	sar	NOUN
amwa-13	25	19	-	-	PUNCT
amwa-13	25	20	cov-2	cov-2	PART
amwa-13	25	21	infection	infection	NOUN
amwa-13	25	22	.	.	PUNCT
amwa-13	26	1	some	some	PRON
amwa-13	26	2	of	of	ADP
amwa-13	26	3	these	these	DET
amwa-13	26	4	host	host	NOUN
amwa-13	26	5	cells	cell	NOUN
amwa-13	26	6	are	be	AUX
amwa-13	26	7	part	part	NOUN
amwa-13	26	8	of	of	ADP
amwa-13	26	9	the	the	DET
amwa-13	26	10	cardiovascular	cardiovascular	ADJ
amwa-13	26	11	system	system	NOUN
amwa-13	26	12	,	,	PUNCT
amwa-13	26	13	macrophages	macrophage	NOUN
amwa-13	26	14	may	may	AUX
amwa-13	26	15	lie	lie	VERB
amwa-13	26	16	within	within	ADP
amwa-13	26	17	or	or	CCONJ
amwa-13	26	18	outside	outside	ADP
amwa-13	26	19	of	of	ADP
amwa-13	26	20	the	the	DET
amwa-13	26	21	cardiovascular	cardiovascular	ADJ
amwa-13	26	22	system	system	NOUN
amwa-13	26	23	,	,	PUNCT
amwa-13	26	24	and	and	CCONJ
amwa-13	26	25	other	other	ADJ
amwa-13	26	26	sites	site	NOUN
amwa-13	26	27	lie	lie	VERB
amwa-13	26	28	outside	outside	ADV
amwa-13	26	29	of	of	ADP
amwa-13	26	30	the	the	DET
amwa-13	26	31	cardiovascular	cardiovascular	ADJ
amwa-13	26	32	system	system	NOUN
amwa-13	26	33	.	.	PUNCT
amwa-13	27	1	(	(	PUNCT
amwa-13	27	2	the	the	DET
amwa-13	27	3	cardiovascular	cardiovascular	ADJ
amwa-13	27	4	system	system	NOUN
amwa-13	27	5	is	be	AUX
amwa-13	27	6	defined	define	VERB
amwa-13	27	7	by	by	ADP
amwa-13	27	8	the	the	DET
amwa-13	27	9	thin	thin	ADV
amwa-13	27	10	-	-	PUNCT
amwa-13	27	11	dashed	dash	VERB
amwa-13	27	12	enclosure	enclosure	NOUN
amwa-13	27	13	.	.	PUNCT
amwa-13	27	14	)	)	PUNCT
amwa-13	28	1	infections	infection	NOUN
amwa-13	28	2	initiate	initiate	VERB
amwa-13	28	3	a	a	DET
amwa-13	28	4	variety	variety	NOUN
amwa-13	28	5	of	of	ADP
amwa-13	28	6	cardiovascular	cardiovascular	ADJ
amwa-13	28	7	symptoms	symptom	NOUN
amwa-13	28	8	(	(	PUNCT
amwa-13	28	9	shaded	shade	VERB
amwa-13	28	10	boxes	box	NOUN
amwa-13	28	11	)	)	PUNCT
amwa-13	28	12	that	that	PRON
amwa-13	28	13	,	,	PUNCT
amwa-13	28	14	if	if	SCONJ
amwa-13	28	15	prolonged	prolonged	ADJ
amwa-13	28	16	and	and	CCONJ
amwa-13	28	17	severe	severe	ADJ
amwa-13	28	18	enough	enough	ADV
amwa-13	28	19	,	,	PUNCT
amwa-13	28	20	cause	cause	VERB
amwa-13	28	21	arrhythmias	arrhythmia	NOUN
amwa-13	28	22	and	and	CCONJ
amwa-13	28	23	heart	heart	NOUN
amwa-13	28	24	failure	failure	NOUN
amwa-13	28	25	(	(	PUNCT
amwa-13	28	26	shaded	shade	VERB
amwa-13	28	27	boxes	box	NOUN
amwa-13	28	28	with	with	ADP
amwa-13	28	29	thick	thick	ADJ
amwa-13	28	30	outline	outline	NOUN
amwa-13	28	31	)	)	PUNCT
amwa-13	28	32	.	.	PUNCT
amwa-13	29	1	viral	viral	ADJ
amwa-13	29	2	infection	infection	NOUN
amwa-13	29	3	of	of	ADP
amwa-13	29	4	other	other	ADJ
amwa-13	29	5	organs	organ	NOUN
amwa-13	29	6	may	may	AUX
amwa-13	29	7	also	also	ADV
amwa-13	29	8	affect	affect	VERB
amwa-13	29	9	the	the	DET
amwa-13	29	10	cardiovascular	cardiovascular	ADJ
amwa-13	29	11	system	system	NOUN
amwa-13	29	12	in	in	ADP
amwa-13	29	13	ways	way	NOUN
amwa-13	29	14	not	not	PART
amwa-13	29	15	specified	specify	VERB
amwa-13	29	16	here	here	ADV
amwa-13	29	17	.	.	PUNCT
amwa-13	30	1	related	related	ADJ
amwa-13	30	2	schematics	schematic	NOUN
amwa-13	30	3	can	can	AUX
amwa-13	30	4	be	be	AUX
amwa-13	30	5	found	find	VERB
amwa-13	30	6	in	in	ADP
amwa-13	30	7	guzik	guzik	NOUN
amwa-13	30	8	et	et	NOUN
amwa-13	31	1	al17	al17	PROPN
amwa-13	31	2	and	and	CCONJ
amwa-13	31	3	atri	atri	PROPN
amwa-13	31	4	et	et	PROPN
amwa-13	31	5	al.16	al.16	PROPN
amwa-13	31	6	ashd	ashd	PROPN
amwa-13	31	7	,	,	PUNCT
amwa-13	31	8	arteriosclerotic	arteriosclerotic	ADJ
amwa-13	31	9	heart	heart	NOUN
amwa-13	31	10	disease	disease	NOUN
amwa-13	31	11	.	.	PUNCT
amwa-13	32	1	figure	figure	NOUN
amwa-13	32	2	2	2	NUM
amwa-13	32	3	.	.	PUNCT
amwa-13	33	1	the	the	DET
amwa-13	33	2	renin	renin	ADJ
amwa-13	33	3	–	–	PUNCT
amwa-13	33	4	angiotensin	angiotensin	NOUN
amwa-13	33	5	system	system	NOUN
amwa-13	33	6	(	(	PUNCT
amwa-13	33	7	ras	ras	NOUN
amwa-13	33	8	)	)	PUNCT
amwa-13	33	9	pathway	pathway	NOUN
amwa-13	33	10	and	and	CCONJ
amwa-13	33	11	sites	site	NOUN
amwa-13	33	12	of	of	ADP
amwa-13	33	13	angiotensin	angiotensin	NOUN
amwa-13	33	14	-	-	PUNCT
amwa-13	33	15	converting	convert	VERB
amwa-13	33	16	enzyme	enzyme	NOUN
amwa-13	33	17	(	(	PUNCT
amwa-13	33	18	ace	ace	NOUN
amwa-13	33	19	)	)	PUNCT
amwa-13	33	20	inhibitor	inhibitor	NOUN
amwa-13	33	21	(	(	PUNCT
amwa-13	33	22	acei	acei	NOUN
amwa-13	33	23	)	)	PUNCT
amwa-13	33	24	and	and	CCONJ
amwa-13	33	25	angiotensin	angiotensin	NOUN
amwa-13	33	26	receptor	receptor	NOUN
amwa-13	33	27	blocker	blocker	NOUN
amwa-13	33	28	(	(	PUNCT
amwa-13	33	29	arb	arb	NOUN
amwa-13	33	30	)	)	PUNCT
amwa-13	33	31	inhibition	inhibition	NOUN
amwa-13	33	32	.	.	PUNCT
amwa-13	34	1	in	in	ADP
amwa-13	34	2	the	the	DET
amwa-13	34	3	ras	ras	PROPN
amwa-13	34	4	pathway	pathway	NOUN
amwa-13	34	5	,	,	PUNCT
amwa-13	34	6	renin	renin	ADJ
amwa-13	34	7	(	(	PUNCT
amwa-13	34	8	produced	produce	VERB
amwa-13	34	9	by	by	ADP
amwa-13	34	10	the	the	DET
amwa-13	34	11	kidneys	kidney	NOUN
amwa-13	34	12	)	)	PUNCT
amwa-13	34	13	converts	convert	NOUN
amwa-13	34	14	angiotensinogen	angiotensinogen	NOUN
amwa-13	34	15	(	(	PUNCT
amwa-13	34	16	produced	produce	VERB
amwa-13	34	17	by	by	ADP
amwa-13	34	18	the	the	DET
amwa-13	34	19	liver	liver	NOUN
amwa-13	34	20	)	)	PUNCT
amwa-13	34	21	into	into	ADP
amwa-13	34	22	angiotensin	angiotensin	NOUN
amwa-13	34	23	i.	i.	PROPN
amwa-13	34	24	angiotensin	angiotensin	PROPN
amwa-13	34	25	i	i	PRON
amwa-13	34	26	is	be	AUX
amwa-13	34	27	modified	modify	VERB
amwa-13	34	28	into	into	ADP
amwa-13	34	29	angiotensin	angiotensin	PROPN
amwa-13	34	30	ii	ii	PROPN
amwa-13	34	31	,	,	PUNCT
amwa-13	34	32	an	an	DET
amwa-13	34	33	active	active	ADJ
amwa-13	34	34	vasoconstrictor	vasoconstrictor	NOUN
amwa-13	34	35	,	,	PUNCT
amwa-13	34	36	by	by	ADP
amwa-13	34	37	ace1	ace1	PROPN
amwa-13	34	38	.	.	PUNCT
amwa-13	35	1	ace2	ace2	PROPN
amwa-13	35	2	(	(	PUNCT
amwa-13	35	3	the	the	DET
amwa-13	35	4	target	target	NOUN
amwa-13	35	5	for	for	ADP
amwa-13	35	6	sars	sar	NOUN
amwa-13	35	7	-	-	PUNCT
amwa-13	35	8	cov-2	cov-2	PART
amwa-13	35	9	infection	infection	NOUN
amwa-13	35	10	)	)	PUNCT
amwa-13	35	11	produces	produce	VERB
amwa-13	35	12	the	the	DET
amwa-13	35	13	vasodilator	vasodilator	NOUN
amwa-13	35	14	angiotensin	angiotensin	NOUN
amwa-13	35	15	(	(	PUNCT
amwa-13	35	16	1	1	NUM
amwa-13	35	17	-	-	SYM
amwa-13	35	18	7	7	NUM
amwa-13	35	19	)	)	PUNCT
amwa-13	35	20	from	from	ADP
amwa-13	35	21	angiotensin	angiotensin	PROPN
amwa-13	35	22	ii	ii	PROPN
amwa-13	35	23	.	.	PUNCT
amwa-13	36	1	the	the	DET
amwa-13	36	2	acei	acei	NOUN
amwa-13	36	3	and	and	CCONJ
amwa-13	36	4	arb	arb	PRON
amwa-13	36	5	high	high	ADJ
amwa-13	36	6	-	-	PUNCT
amwa-13	36	7	blood	blood	NOUN
amwa-13	36	8	-	-	PUNCT
amwa-13	36	9	pressure	pressure	NOUN
amwa-13	36	10	medications	medication	NOUN
amwa-13	36	11	work	work	NOUN
amwa-13	36	12	by	by	ADP
amwa-13	36	13	preventing	prevent	VERB
amwa-13	36	14	vasoconstriction	vasoconstriction	NOUN
amwa-13	36	15	.	.	PUNCT
amwa-13	37	1	they	they	PRON
amwa-13	37	2	inhibit	inhibit	VERB
amwa-13	37	3	ace1	ace1	PROPN
amwa-13	37	4	and	and	CCONJ
amwa-13	37	5	binding	binding	NOUN
amwa-13	37	6	of	of	ADP
amwa-13	37	7	angiotensin	angiotensin	PROPN
amwa-13	37	8	ii	ii	PROPN
amwa-13	37	9	to	to	ADP
amwa-13	37	10	its	its	PRON
amwa-13	37	11	receptors	receptor	NOUN
amwa-13	37	12	,	,	PUNCT
amwa-13	37	13	respectively	respectively	ADV
amwa-13	37	14	.	.	PUNCT
amwa-13	38	1	74	74	NUM
amwa-13	38	2	amwa	amwa	PROPN
amwa-13	38	3	journal	journal	PROPN
amwa-13	38	4	/	/	SYM
amwa-13	38	5	v36	v36	PROPN
amwa-13	38	6	n2	n2	PROPN
amwa-13	38	7	/	/	SYM
amwa-13	38	8	2021	2021	NUM
amwa-13	38	9	/	/	SYM
amwa-13	38	10	amwa.org	amwa.org	X
amwa-13	38	11	cells.31	cells.31	PROPN
amwa-13	38	12	-	-	PUNCT
amwa-13	38	13	33	33	NUM
amwa-13	38	14	without	without	ADP
amwa-13	38	15	ace2	ace2	NOUN
amwa-13	38	16	,	,	PUNCT
amwa-13	38	17	levels	level	NOUN
amwa-13	38	18	of	of	ADP
amwa-13	38	19	angiotensin	angiotensin	NOUN
amwa-13	38	20	(	(	PUNCT
amwa-13	38	21	1	1	NUM
amwa-13	38	22	-	-	SYM
amwa-13	38	23	7	7	NUM
amwa-13	38	24	)	)	PUNCT
amwa-13	38	25	would	would	AUX
amwa-13	38	26	decrease	decrease	VERB
amwa-13	38	27	,	,	PUNCT
amwa-13	38	28	and	and	CCONJ
amwa-13	38	29	angiotensin	angiotensin	PROPN
amwa-13	38	30	ii	ii	PROPN
amwa-13	38	31	levels	level	NOUN
amwa-13	38	32	would	would	AUX
amwa-13	38	33	likely	likely	ADV
amwa-13	38	34	increase	increase	VERB
amwa-13	38	35	.	.	PUNCT
amwa-13	39	1	these	these	DET
amwa-13	39	2	events	event	NOUN
amwa-13	39	3	would	would	AUX
amwa-13	39	4	tip	tip	VERB
amwa-13	39	5	the	the	DET
amwa-13	39	6	scales	scale	NOUN
amwa-13	39	7	toward	toward	ADP
amwa-13	39	8	vasoconstriction	vasoconstriction	NOUN
amwa-13	39	9	and	and	CCONJ
amwa-13	39	10	elevated	elevated	ADJ
amwa-13	39	11	blood	blood	NOUN
amwa-13	39	12	pressure	pressure	NOUN
amwa-13	39	13	.	.	PUNCT
amwa-13	40	1	this	this	DET
amwa-13	40	2	mechanistic	mechanistic	ADJ
amwa-13	40	3	explanation	explanation	NOUN
amwa-13	40	4	for	for	ADP
amwa-13	40	5	hypertension	hypertension	NOUN
amwa-13	40	6	,	,	PUNCT
amwa-13	40	7	although	although	SCONJ
amwa-13	40	8	plausible	plausible	ADJ
amwa-13	40	9	,	,	PUNCT
amwa-13	40	10	needs	need	VERB
amwa-13	40	11	to	to	PART
amwa-13	40	12	be	be	AUX
amwa-13	40	13	strengthened	strengthen	VERB
amwa-13	40	14	with	with	ADP
amwa-13	40	15	additional	additional	ADJ
amwa-13	40	16	research	research	NOUN
amwa-13	40	17	.	.	PUNCT
amwa-13	41	1	another	another	DET
amwa-13	41	2	explanation	explanation	NOUN
amwa-13	41	3	for	for	ADP
amwa-13	41	4	hypertension	hypertension	NOUN
amwa-13	41	5	development	development	NOUN
amwa-13	41	6	in	in	ADP
amwa-13	41	7	patients	patient	NOUN
amwa-13	41	8	with	with	ADP
amwa-13	41	9	covid-19	covid-19	PROPN
amwa-13	41	10	lies	lie	VERB
amwa-13	41	11	in	in	ADP
amwa-13	41	12	direct	direct	ADJ
amwa-13	41	13	viral	viral	ADJ
amwa-13	41	14	infection	infection	NOUN
amwa-13	41	15	of	of	ADP
amwa-13	41	16	ecs	ecs	PROPN
amwa-13	41	17	and	and	CCONJ
amwa-13	41	18	perhaps	perhaps	ADV
amwa-13	41	19	pericytes	pericyte	NOUN
amwa-13	41	20	.	.	PUNCT
amwa-13	42	1	both	both	PRON
amwa-13	42	2	of	of	ADP
amwa-13	42	3	these	these	DET
amwa-13	42	4	cell	cell	NOUN
amwa-13	42	5	types	type	NOUN
amwa-13	42	6	impact	impact	VERB
amwa-13	42	7	blood	blood	NOUN
amwa-13	42	8	vessel	vessel	NOUN
amwa-13	42	9	diameter	diameter	NOUN
amwa-13	42	10	(	(	PUNCT
amwa-13	42	11	figure	figure	VERB
amwa-13	42	12	1).34	1).34	NUM
amwa-13	42	13	-	-	SYM
amwa-13	42	14	36	36	NUM
amwa-13	42	15	a	a	DET
amwa-13	42	16	deficit	deficit	NOUN
amwa-13	42	17	of	of	ADP
amwa-13	42	18	vasodilation	vasodilation	NOUN
amwa-13	42	19	or	or	CCONJ
amwa-13	42	20	a	a	DET
amwa-13	42	21	prevalence	prevalence	NOUN
amwa-13	42	22	of	of	ADP
amwa-13	42	23	vasoconstriction	vasoconstriction	NOUN
amwa-13	42	24	likely	likely	ADV
amwa-13	42	25	causes	cause	VERB
amwa-13	42	26	hypertension	hypertension	NOUN
amwa-13	42	27	.	.	PUNCT
amwa-13	43	1	some	some	DET
amwa-13	43	2	patients	patient	NOUN
amwa-13	43	3	with	with	ADP
amwa-13	43	4	covid-19	covid-19	PROPN
amwa-13	43	5	develop	develop	VERB
amwa-13	43	6	low	low	ADJ
amwa-13	43	7	blood	blood	NOUN
amwa-13	43	8	pressure	pressure	NOUN
amwa-13	43	9	(	(	PUNCT
amwa-13	43	10	hypotension	hypotension	NOUN
amwa-13	43	11	)	)	PUNCT
amwa-13	43	12	rather	rather	ADV
amwa-13	43	13	than	than	ADP
amwa-13	43	14	high	high	ADJ
amwa-13	43	15	blood	blood	NOUN
amwa-13	43	16	pressure.22	pressure.22	NOUN
amwa-13	43	17	hypotension	hypotension	NOUN
amwa-13	43	18	is	be	AUX
amwa-13	43	19	a	a	DET
amwa-13	43	20	symptom	symptom	NOUN
amwa-13	43	21	of	of	ADP
amwa-13	43	22	acute	acute	ADJ
amwa-13	43	23	respiratory	respiratory	ADJ
amwa-13	43	24	distress	distress	NOUN
amwa-13	43	25	syndrome	syndrome	NOUN
amwa-13	43	26	(	(	PUNCT
amwa-13	43	27	ards),37	ards),37	VERB
amwa-13	43	28	so	so	ADV
amwa-13	43	29	it	it	PRON
amwa-13	43	30	is	be	AUX
amwa-13	43	31	likely	likely	ADJ
amwa-13	43	32	the	the	DET
amwa-13	43	33	result	result	NOUN
amwa-13	43	34	of	of	ADP
amwa-13	43	35	sars	sar	NOUN
amwa-13	43	36	-	-	PUNCT
amwa-13	43	37	cov-2	cov-2	PART
amwa-13	43	38	infection	infection	NOUN
amwa-13	43	39	of	of	ADP
amwa-13	43	40	lung	lung	NOUN
amwa-13	43	41	cells	cell	NOUN
amwa-13	43	42	.	.	PUNCT
amwa-13	44	1	thrombi	thrombi	NOUN
amwa-13	44	2	formation	formation	NOUN
amwa-13	44	3	and	and	CCONJ
amwa-13	44	4	hypoxia	hypoxia	VERB
amwa-13	44	5	another	another	DET
amwa-13	44	6	blood	blood	NOUN
amwa-13	44	7	-	-	PUNCT
amwa-13	44	8	related	relate	VERB
amwa-13	44	9	condition	condition	NOUN
amwa-13	44	10	found	find	VERB
amwa-13	44	11	in	in	ADP
amwa-13	44	12	some	some	DET
amwa-13	44	13	patients	patient	NOUN
amwa-13	44	14	with	with	ADP
amwa-13	44	15	covid-19	covid-19	PROPN
amwa-13	44	16	is	be	AUX
amwa-13	44	17	the	the	DET
amwa-13	44	18	presence	presence	NOUN
amwa-13	44	19	of	of	ADP
amwa-13	44	20	thrombi.23	thrombi.23	PROPN
amwa-13	44	21	-	-	NOUN
amwa-13	44	22	25	25	NUM
amwa-13	44	23	these	these	DET
amwa-13	44	24	abnormal	abnormal	ADJ
amwa-13	44	25	blood	blood	NOUN
amwa-13	44	26	clots	clot	NOUN
amwa-13	44	27	form	form	NOUN
amwa-13	44	28	in	in	ADP
amwa-13	44	29	arteries	artery	NOUN
amwa-13	44	30	or	or	CCONJ
amwa-13	44	31	veins	vein	NOUN
amwa-13	44	32	.	.	PUNCT
amwa-13	45	1	interference	interference	NOUN
amwa-13	45	2	of	of	ADP
amwa-13	45	3	arterial	arterial	ADJ
amwa-13	45	4	blood	blood	NOUN
amwa-13	45	5	flow	flow	NOUN
amwa-13	45	6	jeopardizes	jeopardize	VERB
amwa-13	45	7	delivery	delivery	NOUN
amwa-13	45	8	of	of	ADP
amwa-13	45	9	o2	o2	PROPN
amwa-13	45	10	and	and	CCONJ
amwa-13	45	11	nutrients	nutrient	NOUN
amwa-13	45	12	to	to	ADP
amwa-13	45	13	areas	area	NOUN
amwa-13	45	14	downstream	downstream	ADV
amwa-13	45	15	of	of	ADP
amwa-13	45	16	the	the	DET
amwa-13	45	17	blockage	blockage	NOUN
amwa-13	45	18	,	,	PUNCT
amwa-13	45	19	whereas	whereas	SCONJ
amwa-13	45	20	impedance	impedance	NOUN
amwa-13	45	21	of	of	ADP
amwa-13	45	22	blood	blood	NOUN
amwa-13	45	23	flow	flow	NOUN
amwa-13	45	24	through	through	ADP
amwa-13	45	25	a	a	DET
amwa-13	45	26	vein	vein	NOUN
amwa-13	45	27	may	may	AUX
amwa-13	45	28	cause	cause	VERB
amwa-13	45	29	swelling	swell	VERB
amwa-13	45	30	in	in	ADP
amwa-13	45	31	the	the	DET
amwa-13	45	32	body	body	NOUN
amwa-13	45	33	upstream	upstream	NOUN
amwa-13	45	34	of	of	ADP
amwa-13	45	35	the	the	DET
amwa-13	45	36	clot	clot	NOUN
amwa-13	45	37	.	.	PUNCT
amwa-13	46	1	besides	besides	SCONJ
amwa-13	46	2	blood	blood	NOUN
amwa-13	46	3	-	-	PUNCT
amwa-13	46	4	flow	flow	NOUN
amwa-13	46	5	alteration	alteration	NOUN
amwa-13	46	6	,	,	PUNCT
amwa-13	46	7	thrombi	thrombi	NOUN
amwa-13	46	8	pose	pose	VERB
amwa-13	46	9	an	an	DET
amwa-13	46	10	additional	additional	ADJ
amwa-13	46	11	risk	risk	NOUN
amwa-13	46	12	to	to	ADP
amwa-13	46	13	patients	patient	NOUN
amwa-13	46	14	:	:	PUNCT
amwa-13	46	15	pieces	piece	NOUN
amwa-13	46	16	may	may	AUX
amwa-13	46	17	break	break	VERB
amwa-13	46	18	off	off	ADP
amwa-13	46	19	the	the	DET
amwa-13	46	20	clot	clot	NOUN
amwa-13	46	21	,	,	PUNCT
amwa-13	46	22	travel	travel	VERB
amwa-13	46	23	through	through	ADP
amwa-13	46	24	the	the	DET
amwa-13	46	25	bloodstream	bloodstream	NOUN
amwa-13	46	26	,	,	PUNCT
amwa-13	46	27	and	and	CCONJ
amwa-13	46	28	lodge	lodge	NOUN
amwa-13	46	29	in	in	ADP
amwa-13	46	30	another	another	DET
amwa-13	46	31	blood	blood	NOUN
amwa-13	46	32	vessel	vessel	NOUN
amwa-13	46	33	.	.	PUNCT
amwa-13	47	1	these	these	DET
amwa-13	47	2	traveling	travel	VERB
amwa-13	47	3	clots	clot	NOUN
amwa-13	47	4	(	(	PUNCT
amwa-13	47	5	emboli	emboli	X
amwa-13	47	6	)	)	PUNCT
amwa-13	47	7	endanger	endanger	VERB
amwa-13	47	8	other	other	ADJ
amwa-13	47	9	organs	organ	NOUN
amwa-13	47	10	.	.	PUNCT
amwa-13	48	1	when	when	SCONJ
amwa-13	48	2	an	an	DET
amwa-13	48	3	embolus	embolus	NOUN
amwa-13	48	4	in	in	ADP
amwa-13	48	5	a	a	DET
amwa-13	48	6	large	large	ADJ
amwa-13	48	7	systemic	systemic	ADJ
amwa-13	48	8	artery	artery	NOUN
amwa-13	48	9	flows	flow	VERB
amwa-13	48	10	to	to	ADP
amwa-13	48	11	a	a	DET
amwa-13	48	12	narrower	narrow	ADJ
amwa-13	48	13	artery	artery	NOUN
amwa-13	48	14	within	within	ADP
amwa-13	48	15	an	an	DET
amwa-13	48	16	organ	organ	NOUN
amwa-13	48	17	,	,	PUNCT
amwa-13	48	18	it	it	PRON
amwa-13	48	19	may	may	AUX
amwa-13	48	20	get	get	AUX
amwa-13	48	21	stuck	stick	VERB
amwa-13	48	22	,	,	PUNCT
amwa-13	48	23	hinder	hinder	VERB
amwa-13	48	24	blood	blood	NOUN
amwa-13	48	25	flow	flow	NOUN
amwa-13	48	26	,	,	PUNCT
amwa-13	48	27	and	and	CCONJ
amwa-13	48	28	deprive	deprive	VERB
amwa-13	48	29	downstream	downstream	ADJ
amwa-13	48	30	organs	organ	NOUN
amwa-13	48	31	—	—	PUNCT
amwa-13	48	32	or	or	CCONJ
amwa-13	48	33	areas	area	NOUN
amwa-13	48	34	within	within	ADP
amwa-13	48	35	an	an	DET
amwa-13	48	36	organ	organ	NOUN
amwa-13	48	37	—	—	PUNCT
amwa-13	48	38	of	of	ADP
amwa-13	48	39	o2	o2	PROPN
amwa-13	48	40	.	.	PROPN
amwa-13	48	41	emboli	emboli	PROPN
amwa-13	48	42	in	in	ADP
amwa-13	48	43	veins	vein	NOUN
amwa-13	48	44	pose	pose	VERB
amwa-13	48	45	a	a	DET
amwa-13	48	46	significant	significant	ADJ
amwa-13	48	47	risk	risk	NOUN
amwa-13	48	48	to	to	ADP
amwa-13	48	49	the	the	DET
amwa-13	48	50	lungs	lung	NOUN
amwa-13	48	51	.	.	PUNCT
amwa-13	49	1	such	such	ADJ
amwa-13	49	2	emboli	emboli	NOUN
amwa-13	49	3	could	could	AUX
amwa-13	49	4	migrate	migrate	VERB
amwa-13	49	5	through	through	ADP
amwa-13	49	6	the	the	DET
amwa-13	49	7	right	right	ADJ
amwa-13	49	8	heart	heart	NOUN
amwa-13	49	9	chambers	chamber	NOUN
amwa-13	49	10	,	,	PUNCT
amwa-13	49	11	lodge	lodge	NOUN
amwa-13	49	12	in	in	ADP
amwa-13	49	13	the	the	DET
amwa-13	49	14	lungs	lung	NOUN
amwa-13	49	15	’	'	PUNCT
amwa-13	49	16	narrow	narrow	ADJ
amwa-13	49	17	arterial	arterial	ADJ
amwa-13	49	18	branches	branch	NOUN
amwa-13	49	19	,	,	PUNCT
amwa-13	49	20	and	and	CCONJ
amwa-13	49	21	impede	impede	VERB
amwa-13	49	22	blood	blood	NOUN
amwa-13	49	23	flow	flow	NOUN
amwa-13	49	24	to	to	ADP
amwa-13	49	25	the	the	DET
amwa-13	49	26	pulmonary	pulmonary	ADJ
amwa-13	49	27	capillaries	capillary	NOUN
amwa-13	49	28	.	.	PUNCT
amwa-13	50	1	complications	complication	NOUN
amwa-13	50	2	of	of	ADP
amwa-13	50	3	pulmonary	pulmonary	ADJ
amwa-13	50	4	emboli	embolus	NOUN
amwa-13	50	5	include	include	VERB
amwa-13	50	6	right	right	ADJ
amwa-13	50	7	ventricular	ventricular	ADJ
amwa-13	50	8	hypertrophy	hypertrophy	NOUN
amwa-13	50	9	,	,	PUNCT
amwa-13	50	10	swelling	swell	VERB
amwa-13	50	11	(	(	PUNCT
amwa-13	50	12	edema	edema	NOUN
amwa-13	50	13	)	)	PUNCT
amwa-13	50	14	,	,	PUNCT
amwa-13	50	15	and	and	CCONJ
amwa-13	50	16	low	low	ADJ
amwa-13	50	17	o2	o2	ADJ
amwa-13	50	18	levels	level	NOUN
amwa-13	50	19	in	in	ADP
amwa-13	50	20	the	the	DET
amwa-13	50	21	blood	blood	NOUN
amwa-13	50	22	(	(	PUNCT
amwa-13	50	23	hypoxia	hypoxia	NOUN
amwa-13	50	24	)	)	PUNCT
amwa-13	50	25	(	(	PUNCT
amwa-13	50	26	figure	figure	NOUN
amwa-13	50	27	1	1	NUM
amwa-13	50	28	)	)	PUNCT
amwa-13	50	29	.	.	PUNCT
amwa-13	51	1	right	right	ADJ
amwa-13	51	2	ventricular	ventricular	ADJ
amwa-13	51	3	hypertrophy	hypertrophy	NOUN
amwa-13	51	4	and	and	CCONJ
amwa-13	51	5	edema	edema	NOUN
amwa-13	51	6	are	be	AUX
amwa-13	51	7	indirect	indirect	ADJ
amwa-13	51	8	effects	effect	NOUN
amwa-13	51	9	of	of	ADP
amwa-13	51	10	a	a	DET
amwa-13	51	11	pulmonary	pulmonary	ADJ
amwa-13	51	12	embolism	embolism	NOUN
amwa-13	51	13	.	.	PUNCT
amwa-13	52	1	to	to	PART
amwa-13	52	2	force	force	VERB
amwa-13	52	3	blood	blood	NOUN
amwa-13	52	4	past	past	ADP
amwa-13	52	5	the	the	DET
amwa-13	52	6	pulmonary	pulmonary	ADJ
amwa-13	52	7	embolism	embolism	NOUN
amwa-13	52	8	,	,	PUNCT
amwa-13	52	9	the	the	DET
amwa-13	52	10	heart	heart	NOUN
amwa-13	52	11	’s	’s	PART
amwa-13	52	12	right	right	ADJ
amwa-13	52	13	ventricle	ventricle	NOUN
amwa-13	52	14	hypertrophies	hypertrophy	NOUN
amwa-13	52	15	in	in	ADP
amwa-13	52	16	an	an	DET
amwa-13	52	17	attempt	attempt	NOUN
amwa-13	52	18	to	to	PART
amwa-13	52	19	strengthen	strengthen	VERB
amwa-13	52	20	its	its	PRON
amwa-13	52	21	pumping	pumping	NOUN
amwa-13	52	22	power	power	NOUN
amwa-13	52	23	.	.	PUNCT
amwa-13	53	1	at	at	ADP
amwa-13	53	2	best	well	ADV
amwa-13	53	3	,	,	PUNCT
amwa-13	53	4	this	this	DET
amwa-13	53	5	adjustment	adjustment	NOUN
amwa-13	53	6	is	be	AUX
amwa-13	53	7	a	a	DET
amwa-13	53	8	temporary	temporary	ADJ
amwa-13	53	9	fix	fix	NOUN
amwa-13	53	10	.	.	PUNCT
amwa-13	54	1	persistence	persistence	NOUN
amwa-13	54	2	of	of	ADP
amwa-13	54	3	the	the	DET
amwa-13	54	4	embolism	embolism	NOUN
amwa-13	54	5	increases	increase	VERB
amwa-13	54	6	blood	blood	NOUN
amwa-13	54	7	pressure	pressure	NOUN
amwa-13	54	8	in	in	ADP
amwa-13	54	9	the	the	DET
amwa-13	54	10	right	right	ADJ
amwa-13	54	11	side	side	NOUN
amwa-13	54	12	of	of	ADP
amwa-13	54	13	heart	heart	NOUN
amwa-13	54	14	,	,	PUNCT
amwa-13	54	15	and	and	CCONJ
amwa-13	54	16	by	by	ADP
amwa-13	54	17	extension	extension	NOUN
amwa-13	54	18	,	,	PUNCT
amwa-13	54	19	in	in	ADP
amwa-13	54	20	the	the	DET
amwa-13	54	21	body	body	NOUN
amwa-13	54	22	’s	’s	PART
amwa-13	54	23	veins	vein	NOUN
amwa-13	54	24	.	.	PUNCT
amwa-13	55	1	this	this	DET
amwa-13	55	2	elevated	elevated	ADJ
amwa-13	55	3	vascular	vascular	ADJ
amwa-13	55	4	pressure	pressure	NOUN
amwa-13	55	5	induces	induce	VERB
amwa-13	55	6	edema	edema	NOUN
amwa-13	55	7	.	.	PUNCT
amwa-13	56	1	gravity	gravity	NOUN
amwa-13	56	2	causes	cause	VERB
amwa-13	56	3	the	the	DET
amwa-13	56	4	swelling	swelling	NOUN
amwa-13	56	5	to	to	PART
amwa-13	56	6	be	be	AUX
amwa-13	56	7	most	most	ADV
amwa-13	56	8	prominent	prominent	ADJ
amwa-13	56	9	in	in	ADP
amwa-13	56	10	the	the	DET
amwa-13	56	11	lower	low	ADJ
amwa-13	56	12	limbs	limb	NOUN
amwa-13	56	13	.	.	PUNCT
amwa-13	57	1	such	such	ADJ
amwa-13	57	2	edema	edema	PROPN
amwa-13	57	3	also	also	ADV
amwa-13	57	4	occurs	occur	VERB
amwa-13	57	5	in	in	ADP
amwa-13	57	6	the	the	DET
amwa-13	57	7	lungs	lung	NOUN
amwa-13	57	8	.	.	PUNCT
amwa-13	58	1	this	this	DET
amwa-13	58	2	fluid	fluid	ADJ
amwa-13	58	3	buildup	buildup	NOUN
amwa-13	58	4	impedes	impede	VERB
amwa-13	58	5	the	the	DET
amwa-13	58	6	diffusion	diffusion	NOUN
amwa-13	58	7	of	of	ADP
amwa-13	58	8	o2	o2	PROPN
amwa-13	58	9	from	from	ADP
amwa-13	58	10	the	the	DET
amwa-13	58	11	lungs	lung	NOUN
amwa-13	58	12	’	'	PUNCT
amwa-13	58	13	alveoli	alveoli	NOUN
amwa-13	58	14	to	to	ADP
amwa-13	58	15	the	the	DET
amwa-13	58	16	blood	blood	NOUN
amwa-13	58	17	in	in	ADP
amwa-13	58	18	the	the	DET
amwa-13	58	19	pulmonary	pulmonary	ADJ
amwa-13	58	20	capillaries	capillary	NOUN
amwa-13	58	21	.	.	PUNCT
amwa-13	59	1	it	it	PRON
amwa-13	59	2	also	also	ADV
amwa-13	59	3	reduces	reduce	VERB
amwa-13	59	4	alveolar	alveolar	ADJ
amwa-13	59	5	ventilation	ventilation	NOUN
amwa-13	59	6	(	(	PUNCT
amwa-13	59	7	o2	o2	ADJ
amwa-13	59	8	entry	entry	NOUN
amwa-13	59	9	into	into	ADP
amwa-13	59	10	the	the	DET
amwa-13	59	11	alveoli	alveoli	NOUN
amwa-13	59	12	)	)	PUNCT
amwa-13	59	13	,	,	PUNCT
amwa-13	59	14	as	as	SCONJ
amwa-13	59	15	fluid	fluid	NOUN
amwa-13	59	16	-	-	PUNCT
amwa-13	59	17	filled	fill	VERB
amwa-13	59	18	sacs	sac	NOUN
amwa-13	59	19	fail	fail	VERB
amwa-13	59	20	to	to	PART
amwa-13	59	21	remain	remain	VERB
amwa-13	59	22	open	open	ADJ
amwa-13	59	23	.	.	PUNCT
amwa-13	60	1	diminished	diminish	VERB
amwa-13	60	2	blood	blood	NOUN
amwa-13	60	3	flow	flow	NOUN
amwa-13	60	4	to	to	ADP
amwa-13	60	5	alveoli	alveoli	NOUN
amwa-13	60	6	on	on	ADP
amwa-13	60	7	account	account	NOUN
amwa-13	60	8	of	of	ADP
amwa-13	60	9	pulmonary	pulmonary	ADJ
amwa-13	60	10	emboli	emboli	NOUN
amwa-13	60	11	may	may	AUX
amwa-13	60	12	also	also	ADV
amwa-13	60	13	prevent	prevent	VERB
amwa-13	60	14	the	the	DET
amwa-13	60	15	blood	blood	NOUN
amwa-13	60	16	from	from	ADP
amwa-13	60	17	picking	pick	VERB
amwa-13	60	18	up	up	ADP
amwa-13	60	19	adequate	adequate	ADJ
amwa-13	60	20	o2	o2	PROPN
amwa-13	60	21	.	.	PUNCT
amwa-13	61	1	collectively	collectively	ADV
amwa-13	61	2	,	,	PUNCT
amwa-13	61	3	these	these	DET
amwa-13	61	4	emboli	emboli	ADV
amwa-13	61	5	-	-	PUNCT
amwa-13	61	6	initiated	initiate	VERB
amwa-13	61	7	events	event	NOUN
amwa-13	61	8	cause	cause	VERB
amwa-13	61	9	hypoxia	hypoxia	NOUN
amwa-13	61	10	.	.	PUNCT
amwa-13	62	1	two	two	NUM
amwa-13	62	2	culprits	culprit	NOUN
amwa-13	62	3	induce	induce	VERB
amwa-13	62	4	thrombi	thrombi	NOUN
amwa-13	62	5	formation	formation	NOUN
amwa-13	62	6	:	:	PUNCT
amwa-13	62	7	injured	injure	VERB
amwa-13	62	8	ecs	ec	NOUN
amwa-13	62	9	and	and	CCONJ
amwa-13	62	10	pro	pro	ADJ
amwa-13	62	11	-	-	ADJ
amwa-13	62	12	inflammatory	inflammatory	ADJ
amwa-13	62	13	chemicals	chemical	NOUN
amwa-13	62	14	(	(	PUNCT
amwa-13	62	15	figure	figure	NOUN
amwa-13	62	16	1	1	NUM
amwa-13	62	17	)	)	PUNCT
amwa-13	62	18	.	.	PUNCT
amwa-13	63	1	ecs	ecs	PROPN
amwa-13	63	2	may	may	AUX
amwa-13	63	3	be	be	AUX
amwa-13	63	4	damaged	damage	VERB
amwa-13	63	5	by	by	ADP
amwa-13	63	6	direct	direct	ADJ
amwa-13	63	7	sars	sar	NOUN
amwa-13	63	8	-	-	PUNCT
amwa-13	63	9	cov-2	cov-2	NOUN
amwa-13	63	10	infection.38	infection.38	NOUN
amwa-13	63	11	such	such	ADJ
amwa-13	63	12	damaged	damage	VERB
amwa-13	63	13	cells	cell	NOUN
amwa-13	63	14	activate	activate	VERB
amwa-13	63	15	platelets	platelet	NOUN
amwa-13	63	16	and	and	CCONJ
amwa-13	63	17	make	make	VERB
amwa-13	63	18	them	they	PRON
amwa-13	63	19	more	more	ADV
amwa-13	63	20	“	"	PUNCT
amwa-13	63	21	sticky	sticky	ADJ
amwa-13	63	22	”	"	PUNCT
amwa-13	63	23	;	;	PUNCT
amwa-13	63	24	thus	thus	ADV
amwa-13	63	25	,	,	PUNCT
amwa-13	63	26	they	they	PRON
amwa-13	63	27	adhere	adhere	VERB
amwa-13	63	28	to	to	ADP
amwa-13	63	29	the	the	DET
amwa-13	63	30	vessel	vessel	NOUN
amwa-13	63	31	wall	wall	NOUN
amwa-13	63	32	and	and	CCONJ
amwa-13	63	33	to	to	ADP
amwa-13	63	34	each	each	DET
amwa-13	63	35	other	other	ADJ
amwa-13	63	36	.	.	PUNCT
amwa-13	64	1	clotting	clot	VERB
amwa-13	64	2	factors	factor	NOUN
amwa-13	64	3	in	in	ADP
amwa-13	64	4	the	the	DET
amwa-13	64	5	blood	blood	NOUN
amwa-13	64	6	set	set	VERB
amwa-13	64	7	off	off	ADP
amwa-13	64	8	a	a	DET
amwa-13	64	9	chain	chain	NOUN
amwa-13	64	10	reaction	reaction	NOUN
amwa-13	64	11	that	that	PRON
amwa-13	64	12	culminates	culminate	VERB
amwa-13	64	13	in	in	ADP
amwa-13	64	14	the	the	DET
amwa-13	64	15	modification	modification	NOUN
amwa-13	64	16	of	of	ADP
amwa-13	64	17	fibrinogen	fibrinogen	NOUN
amwa-13	64	18	to	to	PART
amwa-13	64	19	fibrin	fibrin	VERB
amwa-13	64	20	.	.	PUNCT
amwa-13	65	1	fibrin	fibrin	NOUN
amwa-13	65	2	threads	thread	NOUN
amwa-13	65	3	attach	attach	VERB
amwa-13	65	4	to	to	ADP
amwa-13	65	5	the	the	DET
amwa-13	65	6	mass	mass	NOUN
amwa-13	65	7	of	of	ADP
amwa-13	65	8	platelets	platelet	NOUN
amwa-13	65	9	to	to	PART
amwa-13	65	10	form	form	VERB
amwa-13	65	11	the	the	DET
amwa-13	65	12	clot	clot	NOUN
amwa-13	65	13	.	.	PUNCT
amwa-13	66	1	if	if	SCONJ
amwa-13	66	2	ecs	ecs	PROPN
amwa-13	66	3	are	be	AUX
amwa-13	66	4	undamaged	undamaged	ADJ
amwa-13	66	5	,	,	PUNCT
amwa-13	66	6	a	a	DET
amwa-13	66	7	clot	clot	NOUN
amwa-13	66	8	may	may	AUX
amwa-13	66	9	still	still	ADV
amwa-13	66	10	form	form	VERB
amwa-13	66	11	:	:	PUNCT
amwa-13	66	12	pro	pro	ADJ
amwa-13	66	13	-	-	ADJ
amwa-13	66	14	inflammatory	inflammatory	ADJ
amwa-13	66	15	chemicals	chemical	NOUN
amwa-13	66	16	may	may	AUX
amwa-13	66	17	activate	activate	VERB
amwa-13	66	18	platelets	platelet	NOUN
amwa-13	66	19	and	and	CCONJ
amwa-13	66	20	clotting	clot	VERB
amwa-13	66	21	factors	factor	NOUN
amwa-13	66	22	(	(	PUNCT
amwa-13	66	23	figure	figure	VERB
amwa-13	66	24	1).39	1).39	NUM
amwa-13	66	25	ashd	ashd	PROPN
amwa-13	66	26	,	,	PUNCT
amwa-13	66	27	mis	mi	NOUN
amwa-13	66	28	,	,	PUNCT
amwa-13	66	29	and	and	CCONJ
amwa-13	66	30	arrhythmias	arrhythmias	PROPN
amwa-13	66	31	thrombi	thrombi	NOUN
amwa-13	66	32	may	may	AUX
amwa-13	66	33	form	form	VERB
amwa-13	66	34	in	in	ADP
amwa-13	66	35	the	the	DET
amwa-13	66	36	coronary	coronary	ADJ
amwa-13	66	37	arteries	artery	NOUN
amwa-13	66	38	of	of	ADP
amwa-13	66	39	some	some	DET
amwa-13	66	40	patients	patient	NOUN
amwa-13	66	41	with	with	ADP
amwa-13	66	42	covid-19	covid-19	PROPN
amwa-13	66	43	,	,	PUNCT
amwa-13	66	44	a	a	DET
amwa-13	66	45	condition	condition	NOUN
amwa-13	66	46	known	know	VERB
amwa-13	66	47	as	as	ADP
amwa-13	66	48	ashd.26	ashd.26	ADJ
amwa-13	66	49	-	-	PUNCT
amwa-13	66	50	28	28	NUM
amwa-13	66	51	coronary	coronary	ADJ
amwa-13	66	52	arteries	artery	NOUN
amwa-13	66	53	carry	carry	VERB
amwa-13	66	54	o2	o2	ADJ
amwa-13	66	55	-	-	PUNCT
amwa-13	66	56	rich	rich	ADJ
amwa-13	66	57	blood	blood	NOUN
amwa-13	66	58	to	to	ADP
amwa-13	66	59	the	the	DET
amwa-13	66	60	heart	heart	NOUN
amwa-13	66	61	tissue	tissue	NOUN
amwa-13	66	62	.	.	PUNCT
amwa-13	67	1	such	such	ADJ
amwa-13	67	2	o2	o2	PROPN
amwa-13	67	3	helps	helps	AUX
amwa-13	67	4	fuel	fuel	VERB
amwa-13	67	5	the	the	DET
amwa-13	67	6	heart	heart	NOUN
amwa-13	67	7	’s	’s	PART
amwa-13	67	8	vital	vital	ADJ
amwa-13	67	9	blood	blood	NOUN
amwa-13	67	10	-	-	PUNCT
amwa-13	67	11	pumping	pump	VERB
amwa-13	67	12	actions	action	NOUN
amwa-13	67	13	.	.	PUNCT
amwa-13	68	1	partial	partial	ADJ
amwa-13	68	2	or	or	CCONJ
amwa-13	68	3	complete	complete	ADJ
amwa-13	68	4	blockage	blockage	NOUN
amwa-13	68	5	of	of	ADP
amwa-13	68	6	these	these	DET
amwa-13	68	7	coronary	coronary	ADJ
amwa-13	68	8	vessels	vessel	NOUN
amwa-13	68	9	is	be	AUX
amwa-13	68	10	life	life	NOUN
amwa-13	68	11	-	-	PUNCT
amwa-13	68	12	threatening	threatening	ADJ
amwa-13	68	13	.	.	PUNCT
amwa-13	69	1	whether	whether	SCONJ
amwa-13	69	2	through	through	ADP
amwa-13	69	3	blocked	block	VERB
amwa-13	69	4	delivery	delivery	NOUN
amwa-13	69	5	or	or	CCONJ
amwa-13	69	6	through	through	ADP
amwa-13	69	7	hypoxia	hypoxia	NOUN
amwa-13	69	8	,	,	PUNCT
amwa-13	69	9	insufficient	insufficient	ADJ
amwa-13	69	10	o2	o2	PROPN
amwa-13	69	11	causes	cause	VERB
amwa-13	69	12	heart	heart	NOUN
amwa-13	69	13	muscle	muscle	NOUN
amwa-13	69	14	cells	cell	NOUN
amwa-13	69	15	to	to	ADP
amwa-13	69	16	malfunction	malfunction	NOUN
amwa-13	69	17	and	and	CCONJ
amwa-13	69	18	die	die	VERB
amwa-13	69	19	.	.	PUNCT
amwa-13	70	1	the	the	DET
amwa-13	70	2	likelihood	likelihood	NOUN
amwa-13	70	3	of	of	ADP
amwa-13	70	4	mis	mis	PROPN
amwa-13	70	5	increases	increase	NOUN
amwa-13	70	6	(	(	PUNCT
amwa-13	70	7	figure	figure	NOUN
amwa-13	70	8	1	1	NUM
amwa-13	70	9	)	)	PUNCT
amwa-13	70	10	.	.	PUNCT
amwa-13	71	1	mis	mis	PROPN
amwa-13	71	2	in	in	ADP
amwa-13	71	3	a	a	DET
amwa-13	71	4	small	small	ADJ
amwa-13	71	5	number	number	NOUN
amwa-13	71	6	of	of	ADP
amwa-13	71	7	patients	patient	NOUN
amwa-13	71	8	with	with	ADP
amwa-13	71	9	covid-19	covid-19	PROPN
amwa-13	71	10	have	have	AUX
amwa-13	71	11	been	be	AUX
amwa-13	71	12	reported.26	reported.26	ADJ
amwa-13	71	13	-	-	SYM
amwa-13	71	14	28	28	NUM
amwa-13	71	15	arrhythmias	arrhythmia	NOUN
amwa-13	71	16	have	have	AUX
amwa-13	71	17	also	also	ADV
amwa-13	71	18	been	be	AUX
amwa-13	71	19	reported	report	VERB
amwa-13	71	20	in	in	ADP
amwa-13	71	21	some	some	DET
amwa-13	71	22	patients	patient	NOUN
amwa-13	71	23	with	with	ADP
amwa-13	71	24	covid-19.16,18,29	covid-19.16,18,29	PROPN
amwa-13	71	25	in	in	ADP
amwa-13	71	26	the	the	DET
amwa-13	71	27	general	general	ADJ
amwa-13	71	28	population	population	NOUN
amwa-13	71	29	,	,	PUNCT
amwa-13	71	30	these	these	DET
amwa-13	71	31	altered	alter	VERB
amwa-13	71	32	heart	heart	NOUN
amwa-13	71	33	rhythms	rhythm	NOUN
amwa-13	71	34	are	be	AUX
amwa-13	71	35	caused	cause	VERB
amwa-13	71	36	by	by	ADP
amwa-13	71	37	ashd	ashd	PROPN
amwa-13	71	38	,	,	PUNCT
amwa-13	71	39	mis	mis	PROPN
amwa-13	71	40	,	,	PUNCT
amwa-13	71	41	myocarditis	myocarditis	PROPN
amwa-13	71	42	,	,	PUNCT
amwa-13	71	43	and	and	CCONJ
amwa-13	71	44	heart	heart	NOUN
amwa-13	71	45	hypertrophy	hypertrophy	NOUN
amwa-13	71	46	.	.	PUNCT
amwa-13	72	1	therefore	therefore	ADV
amwa-13	72	2	,	,	PUNCT
amwa-13	72	3	these	these	DET
amwa-13	72	4	cardiovascular	cardiovascular	ADJ
amwa-13	72	5	conditions	condition	NOUN
amwa-13	72	6	are	be	AUX
amwa-13	72	7	the	the	DET
amwa-13	72	8	current	current	ADJ
amwa-13	72	9	“	"	PUNCT
amwa-13	72	10	suspects	suspect	NOUN
amwa-13	72	11	”	"	PUNCT
amwa-13	72	12	for	for	ADP
amwa-13	72	13	reported	report	VERB
amwa-13	72	14	arrhythmias	arrhythmia	NOUN
amwa-13	72	15	in	in	ADP
amwa-13	72	16	covid-19	covid-19	PROPN
amwa-13	72	17	–	–	PUNCT
amwa-13	72	18	related	relate	VERB
amwa-13	72	19	cases.16,18,29	cases.16,18,29	ADJ
amwa-13	72	20	heart	heart	NOUN
amwa-13	72	21	failure	failure	NOUN
amwa-13	72	22	persistence	persistence	NOUN
amwa-13	72	23	of	of	ADP
amwa-13	72	24	these	these	DET
amwa-13	72	25	aforementioned	aforementione	VERB
amwa-13	72	26	cardiovascular	cardiovascular	ADJ
amwa-13	72	27	problems	problem	NOUN
amwa-13	72	28	gradually	gradually	ADV
amwa-13	72	29	weakens	weaken	VERB
amwa-13	72	30	the	the	DET
amwa-13	72	31	heart	heart	NOUN
amwa-13	72	32	,	,	PUNCT
amwa-13	72	33	compromises	compromise	VERB
amwa-13	72	34	its	its	PRON
amwa-13	72	35	pumping	pumping	NOUN
amwa-13	72	36	ability	ability	NOUN
amwa-13	72	37	and	and	CCONJ
amwa-13	72	38	effectiveness	effectiveness	NOUN
amwa-13	72	39	,	,	PUNCT
amwa-13	72	40	and	and	CCONJ
amwa-13	72	41	can	can	AUX
amwa-13	72	42	lead	lead	VERB
amwa-13	72	43	to	to	ADP
amwa-13	72	44	heart	heart	NOUN
amwa-13	72	45	failure	failure	NOUN
amwa-13	72	46	(	(	PUNCT
amwa-13	72	47	figure	figure	NOUN
amwa-13	72	48	1	1	NUM
amwa-13	72	49	)	)	PUNCT
amwa-13	72	50	.	.	PUNCT
amwa-13	73	1	the	the	DET
amwa-13	73	2	heart	heart	NOUN
amwa-13	73	3	becomes	become	VERB
amwa-13	73	4	progressively	progressively	ADV
amwa-13	73	5	more	more	ADV
amwa-13	73	6	incapable	incapable	ADJ
amwa-13	73	7	of	of	ADP
amwa-13	73	8	delivering	deliver	VERB
amwa-13	73	9	o2	o2	ADJ
amwa-13	73	10	and	and	CCONJ
amwa-13	73	11	nutrient	nutrient	ADJ
amwa-13	73	12	-	-	PUNCT
amwa-13	73	13	rich	rich	ADJ
amwa-13	73	14	blood	blood	NOUN
amwa-13	73	15	to	to	ADP
amwa-13	73	16	the	the	DET
amwa-13	73	17	body	body	NOUN
amwa-13	73	18	.	.	PUNCT
amwa-13	74	1	preexisting	preexist	VERB
amwa-13	74	2	heart	heart	NOUN
amwa-13	74	3	failure	failure	NOUN
amwa-13	74	4	appears	appear	VERB
amwa-13	74	5	to	to	PART
amwa-13	74	6	increase	increase	VERB
amwa-13	74	7	the	the	DET
amwa-13	74	8	likelihood	likelihood	NOUN
amwa-13	74	9	of	of	ADP
amwa-13	74	10	death	death	NOUN
amwa-13	74	11	from	from	ADP
amwa-13	74	12	the	the	DET
amwa-13	74	13	disease	disease	NOUN
amwa-13	74	14	in	in	ADP
amwa-13	74	15	patients	patient	NOUN
amwa-13	74	16	with	with	ADP
amwa-13	74	17	covid-19.40	covid-19.40	PROPN
amwa-13	74	18	preexisting	preexist	VERB
amwa-13	74	19	hypertension	hypertension	NOUN
amwa-13	74	20	,	,	PUNCT
amwa-13	74	21	ashd	ashd	NOUN
amwa-13	74	22	,	,	PUNCT
amwa-13	74	23	arrhythmias	arrhythmias	PROPN
amwa-13	74	24	,	,	PUNCT
amwa-13	74	25	mis	mi	NOUN
amwa-13	74	26	,	,	PUNCT
amwa-13	74	27	and	and	CCONJ
amwa-13	74	28	heart	heart	NOUN
amwa-13	74	29	failure	failure	NOUN
amwa-13	74	30	seem	seem	VERB
amwa-13	74	31	to	to	PART
amwa-13	74	32	increase	increase	VERB
amwa-13	74	33	the	the	DET
amwa-13	74	34	severity	severity	NOUN
amwa-13	74	35	of	of	ADP
amwa-13	74	36	covid-19	covid-19	PROPN
amwa-13	74	37	symptoms	symptom	NOUN
amwa-13	74	38	in	in	ADP
amwa-13	74	39	patients	patient	NOUN
amwa-13	74	40	.	.	PUNCT
amwa-13	75	1	amwa	amwa	PROPN
amwa-13	75	2	journal	journal	PROPN
amwa-13	75	3	/	/	SYM
amwa-13	75	4	v36	v36	PROPN
amwa-13	75	5	n2	n2	PROPN
amwa-13	75	6	/	/	SYM
amwa-13	75	7	2021	2021	NUM
amwa-13	75	8	/	/	SYM
amwa-13	75	9	amwa.org	amwa.org	PROPN
amwa-13	75	10	75	75	NUM
amwa-13	75	11	medications	medication	NOUN
amwa-13	75	12	and	and	CCONJ
amwa-13	75	13	health	health	NOUN
amwa-13	75	14	(	(	PUNCT
amwa-13	75	15	covid-19	covid-19	PROPN
amwa-13	75	16	and	and	CCONJ
amwa-13	75	17	cardiovascular	cardiovascular	ADJ
amwa-13	75	18	)	)	PUNCT
amwa-13	75	19	risks	risk	VERB
amwa-13	75	20	covid-19	covid-19	PROPN
amwa-13	75	21	impacts	impact	VERB
amwa-13	75	22	the	the	DET
amwa-13	75	23	cardiovascular	cardiovascular	ADJ
amwa-13	75	24	system	system	NOUN
amwa-13	75	25	,	,	PUNCT
amwa-13	75	26	but	but	CCONJ
amwa-13	75	27	the	the	DET
amwa-13	75	28	inverse	inverse	NOUN
amwa-13	75	29	may	may	AUX
amwa-13	75	30	also	also	ADV
amwa-13	75	31	be	be	AUX
amwa-13	75	32	true	true	ADJ
amwa-13	75	33	.	.	PUNCT
amwa-13	76	1	percentages	percentage	NOUN
amwa-13	76	2	of	of	ADP
amwa-13	76	3	patients	patient	NOUN
amwa-13	76	4	with	with	ADP
amwa-13	76	5	covid-19	covid-19	PROPN
amwa-13	76	6	and	and	CCONJ
amwa-13	76	7	cardiovascular	cardiovascular	ADJ
amwa-13	76	8	conditions	condition	NOUN
amwa-13	76	9	are	be	AUX
amwa-13	76	10	not	not	PART
amwa-13	76	11	higher	high	ADJ
amwa-13	76	12	than	than	ADP
amwa-13	76	13	the	the	DET
amwa-13	76	14	prevalence	prevalence	NOUN
amwa-13	76	15	of	of	ADP
amwa-13	76	16	these	these	DET
amwa-13	76	17	conditions	condition	NOUN
amwa-13	76	18	in	in	ADP
amwa-13	76	19	the	the	DET
amwa-13	76	20	general	general	ADJ
amwa-13	76	21	population.18	population.18	PROPN
amwa-13	76	22	-	-	PUNCT
amwa-13	76	23	20,40	20,40	VERB
amwa-13	76	24	-	-	SYM
amwa-13	76	25	46	46	NUM
amwa-13	76	26	therefore	therefore	ADV
amwa-13	76	27	,	,	PUNCT
amwa-13	76	28	these	these	DET
amwa-13	76	29	cardiovascular	cardiovascular	ADJ
amwa-13	76	30	illnesses	illness	NOUN
amwa-13	76	31	do	do	AUX
amwa-13	76	32	not	not	PART
amwa-13	76	33	appear	appear	VERB
amwa-13	76	34	to	to	PART
amwa-13	76	35	increase	increase	VERB
amwa-13	76	36	one	one	NUM
amwa-13	76	37	’s	’s	PART
amwa-13	76	38	risk	risk	NOUN
amwa-13	76	39	of	of	ADP
amwa-13	76	40	developing	develop	VERB
amwa-13	76	41	covid-19	covid-19	PROPN
amwa-13	76	42	.	.	PUNCT
amwa-13	77	1	however	however	ADV
amwa-13	77	2	,	,	PUNCT
amwa-13	77	3	preexisting	preexist	VERB
amwa-13	77	4	hypertension,18	hypertension,18	NOUN
amwa-13	77	5	-	-	PUNCT
amwa-13	77	6	20,40,41	20,40,41	NUM
amwa-13	77	7	ashd,18,19,40,41	ashd,18,19,40,41	ADV
amwa-13	77	8	arrhythmias,19,20,41	arrhythmias,19,20,41	PROPN
amwa-13	77	9	mis,20	mis,20	NOUN
amwa-13	77	10	and	and	CCONJ
amwa-13	77	11	heart	heart	NOUN
amwa-13	77	12	failure19,20,41	failure19,20,41	PROPN
amwa-13	77	13	seem	seem	VERB
amwa-13	77	14	to	to	PART
amwa-13	77	15	increase	increase	VERB
amwa-13	77	16	the	the	DET
amwa-13	77	17	severity	severity	NOUN
amwa-13	77	18	of	of	ADP
amwa-13	77	19	covid-19	covid-19	PROPN
amwa-13	77	20	symptoms	symptom	NOUN
amwa-13	77	21	in	in	ADP
amwa-13	77	22	patients	patient	NOUN
amwa-13	77	23	.	.	PUNCT
amwa-13	78	1	this	this	DET
amwa-13	78	2	observation	observation	NOUN
amwa-13	78	3	led	lead	VERB
amwa-13	78	4	scientists	scientist	NOUN
amwa-13	78	5	to	to	PART
amwa-13	78	6	examine	examine	VERB
amwa-13	78	7	whether	whether	SCONJ
amwa-13	78	8	certain	certain	ADJ
amwa-13	78	9	cardiovascularly	cardiovascularly	PROPN
amwa-13	78	10	related	relate	VERB
amwa-13	78	11	medications	medication	NOUN
amwa-13	78	12	alter	alter	NOUN
amwa-13	78	13	patients	patient	NOUN
amwa-13	78	14	’	'	PUNCT
amwa-13	78	15	risk	risk	NOUN
amwa-13	78	16	of	of	ADP
amwa-13	78	17	sars	sar	NOUN
amwa-13	78	18	-	-	PUNCT
amwa-13	78	19	cov-2	cov-2	PART
amwa-13	78	20	infection	infection	NOUN
amwa-13	78	21	and/or	and/or	CCONJ
amwa-13	78	22	covid-19	covid-19	PROPN
amwa-13	78	23	severity	severity	NOUN
amwa-13	78	24	.	.	PUNCT
amwa-13	79	1	(	(	PUNCT
amwa-13	79	2	it	it	PRON
amwa-13	79	3	is	be	AUX
amwa-13	79	4	worth	worth	ADJ
amwa-13	79	5	noting	note	VERB
amwa-13	79	6	that	that	SCONJ
amwa-13	79	7	classifications	classification	NOUN
amwa-13	79	8	of	of	ADP
amwa-13	79	9	“	"	PUNCT
amwa-13	79	10	severity	severity	NOUN
amwa-13	79	11	”	"	PUNCT
amwa-13	79	12	vary	vary	VERB
amwa-13	79	13	among	among	ADP
amwa-13	79	14	studies	study	NOUN
amwa-13	79	15	.	.	PUNCT
amwa-13	80	1	distinctions	distinction	NOUN
amwa-13	80	2	include	include	VERB
amwa-13	80	3	normal	normal	ADJ
amwa-13	80	4	vs	vs	ADP
amwa-13	80	5	high	high	ADJ
amwa-13	80	6	protein	protein	NOUN
amwa-13	80	7	[	[	X
amwa-13	80	8	troponin	troponin	ADJ
amwa-13	80	9	]	]	X
amwa-13	80	10	concentrations	concentration	NOUN
amwa-13	80	11	in	in	ADP
amwa-13	80	12	the	the	DET
amwa-13	80	13	blood	blood	NOUN
amwa-13	80	14	,	,	PUNCT
amwa-13	80	15	nonsevere	nonsevere	X
amwa-13	80	16	vs	vs	ADP
amwa-13	80	17	severe	severe	ADJ
amwa-13	80	18	disease	disease	NOUN
amwa-13	80	19	,	,	PUNCT
amwa-13	80	20	nonhospitalized	nonhospitalize	VERB
amwa-13	80	21	patients	patient	NOUN
amwa-13	80	22	vs	vs	ADP
amwa-13	80	23	hospitalized	hospitalize	VERB
amwa-13	80	24	patients	patient	NOUN
amwa-13	80	25	,	,	PUNCT
amwa-13	80	26	non	non	ADJ
amwa-13	80	27	–	–	ADJ
amwa-13	80	28	intensive	intensive	ADJ
amwa-13	80	29	care	care	NOUN
amwa-13	80	30	unit	unit	NOUN
amwa-13	80	31	[	[	X
amwa-13	80	32	icu	icu	X
amwa-13	80	33	]	]	PUNCT
amwa-13	80	34	patients	patient	NOUN
amwa-13	80	35	vs	vs	ADP
amwa-13	80	36	icu	icu	PROPN
amwa-13	80	37	patients	patient	NOUN
amwa-13	80	38	,	,	PUNCT
amwa-13	80	39	and	and	CCONJ
amwa-13	80	40	survivors	survivor	NOUN
amwa-13	80	41	vs	vs	ADP
amwa-13	80	42	nonsurvivors.17,29	nonsurvivors.17,29	NOUN
amwa-13	80	43	)	)	PUNCT
amwa-13	80	44	ace	ace	VERB
amwa-13	80	45	inhibitors	inhibitor	NOUN
amwa-13	80	46	and	and	CCONJ
amwa-13	80	47	angiotensin	angiotensin	NOUN
amwa-13	80	48	receptor	receptor	NOUN
amwa-13	80	49	blockers	blocker	NOUN
amwa-13	80	50	some	some	DET
amwa-13	80	51	antihypertensive	antihypertensive	ADJ
amwa-13	80	52	medications	medication	NOUN
amwa-13	80	53	are	be	AUX
amwa-13	80	54	the	the	DET
amwa-13	80	55	focus	focus	NOUN
amwa-13	80	56	of	of	ADP
amwa-13	80	57	such	such	ADJ
amwa-13	80	58	research	research	NOUN
amwa-13	80	59	.	.	PUNCT
amwa-13	81	1	many	many	ADJ
amwa-13	81	2	americans	americans	PROPN
amwa-13	81	3	(	(	PUNCT
amwa-13	81	4	13	13	NUM
amwa-13	81	5	%	%	NOUN
amwa-13	81	6	to	to	ADP
amwa-13	81	7	nearly	nearly	ADV
amwa-13	81	8	50	50	NUM
amwa-13	81	9	%	%	NOUN
amwa-13	81	10	,	,	PUNCT
amwa-13	81	11	depending	depend	VERB
amwa-13	81	12	on	on	ADP
amwa-13	81	13	definitions	definition	NOUN
amwa-13	81	14	and	and	CCONJ
amwa-13	81	15	the	the	DET
amwa-13	81	16	data	data	NOUN
amwa-13	81	17	source	source	NOUN
amwa-13	81	18	)	)	PUNCT
amwa-13	81	19	have	have	VERB
amwa-13	81	20	hypertension.42,45,46	hypertension.42,45,46	NOUN
amwa-13	81	21	this	this	DET
amwa-13	81	22	percentage	percentage	NOUN
amwa-13	81	23	increases	increase	VERB
amwa-13	81	24	as	as	ADP
amwa-13	81	25	one	one	NUM
amwa-13	81	26	ages.45	ages.45	NOUN
amwa-13	81	27	to	to	PART
amwa-13	81	28	lower	lower	VERB
amwa-13	81	29	high	high	ADJ
amwa-13	81	30	blood	blood	NOUN
amwa-13	81	31	pressure	pressure	NOUN
amwa-13	81	32	,	,	PUNCT
amwa-13	81	33	physicians	physician	NOUN
amwa-13	81	34	may	may	AUX
amwa-13	81	35	prescribe	prescribe	VERB
amwa-13	81	36	ace	ace	VERB
amwa-13	81	37	inhibitors	inhibitor	NOUN
amwa-13	81	38	(	(	PUNCT
amwa-13	81	39	aceis	aceis	NOUN
amwa-13	81	40	)	)	PUNCT
amwa-13	81	41	and/or	and/or	CCONJ
amwa-13	81	42	angiotensin	angiotensin	NOUN
amwa-13	81	43	receptor	receptor	NOUN
amwa-13	81	44	blockers	blocker	NOUN
amwa-13	81	45	(	(	PUNCT
amwa-13	81	46	arbs	arb	NOUN
amwa-13	81	47	)	)	PUNCT
amwa-13	81	48	.	.	PUNCT
amwa-13	82	1	these	these	DET
amwa-13	82	2	medications	medication	NOUN
amwa-13	82	3	minimize	minimize	VERB
amwa-13	82	4	production	production	NOUN
amwa-13	82	5	of	of	ADP
amwa-13	82	6	angiotensin	angiotensin	PROPN
amwa-13	82	7	ii	ii	PROPN
amwa-13	82	8	and	and	CCONJ
amwa-13	82	9	block	block	PROPN
amwa-13	82	10	angiotensin	angiotensin	PROPN
amwa-13	82	11	ii	ii	PROPN
amwa-13	82	12	’s	’s	PART
amwa-13	82	13	interaction	interaction	NOUN
amwa-13	82	14	with	with	ADP
amwa-13	82	15	receptors	receptor	NOUN
amwa-13	82	16	,	,	PUNCT
amwa-13	82	17	respectively	respectively	ADV
amwa-13	82	18	(	(	PUNCT
amwa-13	82	19	figure	figure	NOUN
amwa-13	82	20	2	2	NUM
amwa-13	82	21	)	)	PUNCT
amwa-13	82	22	,	,	PUNCT
amwa-13	82	23	thereby	thereby	ADV
amwa-13	82	24	preventing	prevent	VERB
amwa-13	82	25	the	the	DET
amwa-13	82	26	vasoconstriction	vasoconstriction	NOUN
amwa-13	82	27	that	that	PRON
amwa-13	82	28	elevates	elevate	VERB
amwa-13	82	29	blood	blood	NOUN
amwa-13	82	30	pressure	pressure	NOUN
amwa-13	82	31	(	(	PUNCT
amwa-13	82	32	figure	figure	NOUN
amwa-13	82	33	2	2	NUM
amwa-13	82	34	)	)	PUNCT
amwa-13	82	35	.	.	PUNCT
amwa-13	83	1	however	however	ADV
amwa-13	83	2	,	,	PUNCT
amwa-13	83	3	certain	certain	ADJ
amwa-13	83	4	aceis	aceis	NOUN
amwa-13	83	5	and	and	CCONJ
amwa-13	83	6	arbs	arb	NOUN
amwa-13	83	7	likely	likely	ADV
amwa-13	83	8	increase	increase	VERB
amwa-13	83	9	levels	level	NOUN
amwa-13	83	10	and	and	CCONJ
amwa-13	83	11	activity	activity	NOUN
amwa-13	83	12	of	of	ADP
amwa-13	83	13	ace2	ace2	NOUN
amwa-13	83	14	throughout	throughout	ADP
amwa-13	83	15	the	the	DET
amwa-13	83	16	body.47	body.47	NOUN
amwa-13	83	17	-	-	PUNCT
amwa-13	83	18	49	49	NUM
amwa-13	83	19	because	because	SCONJ
amwa-13	83	20	ace2	ace2	PROPN
amwa-13	83	21	is	be	AUX
amwa-13	83	22	the	the	DET
amwa-13	83	23	receptor	receptor	NOUN
amwa-13	83	24	for	for	ADP
amwa-13	83	25	sars	sar	NOUN
amwa-13	83	26	-	-	PUNCT
amwa-13	83	27	cov-2	cov-2	NOUN
amwa-13	83	28	binding	bind	VERB
amwa-13	83	29	,	,	PUNCT
amwa-13	83	30	it	it	PRON
amwa-13	83	31	is	be	AUX
amwa-13	83	32	important	important	ADJ
amwa-13	83	33	to	to	PART
amwa-13	83	34	ascertain	ascertain	VERB
amwa-13	83	35	whether	whether	SCONJ
amwa-13	83	36	aceis	aceis	NOUN
amwa-13	83	37	and	and	CCONJ
amwa-13	83	38	arbs	arbs	PROPN
amwa-13	83	39	alter	alter	PROPN
amwa-13	83	40	patients	patient	NOUN
amwa-13	83	41	’	'	PUNCT
amwa-13	83	42	risk	risk	NOUN
amwa-13	83	43	of	of	ADP
amwa-13	83	44	contracting	contract	VERB
amwa-13	83	45	sars	sar	NOUN
amwa-13	83	46	-	-	PUNCT
amwa-13	83	47	cov-2	cov-2	NOUN
amwa-13	83	48	and/or	and/or	CCONJ
amwa-13	83	49	developing	develop	VERB
amwa-13	83	50	covid-19	covid-19	PROPN
amwa-13	83	51	.	.	PUNCT
amwa-13	84	1	mackey	mackey	PROPN
amwa-13	84	2	et	et	PROPN
amwa-13	84	3	al50	al50	PROPN
amwa-13	84	4	provide	provide	VERB
amwa-13	84	5	regular	regular	ADJ
amwa-13	84	6	updates	update	NOUN
amwa-13	84	7	on	on	ADP
amwa-13	84	8	newly	newly	ADV
amwa-13	84	9	published	publish	VERB
amwa-13	84	10	research	research	NOUN
amwa-13	84	11	articles	article	NOUN
amwa-13	84	12	pertaining	pertain	VERB
amwa-13	84	13	to	to	ADP
amwa-13	84	14	this	this	DET
amwa-13	84	15	topic	topic	NOUN
amwa-13	84	16	.	.	PUNCT
amwa-13	85	1	articles	article	NOUN
amwa-13	85	2	sampled	sample	VERB
amwa-13	85	3	from	from	ADP
amwa-13	85	4	this	this	DET
amwa-13	85	5	compilation	compilation	NOUN
amwa-13	85	6	show	show	VERB
amwa-13	85	7	wide	wide	ADJ
amwa-13	85	8	variability	variability	NOUN
amwa-13	85	9	in	in	ADP
amwa-13	85	10	the	the	DET
amwa-13	85	11	study	study	NOUN
amwa-13	85	12	design.44,50	design.44,50	VERB
amwa-13	85	13	-	-	PUNCT
amwa-13	85	14	54	54	NUM
amwa-13	85	15	differences	difference	NOUN
amwa-13	85	16	include	include	VERB
amwa-13	85	17	variations	variation	NOUN
amwa-13	85	18	in	in	ADP
amwa-13	85	19	comparison	comparison	NOUN
amwa-13	85	20	groups	group	NOUN
amwa-13	85	21	,	,	PUNCT
amwa-13	85	22	ethnic	ethnic	ADJ
amwa-13	85	23	groups	group	NOUN
amwa-13	85	24	,	,	PUNCT
amwa-13	85	25	statistical	statistical	ADJ
amwa-13	85	26	analyses	analysis	NOUN
amwa-13	85	27	,	,	PUNCT
amwa-13	85	28	sample	sample	NOUN
amwa-13	85	29	sizes	size	NOUN
amwa-13	85	30	,	,	PUNCT
amwa-13	85	31	dates	date	NOUN
amwa-13	85	32	of	of	ADP
amwa-13	85	33	studies	study	NOUN
amwa-13	85	34	(	(	PUNCT
amwa-13	85	35	before	before	ADP
amwa-13	85	36	or	or	CCONJ
amwa-13	85	37	after	after	ADP
amwa-13	85	38	widespread	widespread	ADJ
amwa-13	85	39	covid-19	covid-19	PROPN
amwa-13	85	40	testing	testing	NOUN
amwa-13	85	41	)	)	PUNCT
amwa-13	85	42	,	,	PUNCT
amwa-13	85	43	lengths	length	NOUN
amwa-13	85	44	of	of	ADP
amwa-13	85	45	time	time	NOUN
amwa-13	85	46	on	on	ADP
amwa-13	85	47	aceis	aceis	NOUN
amwa-13	85	48	or	or	CCONJ
amwa-13	85	49	arbs	arb	NOUN
amwa-13	85	50	,	,	PUNCT
amwa-13	85	51	attention	attention	NOUN
amwa-13	85	52	levels	level	NOUN
amwa-13	85	53	paid	pay	VERB
amwa-13	85	54	to	to	ADP
amwa-13	85	55	confounding	confound	VERB
amwa-13	85	56	health	health	NOUN
amwa-13	85	57	issues	issue	NOUN
amwa-13	85	58	,	,	PUNCT
amwa-13	85	59	and	and	CCONJ
amwa-13	85	60	definitions	definition	NOUN
amwa-13	85	61	of	of	ADP
amwa-13	85	62	“	"	PUNCT
amwa-13	85	63	severe	severe	ADJ
amwa-13	85	64	covid-19	covid-19	PROPN
amwa-13	85	65	.	.	PUNCT
amwa-13	85	66	”	"	PUNCT
amwa-13	86	1	some	some	DET
amwa-13	86	2	articles	article	NOUN
amwa-13	86	3	are	be	AUX
amwa-13	86	4	retrospective	retrospective	ADJ
amwa-13	86	5	observational	observational	ADJ
amwa-13	86	6	studies	study	NOUN
amwa-13	86	7	.	.	PUNCT
amwa-13	87	1	such	such	ADJ
amwa-13	87	2	studies	study	NOUN
amwa-13	87	3	are	be	AUX
amwa-13	87	4	subjective	subjective	ADJ
amwa-13	87	5	to	to	ADP
amwa-13	87	6	selection	selection	NOUN
amwa-13	87	7	bias	bias	NOUN
amwa-13	87	8	;	;	PUNCT
amwa-13	87	9	for	for	ADP
amwa-13	87	10	example	example	NOUN
amwa-13	87	11	,	,	PUNCT
amwa-13	87	12	a	a	DET
amwa-13	87	13	cohort	cohort	NOUN
amwa-13	87	14	of	of	ADP
amwa-13	87	15	hypertensive	hypertensive	ADJ
amwa-13	87	16	patients	patient	NOUN
amwa-13	87	17	tested	test	VERB
amwa-13	87	18	for	for	ADP
amwa-13	87	19	covid-19	covid-19	PROPN
amwa-13	87	20	leaves	leave	VERB
amwa-13	87	21	out	out	ADP
amwa-13	87	22	hypertensive	hypertensive	ADJ
amwa-13	87	23	patients	patient	NOUN
amwa-13	87	24	who	who	PRON
amwa-13	87	25	did	do	AUX
amwa-13	87	26	not	not	PART
amwa-13	87	27	get	get	AUX
amwa-13	87	28	tested	test	VERB
amwa-13	87	29	because	because	SCONJ
amwa-13	87	30	they	they	PRON
amwa-13	87	31	were	be	AUX
amwa-13	87	32	asymptomatic	asymptomatic	ADJ
amwa-13	87	33	.	.	PUNCT
amwa-13	88	1	identification	identification	NOUN
amwa-13	88	2	of	of	ADP
amwa-13	88	3	patients	patient	NOUN
amwa-13	88	4	prescribed	prescribe	VERB
amwa-13	88	5	aceis	aceis	NOUN
amwa-13	88	6	or	or	CCONJ
amwa-13	88	7	arbs	arb	NOUN
amwa-13	88	8	also	also	ADV
amwa-13	88	9	assumes	assume	VERB
amwa-13	88	10	that	that	SCONJ
amwa-13	88	11	the	the	DET
amwa-13	88	12	patients	patient	NOUN
amwa-13	88	13	take	take	VERB
amwa-13	88	14	these	these	DET
amwa-13	88	15	medications	medication	NOUN
amwa-13	88	16	as	as	ADP
amwa-13	88	17	prescribed	prescribe	VERB
amwa-13	88	18	,	,	PUNCT
amwa-13	88	19	which	which	PRON
amwa-13	88	20	may	may	AUX
amwa-13	88	21	not	not	PART
amwa-13	88	22	be	be	AUX
amwa-13	88	23	the	the	DET
amwa-13	88	24	case	case	NOUN
amwa-13	88	25	.	.	PUNCT
amwa-13	89	1	nevertheless	nevertheless	ADV
amwa-13	89	2	,	,	PUNCT
amwa-13	89	3	most	most	ADJ
amwa-13	89	4	studies	study	NOUN
amwa-13	89	5	come	come	VERB
amwa-13	89	6	to	to	ADP
amwa-13	89	7	the	the	DET
amwa-13	89	8	same	same	ADJ
amwa-13	89	9	conclusion	conclusion	NOUN
amwa-13	89	10	:	:	PUNCT
amwa-13	89	11	use	use	NOUN
amwa-13	89	12	of	of	ADP
amwa-13	89	13	aceis	aceis	NOUN
amwa-13	89	14	or	or	CCONJ
amwa-13	89	15	arbs	arb	NOUN
amwa-13	89	16	does	do	AUX
amwa-13	89	17	not	not	PART
amwa-13	89	18	increase	increase	VERB
amwa-13	89	19	one	one	NUM
amwa-13	89	20	’s	’s	PART
amwa-13	89	21	risk	risk	NOUN
amwa-13	89	22	of	of	ADP
amwa-13	89	23	sars	sar	NOUN
amwa-13	89	24	-	-	PUNCT
amwa-13	89	25	cov-2	cov-2	PART
amwa-13	89	26	infection	infection	NOUN
amwa-13	89	27	or	or	CCONJ
amwa-13	89	28	development	development	NOUN
amwa-13	89	29	of	of	ADP
amwa-13	89	30	severe	severe	ADJ
amwa-13	89	31	covid-19.55,56	covid-19.55,56	PROPN
amwa-13	89	32	currently	currently	ADV
amwa-13	89	33	,	,	PUNCT
amwa-13	89	34	the	the	DET
amwa-13	89	35	centers	center	NOUN
amwa-13	89	36	for	for	ADP
amwa-13	89	37	disease	disease	NOUN
amwa-13	89	38	control	control	NOUN
amwa-13	89	39	and	and	CCONJ
amwa-13	89	40	prevention	prevention	NOUN
amwa-13	89	41	(	(	PUNCT
amwa-13	89	42	cdc	cdc	PROPN
amwa-13	89	43	)	)	PUNCT
amwa-13	89	44	and	and	CCONJ
amwa-13	89	45	other	other	ADJ
amwa-13	89	46	cardiovascular	cardiovascular	ADJ
amwa-13	89	47	health	health	NOUN
amwa-13	89	48	organizations	organization	NOUN
amwa-13	89	49	advise	advise	VERB
amwa-13	89	50	patients	patient	NOUN
amwa-13	89	51	to	to	PART
amwa-13	89	52	continue	continue	VERB
amwa-13	89	53	their	their	PRON
amwa-13	89	54	acei	acei	NOUN
amwa-13	89	55	or	or	CCONJ
amwa-13	89	56	arb	arb	NOUN
amwa-13	89	57	prescriptions	prescription	NOUN
amwa-13	89	58	,	,	PUNCT
amwa-13	89	59	unless	unless	SCONJ
amwa-13	89	60	advised	advise	VERB
amwa-13	89	61	otherwise	otherwise	ADV
amwa-13	89	62	by	by	ADP
amwa-13	89	63	a	a	DET
amwa-13	89	64	physician.57,58	physician.57,58	NOUN
amwa-13	89	65	clinical	clinical	ADJ
amwa-13	89	66	trials	trial	NOUN
amwa-13	89	67	concerning	concern	VERB
amwa-13	89	68	aceis	aceis	NOUN
amwa-13	89	69	,	,	PUNCT
amwa-13	89	70	arbs	arb	NOUN
amwa-13	89	71	,	,	PUNCT
amwa-13	89	72	and	and	CCONJ
amwa-13	89	73	covid-19	covid-19	PROPN
amwa-13	89	74	are	be	AUX
amwa-13	89	75	ongoing.59	ongoing.59	VERB
amwa-13	89	76	interestingly	interestingly	ADV
amwa-13	89	77	,	,	PUNCT
amwa-13	89	78	the	the	DET
amwa-13	89	79	aceiand	aceiand	ADJ
amwa-13	89	80	arb	arb	ADJ
amwa-13	89	81	-	-	ADJ
amwa-13	89	82	induced	induced	ADJ
amwa-13	89	83	increase	increase	NOUN
amwa-13	89	84	in	in	ADP
amwa-13	89	85	ace2	ace2	NOUN
amwa-13	89	86	expression	expression	NOUN
amwa-13	89	87	levels	level	NOUN
amwa-13	89	88	may	may	AUX
amwa-13	89	89	be	be	AUX
amwa-13	89	90	advantageous	advantageous	ADJ
amwa-13	89	91	to	to	PART
amwa-13	89	92	patients.52,54	patients.52,54	VERB
amwa-13	89	93	it	it	PRON
amwa-13	89	94	may	may	AUX
amwa-13	89	95	counteract	counteract	VERB
amwa-13	89	96	virally	virally	ADV
amwa-13	89	97	induced	induce	VERB
amwa-13	89	98	reduction	reduction	NOUN
amwa-13	89	99	of	of	ADP
amwa-13	89	100	ace2	ace2	NOUN
amwa-13	89	101	levels	level	NOUN
amwa-13	89	102	and	and	CCONJ
amwa-13	89	103	thereby	thereby	ADV
amwa-13	89	104	preserve	preserve	VERB
amwa-13	89	105	the	the	DET
amwa-13	89	106	production	production	NOUN
amwa-13	89	107	of	of	ADP
amwa-13	89	108	angiotensin	angiotensin	NOUN
amwa-13	89	109	(	(	PUNCT
amwa-13	89	110	1	1	NUM
amwa-13	89	111	-	-	SYM
amwa-13	89	112	7	7	NUM
amwa-13	89	113	)	)	PUNCT
amwa-13	89	114	,	,	PUNCT
amwa-13	89	115	which	which	PRON
amwa-13	89	116	lowers	lower	VERB
amwa-13	89	117	elevated	elevated	ADJ
amwa-13	89	118	blood	blood	NOUN
amwa-13	89	119	pressure	pressure	NOUN
amwa-13	89	120	,	,	PUNCT
amwa-13	89	121	promotes	promote	VERB
amwa-13	89	122	structural	structural	ADJ
amwa-13	89	123	health	health	NOUN
amwa-13	89	124	of	of	ADP
amwa-13	89	125	blood	blood	NOUN
amwa-13	89	126	vessels	vessel	NOUN
amwa-13	89	127	and	and	CCONJ
amwa-13	89	128	ecs	ec	NOUN
amwa-13	89	129	,	,	PUNCT
amwa-13	89	130	protects	protect	VERB
amwa-13	89	131	against	against	ADP
amwa-13	89	132	cardiac	cardiac	ADJ
amwa-13	89	133	hypertrophy	hypertrophy	NOUN
amwa-13	89	134	,	,	PUNCT
amwa-13	89	135	and	and	CCONJ
amwa-13	89	136	may	may	AUX
amwa-13	89	137	enhance	enhance	VERB
amwa-13	89	138	blood	blood	NOUN
amwa-13	89	139	cell	cell	NOUN
amwa-13	89	140	production.60,61	production.60,61	NOUN
amwa-13	89	141	covid-19	covid-19	PROPN
amwa-13	89	142	treatments	treatment	NOUN
amwa-13	89	143	and	and	CCONJ
amwa-13	89	144	cardiac	cardiac	ADJ
amwa-13	89	145	health	health	NOUN
amwa-13	89	146	risks	risk	NOUN
amwa-13	89	147	some	some	DET
amwa-13	89	148	medications	medication	NOUN
amwa-13	89	149	—	—	PUNCT
amwa-13	89	150	lopinavir	lopinavir	PROPN
amwa-13	89	151	/	/	SYM
amwa-13	89	152	ritonavir	ritonavir	PROPN
amwa-13	89	153	,	,	PUNCT
amwa-13	89	154	hydroxychloroquine	hydroxychloroquine	PROPN
amwa-13	89	155	(	(	PUNCT
amwa-13	89	156	hcq	hcq	PROPN
amwa-13	89	157	)	)	PUNCT
amwa-13	89	158	,	,	PUNCT
amwa-13	89	159	favipiravir	favipiravir	PROPN
amwa-13	89	160	,	,	PUNCT
amwa-13	89	161	remdesivir	remdesivir	NOUN
amwa-13	89	162	,	,	PUNCT
amwa-13	89	163	and	and	CCONJ
amwa-13	89	164	tocilizumab	tocilizumab	NOUN
amwa-13	89	165	—	—	PUNCT
amwa-13	89	166	were	be	AUX
amwa-13	89	167	originally	originally	ADV
amwa-13	89	168	developed	develop	VERB
amwa-13	89	169	for	for	ADP
amwa-13	89	170	other	other	ADJ
amwa-13	89	171	uses	use	NOUN
amwa-13	89	172	but	but	CCONJ
amwa-13	89	173	demonstrate	demonstrate	VERB
amwa-13	89	174	various	various	ADJ
amwa-13	89	175	levels	level	NOUN
amwa-13	89	176	of	of	ADP
amwa-13	89	177	efficacy	efficacy	NOUN
amwa-13	89	178	in	in	ADP
amwa-13	89	179	treating	treat	VERB
amwa-13	89	180	patients	patient	NOUN
amwa-13	89	181	with	with	ADP
amwa-13	89	182	covid-19	covid-19	PROPN
amwa-13	89	183	.	.	PUNCT
amwa-13	90	1	lopinavir	lopinavir	PROPN
amwa-13	90	2	/	/	SYM
amwa-13	90	3	ritonavir	ritonavir	PROPN
amwa-13	90	4	and	and	CCONJ
amwa-13	90	5	hcq	hcq	PROPN
amwa-13	90	6	reportedly	reportedly	ADV
amwa-13	90	7	disrupt	disrupt	VERB
amwa-13	90	8	sars	sar	NOUN
amwa-13	90	9	-	-	PUNCT
amwa-13	90	10	cov-2	cov-2	NOUN
amwa-13	90	11	’s	’s	PART
amwa-13	90	12	entry	entry	NOUN
amwa-13	90	13	into	into	ADP
amwa-13	90	14	host	host	NOUN
amwa-13	90	15	cells.62	cells.62	NOUN
amwa-13	90	16	favipiravir	favipiravir	NOUN
amwa-13	90	17	and	and	CCONJ
amwa-13	90	18	remdesivir	remdesivir	NOUN
amwa-13	90	19	likely	likely	ADV
amwa-13	90	20	prevent	prevent	VERB
amwa-13	90	21	the	the	DET
amwa-13	90	22	replication	replication	NOUN
amwa-13	90	23	of	of	ADP
amwa-13	90	24	the	the	DET
amwa-13	90	25	virus	virus	NOUN
amwa-13	90	26	’s	’s	PART
amwa-13	90	27	genome.62	genome.62	ADJ
amwa-13	90	28	tocilizumab	tocilizumab	NOUN
amwa-13	90	29	reduces	reduce	VERB
amwa-13	90	30	inflammation	inflammation	NOUN
amwa-13	90	31	by	by	ADP
amwa-13	90	32	limiting	limit	VERB
amwa-13	90	33	the	the	DET
amwa-13	90	34	effectiveness	effectiveness	NOUN
amwa-13	90	35	of	of	ADP
amwa-13	90	36	pro	pro	ADJ
amwa-13	90	37	-	-	ADJ
amwa-13	90	38	inflammatory	inflammatory	ADJ
amwa-13	90	39	chemicals.62	chemicals.62	NOUN
amwa-13	90	40	last	last	ADJ
amwa-13	90	41	year	year	NOUN
amwa-13	90	42	,	,	PUNCT
amwa-13	90	43	a	a	DET
amwa-13	90	44	multinational	multinational	ADJ
amwa-13	90	45	study	study	NOUN
amwa-13	90	46	of	of	ADP
amwa-13	90	47	more	more	ADJ
amwa-13	90	48	than	than	ADP
amwa-13	90	49	10,000	10,000	NUM
amwa-13	90	50	patients	patient	NOUN
amwa-13	90	51	examined	examine	VERB
amwa-13	90	52	the	the	DET
amwa-13	90	53	effects	effect	NOUN
amwa-13	90	54	of	of	ADP
amwa-13	90	55	some	some	PRON
amwa-13	90	56	of	of	ADP
amwa-13	90	57	these	these	DET
amwa-13	90	58	drugs	drug	NOUN
amwa-13	90	59	on	on	ADP
amwa-13	90	60	the	the	DET
amwa-13	90	61	mortality	mortality	NOUN
amwa-13	90	62	of	of	ADP
amwa-13	90	63	patients	patient	NOUN
amwa-13	90	64	with	with	ADP
amwa-13	90	65	covid-19.63	covid-19.63	PROPN
amwa-13	90	66	the	the	DET
amwa-13	90	67	tests	test	NOUN
amwa-13	90	68	using	use	VERB
amwa-13	90	69	hcq	hcq	NOUN
amwa-13	90	70	(	(	PUNCT
amwa-13	90	71	low	low	ADJ
amwa-13	90	72	doses	dose	NOUN
amwa-13	90	73	)	)	PUNCT
amwa-13	90	74	and	and	CCONJ
amwa-13	90	75	lopinavir	lopinavir	PROPN
amwa-13	90	76	/	/	SYM
amwa-13	90	77	ritonavir	ritonavir	PROPN
amwa-13	90	78	were	be	AUX
amwa-13	90	79	halted	halt	VERB
amwa-13	90	80	prematurely	prematurely	ADV
amwa-13	90	81	,	,	PUNCT
amwa-13	90	82	as	as	SCONJ
amwa-13	90	83	no	no	DET
amwa-13	90	84	improvements	improvement	NOUN
amwa-13	90	85	were	be	AUX
amwa-13	90	86	seen.64	seen.64	NOUN
amwa-13	90	87	currently	currently	ADV
amwa-13	90	88	,	,	PUNCT
amwa-13	90	89	the	the	DET
amwa-13	90	90	national	national	PROPN
amwa-13	90	91	institutes	institutes	PROPN
amwa-13	90	92	of	of	ADP
amwa-13	90	93	health	health	PROPN
amwa-13	90	94	(	(	PUNCT
amwa-13	90	95	nih	nih	PROPN
amwa-13	90	96	)	)	PUNCT
amwa-13	90	97	recommends	recommend	VERB
amwa-13	90	98	against	against	ADP
amwa-13	90	99	their	their	PRON
amwa-13	90	100	use	use	NOUN
amwa-13	90	101	as	as	ADP
amwa-13	90	102	a	a	DET
amwa-13	90	103	treatment	treatment	NOUN
amwa-13	90	104	for	for	ADP
amwa-13	90	105	covid-19.65,66	covid-19.65,66	ADJ
amwa-13	90	106	these	these	DET
amwa-13	90	107	drugs	drug	NOUN
amwa-13	90	108	have	have	AUX
amwa-13	90	109	been	be	AUX
amwa-13	90	110	linked	link	VERB
amwa-13	90	111	to	to	ADP
amwa-13	90	112	cardiovascular	cardiovascular	ADJ
amwa-13	90	113	side	side	NOUN
amwa-13	90	114	effects	effect	NOUN
amwa-13	90	115	.	.	PUNCT
amwa-13	91	1	lopinavir	lopinavir	PROPN
amwa-13	91	2	/	/	SYM
amwa-13	91	3	ritonavir	ritonavir	PROPN
amwa-13	91	4	,	,	PUNCT
amwa-13	91	5	hcq	hcq	PROPN
amwa-13	91	6	,	,	PUNCT
amwa-13	91	7	favipiravir	favipiravir	NOUN
amwa-13	91	8	and	and	CCONJ
amwa-13	91	9	remdesivir	remdesivir	NOUN
amwa-13	91	10	may	may	AUX
amwa-13	91	11	cause	cause	VERB
amwa-13	91	12	arrhythmias.29,67	arrhythmias.29,67	NOUN
amwa-13	91	13	-	-	PUNCT
amwa-13	91	14	69	69	NUM
amwa-13	91	15	lopinavir	lopinavir	NOUN
amwa-13	91	16	/	/	SYM
amwa-13	91	17	ritonavir	ritonavir	PROPN
amwa-13	91	18	may	may	AUX
amwa-13	91	19	trigger	trigger	VERB
amwa-13	91	20	mis.70	mis.70	PRON
amwa-13	91	21	furthermore	furthermore	ADV
amwa-13	91	22	,	,	PUNCT
amwa-13	91	23	lopinavir	lopinavir	PROPN
amwa-13	91	24	/	/	SYM
amwa-13	91	25	ritonavir	ritonavir	PROPN
amwa-13	91	26	and	and	CCONJ
amwa-13	91	27	tocilizumab	tocilizumab	NOUN
amwa-13	91	28	may	may	AUX
amwa-13	91	29	compromise	compromise	VERB
amwa-13	91	30	the	the	DET
amwa-13	91	31	effectiveness	effectiveness	NOUN
amwa-13	91	32	of	of	ADP
amwa-13	91	33	cardiovascular	cardiovascular	ADJ
amwa-13	91	34	medications.29,71	medications.29,71	NOUN
amwa-13	91	35	these	these	DET
amwa-13	91	36	cardiovascular	cardiovascular	ADJ
amwa-13	91	37	risks	risk	NOUN
amwa-13	91	38	are	be	AUX
amwa-13	91	39	inferred	infer	VERB
amwa-13	91	40	primarily	primarily	ADV
amwa-13	91	41	from	from	ADP
amwa-13	91	42	a	a	DET
amwa-13	91	43	small	small	ADJ
amwa-13	91	44	number	number	NOUN
amwa-13	91	45	of	of	ADP
amwa-13	91	46	studies	study	NOUN
amwa-13	91	47	with	with	ADP
amwa-13	91	48	a	a	DET
amwa-13	91	49	small	small	ADJ
amwa-13	91	50	number	number	NOUN
amwa-13	91	51	of	of	ADP
amwa-13	91	52	subjects	subject	NOUN
amwa-13	91	53	without	without	ADP
amwa-13	91	54	covid-19	covid-19	PROPN
amwa-13	91	55	.	.	PUNCT
amwa-13	92	1	a	a	DET
amwa-13	92	2	more	more	ADV
amwa-13	92	3	robust	robust	ADJ
amwa-13	92	4	examination	examination	NOUN
amwa-13	92	5	of	of	ADP
amwa-13	92	6	these	these	DET
amwa-13	92	7	drugs	drug	NOUN
amwa-13	92	8	’	'	PUNCT
amwa-13	92	9	cardiovascular	cardiovascular	ADJ
amwa-13	92	10	effects	effect	NOUN
amwa-13	92	11	in	in	ADP
amwa-13	92	12	patients	patient	NOUN
amwa-13	92	13	with	with	ADP
amwa-13	92	14	covid-19	covid-19	PROPN
amwa-13	92	15	has	have	AUX
amwa-13	92	16	begun	begin	VERB
amwa-13	92	17	in	in	ADP
amwa-13	92	18	several	several	ADJ
amwa-13	92	19	clinical	clinical	ADJ
amwa-13	92	20	trials	trial	NOUN
amwa-13	92	21	funded	fund	VERB
amwa-13	92	22	by	by	ADP
amwa-13	92	23	the	the	DET
amwa-13	92	24	nih.29	nih.29	NOUN
amwa-13	92	25	conclusion	conclusion	NOUN
amwa-13	92	26	approximately	approximately	ADV
amwa-13	92	27	1.5	1.5	NUM
amwa-13	92	28	years	year	NOUN
amwa-13	92	29	have	have	AUX
amwa-13	92	30	passed	pass	VERB
amwa-13	92	31	since	since	SCONJ
amwa-13	92	32	sars	sar	NOUN
amwa-13	92	33	-	-	PUNCT
amwa-13	92	34	cov-2	cov-2	PUNCT
amwa-13	92	35	and	and	CCONJ
amwa-13	92	36	covid-19	covid-19	PROPN
amwa-13	92	37	were	be	AUX
amwa-13	92	38	identified.1,72,73	identified.1,72,73	NOUN
amwa-13	92	39	in	in	ADP
amwa-13	92	40	this	this	DET
amwa-13	92	41	time	time	NOUN
amwa-13	92	42	,	,	PUNCT
amwa-13	92	43	much	much	ADJ
amwa-13	92	44	scientific	scientific	ADJ
amwa-13	92	45	understanding	understanding	NOUN
amwa-13	92	46	of	of	ADP
amwa-13	92	47	sars	sar	NOUN
amwa-13	92	48	-	-	PUNCT
amwa-13	92	49	cov-2	cov-2	PART
amwa-13	92	50	infection	infection	NOUN
amwa-13	92	51	patterns	pattern	NOUN
amwa-13	92	52	and	and	CCONJ
amwa-13	92	53	covid19	covid19	NOUN
amwa-13	92	54	comorbidities	comorbiditie	NOUN
amwa-13	92	55	has	have	AUX
amwa-13	92	56	been	be	AUX
amwa-13	92	57	acquired	acquire	VERB
amwa-13	92	58	.	.	PUNCT
amwa-13	93	1	improved	improve	VERB
amwa-13	93	2	treatment	treatment	NOUN
amwa-13	93	3	procedures	procedure	NOUN
amwa-13	93	4	enhance	enhance	VERB
amwa-13	93	5	patients	patient	NOUN
amwa-13	93	6	’	'	PUNCT
amwa-13	93	7	prognoses	prognosis	NOUN
amwa-13	93	8	,	,	PUNCT
amwa-13	93	9	and	and	CCONJ
amwa-13	93	10	awareness	awareness	NOUN
amwa-13	93	11	of	of	ADP
amwa-13	93	12	drug	drug	NOUN
amwa-13	93	13	side	side	NOUN
amwa-13	93	14	effects	effect	NOUN
amwa-13	93	15	likely	likely	ADV
amwa-13	93	16	reduces	reduce	VERB
amwa-13	93	17	health	health	NOUN
amwa-13	93	18	complications	complication	NOUN
amwa-13	93	19	.	.	PUNCT
amwa-13	94	1	this	this	DET
amwa-13	94	2	article	article	NOUN
amwa-13	94	3	76	76	NUM
amwa-13	94	4	amwa	amwa	PROPN
amwa-13	94	5	journal	journal	PROPN
amwa-13	94	6	/	/	SYM
amwa-13	94	7	v36	v36	PROPN
amwa-13	94	8	n2	n2	PROPN
amwa-13	94	9	/	/	SYM
amwa-13	94	10	2021	2021	NUM
amwa-13	94	11	/	/	SYM
amwa-13	94	12	amwa.org	amwa.org	X
amwa-13	94	13	illuminates	illuminate	VERB
amwa-13	94	14	the	the	DET
amwa-13	94	15	landscape	landscape	NOUN
amwa-13	94	16	of	of	ADP
amwa-13	94	17	sars	sar	NOUN
amwa-13	94	18	-	-	PUNCT
amwa-13	94	19	cov-2	cov-2	PUNCT
amwa-13	94	20	and	and	CCONJ
amwa-13	94	21	covid-19	covid-19	PROPN
amwa-13	94	22	in	in	ADP
amwa-13	94	23	relationship	relationship	NOUN
amwa-13	94	24	with	with	ADP
amwa-13	94	25	the	the	DET
amwa-13	94	26	cardiovascular	cardiovascular	ADJ
amwa-13	94	27	system	system	NOUN
amwa-13	94	28	and	and	CCONJ
amwa-13	94	29	provides	provide	VERB
amwa-13	94	30	a	a	DET
amwa-13	94	31	biological	biological	ADJ
amwa-13	94	32	foundation	foundation	NOUN
amwa-13	94	33	to	to	PART
amwa-13	94	34	support	support	VERB
amwa-13	94	35	readers	reader	NOUN
amwa-13	94	36	as	as	SCONJ
amwa-13	94	37	they	they	PRON
amwa-13	94	38	engage	engage	VERB
amwa-13	94	39	with	with	ADP
amwa-13	94	40	the	the	DET
amwa-13	94	41	burgeoning	burgeon	VERB
amwa-13	94	42	quantity	quantity	NOUN
amwa-13	94	43	of	of	ADP
amwa-13	94	44	scientific	scientific	ADJ
amwa-13	94	45	studies	study	NOUN
amwa-13	94	46	on	on	ADP
amwa-13	94	47	this	this	DET
amwa-13	94	48	topic	topic	NOUN
amwa-13	94	49	.	.	PUNCT
amwa-13	95	1	indeed	indeed	ADV
amwa-13	95	2	,	,	PUNCT
amwa-13	95	3	the	the	DET
amwa-13	95	4	necessity	necessity	NOUN
amwa-13	95	5	of	of	ADP
amwa-13	95	6	continued	continue	VERB
amwa-13	95	7	research	research	NOUN
amwa-13	95	8	remains	remain	VERB
amwa-13	95	9	.	.	PUNCT
amwa-13	96	1	some	some	DET
amwa-13	96	2	current	current	ADJ
amwa-13	96	3	information	information	NOUN
amwa-13	96	4	is	be	AUX
amwa-13	96	5	conjecture	conjecture	ADJ
amwa-13	96	6	,	,	PUNCT
amwa-13	96	7	drawn	draw	VERB
amwa-13	96	8	from	from	ADP
amwa-13	96	9	studies	study	NOUN
amwa-13	96	10	on	on	ADP
amwa-13	96	11	the	the	DET
amwa-13	96	12	first	first	ADJ
amwa-13	96	13	severe	severe	ADJ
amwa-13	96	14	acute	acute	ADJ
amwa-13	96	15	respiratory	respiratory	ADJ
amwa-13	96	16	syndrome	syndrome	NOUN
amwa-13	96	17	coronavirus	coronavirus	NOUN
amwa-13	96	18	or	or	CCONJ
amwa-13	96	19	in	in	ADP
amwa-13	96	20	patients	patient	NOUN
amwa-13	96	21	without	without	ADP
amwa-13	96	22	covid-19	covid-19	PROPN
amwa-13	96	23	.	.	PUNCT
amwa-13	97	1	other	other	ADJ
amwa-13	97	2	knowledge	knowledge	NOUN
amwa-13	97	3	is	be	AUX
amwa-13	97	4	based	base	VERB
amwa-13	97	5	on	on	ADP
amwa-13	97	6	only	only	ADV
amwa-13	97	7	a	a	DET
amwa-13	97	8	few	few	ADJ
amwa-13	97	9	small	small	ADJ
amwa-13	97	10	studies	study	NOUN
amwa-13	97	11	and	and	CCONJ
amwa-13	97	12	needs	need	VERB
amwa-13	97	13	stronger	strong	ADJ
amwa-13	97	14	support	support	NOUN
amwa-13	97	15	.	.	PUNCT
amwa-13	98	1	longitudinal	longitudinal	ADJ
amwa-13	98	2	studies	study	NOUN
amwa-13	98	3	are	be	AUX
amwa-13	98	4	necessary	necessary	ADJ
amwa-13	98	5	to	to	PART
amwa-13	98	6	determine	determine	VERB
amwa-13	98	7	the	the	DET
amwa-13	98	8	long	long	ADJ
amwa-13	98	9	-	-	PUNCT
amwa-13	98	10	term	term	NOUN
amwa-13	98	11	effects	effect	NOUN
amwa-13	98	12	of	of	ADP
amwa-13	98	13	sars	sar	NOUN
amwa-13	98	14	-	-	PUNCT
amwa-13	98	15	cov-2	cov-2	PUNCT
amwa-13	98	16	and	and	CCONJ
amwa-13	98	17	covid-19	covid-19	PROPN
amwa-13	98	18	on	on	ADP
amwa-13	98	19	human	human	ADJ
amwa-13	98	20	health	health	NOUN
amwa-13	98	21	.	.	PUNCT
amwa-13	99	1	regardless	regardless	ADV
amwa-13	99	2	,	,	PUNCT
amwa-13	99	3	the	the	DET
amwa-13	99	4	approval	approval	NOUN
amwa-13	99	5	of	of	ADP
amwa-13	99	6	effective	effective	ADJ
amwa-13	99	7	sars	sar	NOUN
amwa-13	99	8	-	-	PUNCT
amwa-13	99	9	cov-2	cov-2	NOUN
amwa-13	99	10	vaccines,74,75	vaccines,74,75	ADJ
amwa-13	99	11	enhancements	enhancement	NOUN
amwa-13	99	12	to	to	ADP
amwa-13	99	13	patient	patient	ADJ
amwa-13	99	14	care	care	NOUN
amwa-13	99	15	,	,	PUNCT
amwa-13	99	16	and	and	CCONJ
amwa-13	99	17	funded	fund	VERB
amwa-13	99	18	clinical	clinical	ADJ
amwa-13	99	19	trials	trial	NOUN
amwa-13	99	20	provide	provide	VERB
amwa-13	99	21	hope	hope	NOUN
amwa-13	99	22	for	for	ADP
amwa-13	99	23	a	a	DET
amwa-13	99	24	future	future	NOUN
amwa-13	99	25	in	in	ADP
amwa-13	99	26	which	which	PRON
amwa-13	99	27	sars	sar	NOUN
amwa-13	99	28	-	-	PUNCT
amwa-13	99	29	cov-2	cov-2	PART
amwa-13	99	30	infection	infection	NOUN
amwa-13	99	31	rates	rate	NOUN
amwa-13	99	32	decline	decline	VERB
amwa-13	99	33	,	,	PUNCT
amwa-13	99	34	patient	patient	ADJ
amwa-13	99	35	mortality	mortality	NOUN
amwa-13	99	36	decreases	decrease	VERB
amwa-13	99	37	,	,	PUNCT
amwa-13	99	38	and	and	CCONJ
amwa-13	99	39	life	life	NOUN
amwa-13	99	40	without	without	ADP
amwa-13	99	41	social	social	ADJ
amwa-13	99	42	-	-	PUNCT
amwa-13	99	43	distancing	distance	VERB
amwa-13	99	44	restrictions	restriction	NOUN
amwa-13	99	45	resumes	resume	VERB
amwa-13	99	46	.	.	PUNCT
amwa-13	100	1	author	author	NOUN
amwa-13	100	2	declaration	declaration	NOUN
amwa-13	100	3	and	and	CCONJ
amwa-13	100	4	disclosures	disclosure	NOUN
amwa-13	100	5	:	:	PUNCT
amwa-13	100	6	the	the	DET
amwa-13	100	7	author	author	NOUN
amwa-13	100	8	notes	note	VERB
amwa-13	100	9	no	no	DET
amwa-13	100	10	commercial	commercial	ADJ
amwa-13	100	11	associations	association	NOUN
amwa-13	100	12	that	that	PRON
amwa-13	100	13	may	may	AUX
amwa-13	100	14	pose	pose	VERB
amwa-13	100	15	a	a	DET
amwa-13	100	16	conflict	conflict	NOUN
amwa-13	100	17	of	of	ADP
amwa-13	100	18	interest	interest	NOUN
amwa-13	100	19	in	in	ADP
amwa-13	100	20	relation	relation	NOUN
amwa-13	100	21	to	to	ADP
amwa-13	100	22	this	this	DET
amwa-13	100	23	article	article	NOUN
amwa-13	100	24	.	.	PUNCT
amwa-13	101	1	author	author	NOUN
amwa-13	101	2	contact	contact	PROPN
amwa-13	101	3	:	:	PUNCT
amwa-13	102	1	jennifer.busch@wheaton.edu	jennifer.busch@wheaton.edu	PROPN
amwa-13	102	2	references	reference	NOUN
amwa-13	102	3	1	1	NUM
amwa-13	102	4	.	.	PUNCT
amwa-13	103	1	zhou	zhou	PROPN
amwa-13	103	2	p	p	PROPN
amwa-13	103	3	,	,	PUNCT
amwa-13	103	4	yang	yang	PROPN
amwa-13	103	5	xl	xl	PROPN
amwa-13	103	6	,	,	PUNCT
amwa-13	103	7	wang	wang	PROPN
amwa-13	103	8	xg	xg	PROPN
amwa-13	103	9	,	,	PUNCT
amwa-13	103	10	et	et	PROPN
amwa-13	103	11	al	al	PROPN
amwa-13	103	12	.	.	PUNCT
amwa-13	104	1	a	a	DET
amwa-13	104	2	pneumonia	pneumonia	NOUN
amwa-13	104	3	outbreak	outbreak	NOUN
amwa-13	104	4	associated	associate	VERB
amwa-13	104	5	with	with	ADP
amwa-13	104	6	a	a	DET
amwa-13	104	7	new	new	ADJ
amwa-13	104	8	coronavirus	coronavirus	NOUN
amwa-13	104	9	of	of	ADP
amwa-13	104	10	probable	probable	ADJ
amwa-13	104	11	bat	bat	NOUN
amwa-13	104	12	origin	origin	NOUN
amwa-13	104	13	.	.	PUNCT
amwa-13	105	1	nature	nature	NOUN
amwa-13	105	2	.	.	PUNCT
amwa-13	106	1	2020;579(7798):270273	2020;579(7798):270273	NUM
amwa-13	106	2	.	.	PUNCT
amwa-13	107	1	doi:10.1038	doi:10.1038	NOUN
amwa-13	107	2	/	/	SYM
amwa-13	107	3	s41586	s41586	PROPN
amwa-13	107	4	-	-	PUNCT
amwa-13	107	5	020	020	NUM
amwa-13	107	6	-	-	PUNCT
amwa-13	107	7	2012	2012	NUM
amwa-13	107	8	-	-	SYM
amwa-13	107	9	7	7	NUM
amwa-13	107	10	2	2	NUM
amwa-13	107	11	.	.	PUNCT
amwa-13	108	1	shang	shang	PROPN
amwa-13	108	2	j	j	PROPN
amwa-13	108	3	,	,	PUNCT
amwa-13	108	4	ye	ye	PRON
amwa-13	108	5	g	g	NOUN
amwa-13	108	6	,	,	PUNCT
amwa-13	108	7	shi	shi	PROPN
amwa-13	108	8	k	k	PROPN
amwa-13	108	9	,	,	PUNCT
amwa-13	108	10	et	et	PROPN
amwa-13	108	11	al	al	PROPN
amwa-13	108	12	.	.	PROPN
amwa-13	108	13	structural	structural	ADJ
amwa-13	108	14	basis	basis	NOUN
amwa-13	108	15	of	of	ADP
amwa-13	108	16	receptor	receptor	NOUN
amwa-13	108	17	recognition	recognition	NOUN
amwa-13	108	18	by	by	ADP
amwa-13	108	19	sars	sar	NOUN
amwa-13	108	20	-	-	PUNCT
amwa-13	108	21	cov-2	cov-2	NOUN
amwa-13	108	22	.	.	PUNCT
amwa-13	108	23	nature	nature	NOUN
amwa-13	108	24	.	.	PUNCT
amwa-13	109	1	2020;581(7807):221	2020;581(7807):221	NUM
amwa-13	109	2	-	-	SYM
amwa-13	109	3	224	224	NUM
amwa-13	109	4	.	.	PUNCT
amwa-13	110	1	doi:10.1038	doi:10.1038	NOUN
amwa-13	110	2	/	/	SYM
amwa-13	110	3	s41586	s41586	PROPN
amwa-13	110	4	-	-	PUNCT
amwa-13	110	5	0202179	0202179	NUM
amwa-13	110	6	-	-	SYM
amwa-13	110	7	y	y	PROPN
amwa-13	110	8	3	3	NUM
amwa-13	110	9	.	.	PUNCT
amwa-13	110	10	yan	yan	PROPN
amwa-13	111	1	r	r	PROPN
amwa-13	111	2	,	,	PUNCT
amwa-13	111	3	zhang	zhang	PROPN
amwa-13	111	4	y	y	PROPN
amwa-13	111	5	,	,	PUNCT
amwa-13	111	6	li	li	PROPN
amwa-13	111	7	y	y	PROPN
amwa-13	111	8	,	,	PUNCT
amwa-13	111	9	xia	xia	PROPN
amwa-13	111	10	l	l	PROPN
amwa-13	111	11	,	,	PUNCT
amwa-13	111	12	guo	guo	PROPN
amwa-13	111	13	y	y	PROPN
amwa-13	111	14	,	,	PUNCT
amwa-13	111	15	zhou	zhou	PROPN
amwa-13	111	16	q.	q.	PROPN
amwa-13	111	17	structural	structural	ADJ
amwa-13	111	18	basis	basis	NOUN
amwa-13	111	19	for	for	ADP
amwa-13	111	20	the	the	DET
amwa-13	111	21	recognition	recognition	NOUN
amwa-13	111	22	of	of	ADP
amwa-13	111	23	sars	sar	NOUN
amwa-13	111	24	-	-	PUNCT
amwa-13	111	25	cov-2	cov-2	NUM
amwa-13	111	26	by	by	ADP
amwa-13	111	27	full	full	ADJ
amwa-13	111	28	-	-	PUNCT
amwa-13	111	29	length	length	NOUN
amwa-13	111	30	human	human	ADJ
amwa-13	111	31	ace2	ace2	PROPN
amwa-13	111	32	.	.	PUNCT
amwa-13	112	1	science	science	NOUN
amwa-13	112	2	.	.	PUNCT
amwa-13	113	1	2020;367(6485):1444	2020;367(6485):1444	NUM
amwa-13	113	2	-	-	SYM
amwa-13	113	3	1448	1448	NUM
amwa-13	113	4	.	.	PUNCT
amwa-13	114	1	doi:10.1126	doi:10.1126	PROPN
amwa-13	114	2	/	/	SYM
amwa-13	114	3	science.abb2762	science.abb2762	PROPN
amwa-13	114	4	4	4	NUM
amwa-13	114	5	.	.	PUNCT
amwa-13	115	1	hoffmann	hoffmann	PROPN
amwa-13	115	2	m	m	PROPN
amwa-13	115	3	,	,	PUNCT
amwa-13	115	4	kleine	kleine	PROPN
amwa-13	115	5	-	-	PUNCT
amwa-13	115	6	weber	weber	PROPN
amwa-13	115	7	h	h	PROPN
amwa-13	115	8	,	,	PUNCT
amwa-13	115	9	schroeder	schroeder	PROPN
amwa-13	115	10	s	s	PROPN
amwa-13	115	11	,	,	PUNCT
amwa-13	115	12	et	et	PROPN
amwa-13	115	13	al	al	PROPN
amwa-13	115	14	.	.	PUNCT
amwa-13	116	1	sars	sars	PROPN
amwa-13	116	2	-	-	PUNCT
amwa-13	116	3	cov-2	cov-2	PART
amwa-13	116	4	cell	cell	NOUN
amwa-13	116	5	entry	entry	NOUN
amwa-13	116	6	depends	depend	VERB
amwa-13	116	7	on	on	ADP
amwa-13	116	8	ace2	ace2	NOUN
amwa-13	116	9	and	and	CCONJ
amwa-13	116	10	tmprss2	tmprss2	ADV
amwa-13	116	11	and	and	CCONJ
amwa-13	116	12	is	be	AUX
amwa-13	116	13	blocked	block	VERB
amwa-13	116	14	by	by	ADP
amwa-13	116	15	a	a	DET
amwa-13	116	16	clinically	clinically	ADV
amwa-13	116	17	proven	prove	VERB
amwa-13	116	18	protease	protease	NOUN
amwa-13	116	19	inhibitor	inhibitor	NOUN
amwa-13	116	20	.	.	PUNCT
amwa-13	117	1	cell	cell	NOUN
amwa-13	117	2	.	.	PUNCT
amwa-13	118	1	2020;181(2):271	2020;181(2):271	NOUN
amwa-13	118	2	-	-	SYM
amwa-13	118	3	280	280	NUM
amwa-13	118	4	,	,	PUNCT
amwa-13	118	5	e8	e8	PROPN
amwa-13	118	6	.	.	PROPN
amwa-13	118	7	doi:10.1016	doi:10.1016	PROPN
amwa-13	118	8	/	/	SYM
amwa-13	118	9	j.	j.	PROPN
amwa-13	118	10	cell.2020.02.052	cell.2020.02.052	PRON
amwa-13	119	1	5	5	NUM
amwa-13	119	2	.	.	PUNCT
amwa-13	120	1	wang	wang	PROPN
amwa-13	120	2	q	q	PROPN
amwa-13	120	3	,	,	PUNCT
amwa-13	120	4	zhang	zhang	PROPN
amwa-13	120	5	y	y	PROPN
amwa-13	120	6	,	,	PUNCT
amwa-13	120	7	wu	wu	PROPN
amwa-13	120	8	l	l	PROPN
amwa-13	120	9	,	,	PUNCT
amwa-13	120	10	et	et	PROPN
amwa-13	120	11	al	al	PROPN
amwa-13	120	12	.	.	PROPN
amwa-13	121	1	structural	structural	ADJ
amwa-13	121	2	and	and	CCONJ
amwa-13	121	3	functional	functional	ADJ
amwa-13	121	4	basis	basis	NOUN
amwa-13	121	5	of	of	ADP
amwa-13	121	6	sarscov-2	sarscov-2	NUM
amwa-13	121	7	entry	entry	NOUN
amwa-13	121	8	by	by	ADP
amwa-13	121	9	using	use	VERB
amwa-13	121	10	human	human	ADJ
amwa-13	121	11	ace2	ace2	NOUN
amwa-13	121	12	.	.	PUNCT
amwa-13	122	1	cell	cell	NOUN
amwa-13	122	2	.	.	PUNCT
amwa-13	123	1	2020;181(4):894	2020;181(4):894	NUM
amwa-13	123	2	-	-	SYM
amwa-13	123	3	904	904	NUM
amwa-13	123	4	,	,	PUNCT
amwa-13	123	5	e9	e9	PROPN
amwa-13	123	6	.	.	PUNCT
amwa-13	123	7	doi:10.1016	doi:10.1016	PROPN
amwa-13	123	8	/	/	SYM
amwa-13	123	9	j.cell.2020.03.045	j.cell.2020.03.045	ADV
amwa-13	123	10	6	6	NUM
amwa-13	123	11	.	.	PUNCT
amwa-13	124	1	chen	chen	PROPN
amwa-13	124	2	l	l	PROPN
amwa-13	124	3	,	,	PUNCT
amwa-13	124	4	li	li	PROPN
amwa-13	124	5	x	x	PROPN
amwa-13	124	6	,	,	PUNCT
amwa-13	124	7	chen	chen	PROPN
amwa-13	124	8	m	m	PROPN
amwa-13	124	9	,	,	PUNCT
amwa-13	124	10	feng	feng	PROPN
amwa-13	124	11	y	y	PROPN
amwa-13	124	12	,	,	PUNCT
amwa-13	124	13	xiong	xiong	PROPN
amwa-13	124	14	c.	c.	PROPN
amwa-13	125	1	the	the	DET
amwa-13	125	2	ace2	ace2	PROPN
amwa-13	125	3	expression	expression	NOUN
amwa-13	125	4	in	in	ADP
amwa-13	125	5	human	human	ADJ
amwa-13	125	6	heart	heart	NOUN
amwa-13	125	7	indicates	indicate	VERB
amwa-13	125	8	new	new	ADJ
amwa-13	125	9	potential	potential	ADJ
amwa-13	125	10	mechanism	mechanism	NOUN
amwa-13	125	11	of	of	ADP
amwa-13	125	12	heart	heart	NOUN
amwa-13	125	13	injury	injury	NOUN
amwa-13	125	14	among	among	ADP
amwa-13	125	15	patients	patient	NOUN
amwa-13	125	16	infected	infect	VERB
amwa-13	125	17	with	with	ADP
amwa-13	125	18	sars	sar	NOUN
amwa-13	125	19	-	-	PUNCT
amwa-13	125	20	cov-2	cov-2	NOUN
amwa-13	125	21	.	.	PUNCT
amwa-13	125	22	cardiovasc	cardiovasc	PROPN
amwa-13	125	23	res	res	PROPN
amwa-13	125	24	.	.	PUNCT
amwa-13	126	1	2020;116(6):10971100	2020;116(6):10971100	NUM
amwa-13	126	2	.	.	PUNCT
amwa-13	126	3	doi:10.1093	doi:10.1093	NOUN
amwa-13	126	4	/	/	SYM
amwa-13	126	5	cvr	cvr	PROPN
amwa-13	126	6	/	/	SYM
amwa-13	126	7	cvaa078	cvaa078	PROPN
amwa-13	126	8	7	7	NUM
amwa-13	126	9	.	.	NUM
amwa-13	126	10	nicin	nicin	NUM
amwa-13	126	11	l	l	NOUN
amwa-13	126	12	,	,	PUNCT
amwa-13	126	13	abplanalp	abplanalp	NOUN
amwa-13	126	14	wt	wt	PROPN
amwa-13	126	15	,	,	PUNCT
amwa-13	126	16	mellentin	mellentin	PROPN
amwa-13	126	17	h	h	NOUN
amwa-13	126	18	,	,	PUNCT
amwa-13	126	19	et	et	PROPN
amwa-13	126	20	al	al	PROPN
amwa-13	126	21	.	.	PROPN
amwa-13	126	22	cell	cell	NOUN
amwa-13	126	23	type	type	NOUN
amwa-13	126	24	-	-	PUNCT
amwa-13	126	25	specific	specific	ADJ
amwa-13	126	26	expression	expression	NOUN
amwa-13	126	27	of	of	ADP
amwa-13	126	28	the	the	DET
amwa-13	126	29	putative	putative	ADJ
amwa-13	126	30	sars	sar	NOUN
amwa-13	126	31	-	-	PUNCT
amwa-13	126	32	cov-2	cov-2	NOUN
amwa-13	126	33	receptor	receptor	NOUN
amwa-13	126	34	ace2	ace2	NOUN
amwa-13	126	35	in	in	ADP
amwa-13	126	36	human	human	ADJ
amwa-13	126	37	hearts	heart	NOUN
amwa-13	126	38	.	.	PUNCT
amwa-13	127	1	eur	eur	PROPN
amwa-13	127	2	heart	heart	NOUN
amwa-13	127	3	j.	j.	PROPN
amwa-13	127	4	2020;41(19):1804	2020;41(19):1804	PROPN
amwa-13	127	5	-	-	SYM
amwa-13	127	6	1806	1806	NUM
amwa-13	127	7	.	.	PUNCT
amwa-13	128	1	doi:10.1093	doi:10.1093	NOUN
amwa-13	128	2	/	/	SYM
amwa-13	128	3	eurheartj	eurheartj	PROPN
amwa-13	128	4	/	/	SYM
amwa-13	128	5	ehaa311	ehaa311	NOUN
amwa-13	128	6	8	8	NUM
amwa-13	128	7	.	.	PUNCT
amwa-13	129	1	litvinuková	litvinuková	PROPN
amwa-13	129	2	m	m	PROPN
amwa-13	129	3	,	,	PUNCT
amwa-13	129	4	talavera	talavera	NOUN
amwa-13	129	5	-	-	PUNCT
amwa-13	129	6	lópez	lópez	NOUN
amwa-13	129	7	c	c	NOUN
amwa-13	129	8	,	,	PUNCT
amwa-13	129	9	maatz	maatz	PROPN
amwa-13	129	10	h	h	NOUN
amwa-13	129	11	,	,	PUNCT
amwa-13	129	12	et	et	PROPN
amwa-13	129	13	al	al	PROPN
amwa-13	129	14	.	.	PUNCT
amwa-13	129	15	cells	cell	NOUN
amwa-13	129	16	of	of	ADP
amwa-13	129	17	the	the	DET
amwa-13	129	18	adult	adult	NOUN
amwa-13	129	19	human	human	ADJ
amwa-13	129	20	heart	heart	NOUN
amwa-13	129	21	.	.	PUNCT
amwa-13	130	1	nature	nature	NOUN
amwa-13	130	2	.	.	PUNCT
amwa-13	131	1	2020;588(7838):466	2020;588(7838):466	NUM
amwa-13	131	2	-	-	SYM
amwa-13	131	3	472	472	NUM
amwa-13	131	4	.	.	PUNCT
amwa-13	132	1	doi:10.1038	doi:10.1038	NOUN
amwa-13	132	2	/	/	SYM
amwa-13	132	3	s41586	s41586	PROPN
amwa-13	132	4	-	-	PUNCT
amwa-13	132	5	0202797	0202797	NUM
amwa-13	132	6	-	-	PUNCT
amwa-13	132	7	4	4	NUM
amwa-13	132	8	9	9	NUM
amwa-13	132	9	.	.	PUNCT
amwa-13	133	1	gallagher	gallagher	PROPN
amwa-13	133	2	pe	pe	PROPN
amwa-13	133	3	,	,	PUNCT
amwa-13	133	4	ferrario	ferrario	NOUN
amwa-13	133	5	cm	cm	NOUN
amwa-13	133	6	,	,	PUNCT
amwa-13	133	7	tallant	tallant	NOUN
amwa-13	133	8	ea	ea	NOUN
amwa-13	133	9	.	.	PUNCT
amwa-13	133	10	regulation	regulation	NOUN
amwa-13	133	11	of	of	ADP
amwa-13	133	12	ace2	ace2	NOUN
amwa-13	133	13	in	in	ADP
amwa-13	133	14	cardiac	cardiac	ADJ
amwa-13	133	15	myocytes	myocyte	NOUN
amwa-13	133	16	and	and	CCONJ
amwa-13	133	17	fibroblasts	fibroblast	NOUN
amwa-13	133	18	.	.	PUNCT
amwa-13	133	19	am	be	AUX
amwa-13	133	20	j	j	PROPN
amwa-13	133	21	physiol	physiol	PROPN
amwa-13	133	22	-	-	PUNCT
amwa-13	133	23	heart	heart	PROPN
amwa-13	133	24	circ	circ	PROPN
amwa-13	133	25	physiol	physiol	PROPN
amwa-13	133	26	.	.	PUNCT
amwa-13	134	1	2008;295(6):h2373	2008;295(6):h2373	X
amwa-13	134	2	-	-	SYM
amwa-13	134	3	h2379	h2379	PROPN
amwa-13	134	4	.	.	PROPN
amwa-13	134	5	doi:10.1152	doi:10.1152	NOUN
amwa-13	134	6	/	/	SYM
amwa-13	134	7	ajpheart.00426.2008	ajpheart.00426.2008	NOUN
amwa-13	134	8	10	10	NUM
amwa-13	134	9	.	.	PUNCT
amwa-13	135	1	pérez	pérez	NOUN
amwa-13	135	2	-	-	PUNCT
amwa-13	135	3	bermejo	bermejo	PROPN
amwa-13	135	4	ja	ja	PROPN
amwa-13	135	5	,	,	PUNCT
amwa-13	135	6	kang	kang	PROPN
amwa-13	135	7	s	s	PROPN
amwa-13	135	8	,	,	PUNCT
amwa-13	135	9	rockwood	rockwood	PROPN
amwa-13	135	10	sj	sj	PROPN
amwa-13	135	11	,	,	PUNCT
amwa-13	135	12	et	et	PROPN
amwa-13	135	13	al	al	PROPN
amwa-13	135	14	.	.	PUNCT
amwa-13	136	1	sars	sars	PROPN
amwa-13	136	2	-	-	PUNCT
amwa-13	136	3	cov-2	cov-2	PART
amwa-13	136	4	infection	infection	NOUN
amwa-13	136	5	of	of	ADP
amwa-13	136	6	human	human	ADJ
amwa-13	136	7	ipsc	ipsc	NOUN
amwa-13	136	8	-	-	PUNCT
amwa-13	136	9	derived	derive	VERB
amwa-13	136	10	cardiac	cardiac	ADJ
amwa-13	136	11	cells	cell	NOUN
amwa-13	136	12	predicts	predict	VERB
amwa-13	136	13	novel	novel	ADJ
amwa-13	136	14	cytopathic	cytopathic	ADJ
amwa-13	136	15	features	feature	NOUN
amwa-13	136	16	in	in	ADP
amwa-13	136	17	hearts	heart	NOUN
amwa-13	136	18	of	of	ADP
amwa-13	136	19	covid-19	covid-19	PROPN
amwa-13	136	20	patients	patient	NOUN
amwa-13	136	21	.	.	PUNCT
amwa-13	137	1	sci	sci	PROPN
amwa-13	137	2	transl	transl	PROPN
amwa-13	137	3	med	med	PROPN
amwa-13	137	4	.	.	PUNCT
amwa-13	138	1	published	publish	VERB
amwa-13	138	2	online	online	ADJ
amwa-13	138	3	march	march	PROPN
amwa-13	138	4	15	15	NUM
amwa-13	138	5	,	,	PUNCT
amwa-13	138	6	2021	2021	NUM
amwa-13	138	7	.	.	PUNCT
amwa-13	139	1	doi:10.1126	doi:10.1126	NOUN
amwa-13	139	2	/	/	SYM
amwa-13	139	3	scitranslmed.abf7872	scitranslmed.abf7872	NUM
amwa-13	139	4	11	11	NUM
amwa-13	139	5	.	.	PUNCT
amwa-13	140	1	hikmet	hikmet	PROPN
amwa-13	140	2	f	f	PROPN
amwa-13	140	3	,	,	PUNCT
amwa-13	140	4	méar	méar	PROPN
amwa-13	140	5	l	l	PROPN
amwa-13	140	6	,	,	PUNCT
amwa-13	140	7	edvinsson	edvinsson	PROPN
amwa-13	140	8	å	å	PROPN
amwa-13	140	9	,	,	PUNCT
amwa-13	140	10	micke	micke	PROPN
amwa-13	140	11	p	p	PROPN
amwa-13	140	12	,	,	PUNCT
amwa-13	140	13	uhlén	uhlén	PROPN
amwa-13	140	14	m	m	PROPN
amwa-13	140	15	,	,	PUNCT
amwa-13	140	16	lindskog	lindskog	PROPN
amwa-13	140	17	c.	c.	PROPN
amwa-13	140	18	the	the	DET
amwa-13	140	19	protein	protein	NOUN
amwa-13	140	20	expression	expression	NOUN
amwa-13	140	21	profile	profile	NOUN
amwa-13	140	22	of	of	ADP
amwa-13	140	23	ace2	ace2	PROPN
amwa-13	140	24	in	in	ADP
amwa-13	140	25	human	human	ADJ
amwa-13	140	26	tissues	tissue	NOUN
amwa-13	140	27	.	.	PUNCT
amwa-13	141	1	mol	mol	ADP
amwa-13	141	2	syst	syst	PROPN
amwa-13	141	3	biol	biol	PROPN
amwa-13	141	4	.	.	PUNCT
amwa-13	142	1	2020;16(7):e9610	2020;16(7):e9610	NUM
amwa-13	142	2	.	.	PUNCT
amwa-13	142	3	doi:10.15252	doi:10.15252	PROPN
amwa-13	142	4	/	/	SYM
amwa-13	142	5	msb.20209610	msb.20209610	PROPN
amwa-13	142	6	12	12	NUM
amwa-13	142	7	.	.	PUNCT
amwa-13	143	1	hamming	ham	VERB
amwa-13	143	2	i	i	PRON
amwa-13	143	3	,	,	PUNCT
amwa-13	143	4	timens	timens	PROPN
amwa-13	143	5	w	w	PROPN
amwa-13	143	6	,	,	PUNCT
amwa-13	143	7	bulthuis	bulthuis	PROPN
amwa-13	143	8	mlc	mlc	PROPN
amwa-13	143	9	,	,	PUNCT
amwa-13	143	10	lely	lely	ADV
amwa-13	143	11	at	at	ADP
amwa-13	143	12	,	,	PUNCT
amwa-13	143	13	navis	navis	PROPN
amwa-13	143	14	gj	gj	PROPN
amwa-13	143	15	,	,	PUNCT
amwa-13	143	16	van	van	PROPN
amwa-13	143	17	goor	goor	PROPN
amwa-13	143	18	h.	h.	PROPN
amwa-13	143	19	tissue	tissue	NOUN
amwa-13	143	20	distribution	distribution	NOUN
amwa-13	143	21	of	of	ADP
amwa-13	143	22	ace2	ace2	NOUN
amwa-13	143	23	protein	protein	NOUN
amwa-13	143	24	,	,	PUNCT
amwa-13	143	25	the	the	DET
amwa-13	143	26	functional	functional	ADJ
amwa-13	143	27	receptor	receptor	NOUN
amwa-13	143	28	for	for	ADP
amwa-13	143	29	sars	sars	PROPN
amwa-13	143	30	coronavirus	coronavirus	PROPN
amwa-13	143	31	.	.	PUNCT
amwa-13	144	1	a	a	DET
amwa-13	144	2	first	first	ADJ
amwa-13	144	3	step	step	NOUN
amwa-13	144	4	in	in	ADP
amwa-13	144	5	understanding	understand	VERB
amwa-13	144	6	sars	sar	NOUN
amwa-13	144	7	pathogenesis	pathogenesis	NOUN
amwa-13	144	8	.	.	PUNCT
amwa-13	145	1	j	j	PROPN
amwa-13	145	2	pathol	pathol	NOUN
amwa-13	145	3	.	.	PUNCT
amwa-13	146	1	2004;203(2):631	2004;203(2):631	NUM
amwa-13	146	2	-	-	PUNCT
amwa-13	146	3	637	637	NUM
amwa-13	146	4	.	.	PUNCT
amwa-13	147	1	doi:10.1002	doi:10.1002	NOUN
amwa-13	147	2	/	/	SYM
amwa-13	147	3	path.1570	path.1570	PROPN
amwa-13	147	4	13	13	NUM
amwa-13	147	5	.	.	PUNCT
amwa-13	148	1	bertram	bertram	PROPN
amwa-13	148	2	s	s	PROPN
amwa-13	148	3	,	,	PUNCT
amwa-13	148	4	heurich	heurich	NOUN
amwa-13	148	5	a	a	DET
amwa-13	148	6	,	,	PUNCT
amwa-13	148	7	lavender	lavender	ADJ
amwa-13	148	8	h	h	NOUN
amwa-13	148	9	,	,	PUNCT
amwa-13	148	10	et	et	PROPN
amwa-13	148	11	al	al	PROPN
amwa-13	148	12	.	.	PUNCT
amwa-13	148	13	influenza	influenza	NOUN
amwa-13	148	14	and	and	CCONJ
amwa-13	148	15	sarscoronavirus	sarscoronavirus	NOUN
amwa-13	148	16	activating	activate	VERB
amwa-13	148	17	proteases	protease	NOUN
amwa-13	148	18	tmprss2	tmprss2	NOUN
amwa-13	148	19	and	and	CCONJ
amwa-13	148	20	hat	hat	NOUN
amwa-13	148	21	are	be	AUX
amwa-13	148	22	expressed	express	VERB
amwa-13	148	23	at	at	ADP
amwa-13	148	24	multiple	multiple	ADJ
amwa-13	148	25	sites	site	NOUN
amwa-13	148	26	in	in	ADP
amwa-13	148	27	human	human	ADJ
amwa-13	148	28	respiratory	respiratory	ADJ
amwa-13	148	29	and	and	CCONJ
amwa-13	148	30	gastrointestinal	gastrointestinal	ADJ
amwa-13	148	31	tracts	tract	NOUN
amwa-13	148	32	.	.	PUNCT
amwa-13	149	1	plos	plos	PROPN
amwa-13	149	2	one	one	NUM
amwa-13	149	3	.	.	PUNCT
amwa-13	150	1	2012;7(4):e35876	2012;7(4):e35876	NUM
amwa-13	150	2	.	.	PUNCT
amwa-13	151	1	doi:10.1371	doi:10.1371	PROPN
amwa-13	151	2	/	/	PUNCT
amwa-13	152	1	journal.pone.0035876	journal.pone.0035876	PROPN
amwa-13	152	2	14	14	NUM
amwa-13	152	3	.	.	PUNCT
amwa-13	153	1	zheng	zheng	PROPN
amwa-13	153	2	j	j	PROPN
amwa-13	153	3	,	,	PUNCT
amwa-13	153	4	wang	wang	PROPN
amwa-13	153	5	y	y	PROPN
amwa-13	153	6	,	,	PUNCT
amwa-13	153	7	li	li	PROPN
amwa-13	153	8	k	k	PROPN
amwa-13	153	9	,	,	PUNCT
amwa-13	153	10	meyerholz	meyerholz	PROPN
amwa-13	153	11	dk	dk	PROPN
amwa-13	153	12	,	,	PUNCT
amwa-13	153	13	allamargot	allamargot	VERB
amwa-13	153	14	c	c	NOUN
amwa-13	153	15	,	,	PUNCT
amwa-13	153	16	perlman	perlman	NOUN
amwa-13	153	17	s.	s.	PROPN
amwa-13	153	18	severe	severe	ADJ
amwa-13	153	19	acute	acute	ADJ
amwa-13	153	20	respiratory	respiratory	ADJ
amwa-13	153	21	syndrome	syndrome	NOUN
amwa-13	153	22	coronavirus	coronavirus	NOUN
amwa-13	153	23	2	2	NUM
amwa-13	153	24	–	–	PUNCT
amwa-13	153	25	induced	induce	VERB
amwa-13	153	26	immune	immune	ADJ
amwa-13	153	27	activation	activation	NOUN
amwa-13	153	28	and	and	CCONJ
amwa-13	153	29	death	death	NOUN
amwa-13	153	30	of	of	ADP
amwa-13	153	31	monocyte	monocyte	NOUN
amwa-13	153	32	-	-	PUNCT
amwa-13	153	33	derived	derive	VERB
amwa-13	153	34	human	human	ADJ
amwa-13	153	35	macrophages	macrophage	NOUN
amwa-13	153	36	and	and	CCONJ
amwa-13	153	37	dendritic	dendritic	ADJ
amwa-13	153	38	cells	cell	NOUN
amwa-13	153	39	.	.	PUNCT
amwa-13	154	1	j	j	PROPN
amwa-13	154	2	infect	infect	VERB
amwa-13	154	3	dis	dis	PROPN
amwa-13	154	4	.	.	PUNCT
amwa-13	155	1	2021;223:785	2021;223:785	NUM
amwa-13	155	2	-	-	SYM
amwa-13	155	3	795	795	NUM
amwa-13	155	4	.	.	PUNCT
amwa-13	155	5	doi:10.1093	doi:10.1093	NOUN
amwa-13	155	6	/	/	SYM
amwa-13	155	7	infdis	infdis	PROPN
amwa-13	155	8	/	/	SYM
amwa-13	155	9	jiaa753	jiaa753	PROPN
amwa-13	155	10	15	15	NUM
amwa-13	155	11	.	.	PUNCT
amwa-13	156	1	akhmerov	akhmerov	PROPN
amwa-13	156	2	a	a	DET
amwa-13	156	3	,	,	PUNCT
amwa-13	156	4	marbán	marbán	ADJ
amwa-13	156	5	e.	e.	PROPN
amwa-13	156	6	covid-19	covid-19	PROPN
amwa-13	156	7	and	and	CCONJ
amwa-13	156	8	the	the	DET
amwa-13	156	9	heart	heart	NOUN
amwa-13	156	10	.	.	PUNCT
amwa-13	157	1	circ	circ	PROPN
amwa-13	157	2	res	re	NOUN
amwa-13	157	3	.	.	PUNCT
amwa-13	158	1	2020;126(10):1443	2020;126(10):1443	NUM
amwa-13	158	2	-	-	SYM
amwa-13	158	3	1455	1455	NUM
amwa-13	158	4	.	.	PUNCT
amwa-13	159	1	doi:10.1161	doi:10.1161	ADJ
amwa-13	159	2	/	/	SYM
amwa-13	159	3	circresaha.120.317055	circresaha.120.317055	PROPN
amwa-13	159	4	16	16	NUM
amwa-13	159	5	.	.	PUNCT
amwa-13	160	1	atri	atri	PROPN
amwa-13	160	2	d	d	PROPN
amwa-13	160	3	,	,	PUNCT
amwa-13	160	4	siddiqi	siddiqi	PROPN
amwa-13	160	5	hk	hk	PROPN
amwa-13	160	6	,	,	PUNCT
amwa-13	160	7	lang	lang	PROPN
amwa-13	160	8	jp	jp	PROPN
amwa-13	160	9	,	,	PUNCT
amwa-13	160	10	nauffal	nauffal	PROPN
amwa-13	160	11	v	v	PROPN
amwa-13	160	12	,	,	PUNCT
amwa-13	160	13	morrow	morrow	PROPN
amwa-13	160	14	da	da	PROPN
amwa-13	160	15	,	,	PUNCT
amwa-13	160	16	bohula	bohula	ADP
amwa-13	160	17	ea	ea	PRON
amwa-13	160	18	.	.	PUNCT
amwa-13	161	1	covid-19	covid-19	PROPN
amwa-13	161	2	for	for	ADP
amwa-13	161	3	the	the	DET
amwa-13	161	4	cardiologist	cardiologist	NOUN
amwa-13	161	5	:	:	PUNCT
amwa-13	161	6	basic	basic	ADJ
amwa-13	161	7	virology	virology	NOUN
amwa-13	161	8	,	,	PUNCT
amwa-13	161	9	epidemiology	epidemiology	NOUN
amwa-13	161	10	,	,	PUNCT
amwa-13	161	11	cardiac	cardiac	ADJ
amwa-13	161	12	manifestations	manifestation	NOUN
amwa-13	161	13	,	,	PUNCT
amwa-13	161	14	and	and	CCONJ
amwa-13	161	15	potential	potential	ADJ
amwa-13	161	16	therapeutic	therapeutic	ADJ
amwa-13	161	17	strategies	strategy	NOUN
amwa-13	161	18	.	.	PUNCT
amwa-13	162	1	jacc	jacc	VERB
amwa-13	162	2	basic	basic	ADJ
amwa-13	162	3	transl	transl	PROPN
amwa-13	162	4	sci	sci	PROPN
amwa-13	162	5	.	.	PUNCT
amwa-13	163	1	2020;5(5):518	2020;5(5):518	NUM
amwa-13	163	2	-	-	SYM
amwa-13	163	3	536	536	NUM
amwa-13	163	4	.	.	PUNCT
amwa-13	164	1	doi:10.1016	doi:10.1016	PROPN
amwa-13	164	2	/	/	SYM
amwa-13	164	3	j.jacbts.2020.04.002	j.jacbts.2020.04.002	NOUN
amwa-13	164	4	17	17	NUM
amwa-13	164	5	.	.	PUNCT
amwa-13	165	1	guzik	guzik	NOUN
amwa-13	165	2	tj	tj	PROPN
amwa-13	165	3	,	,	PUNCT
amwa-13	165	4	mohiddin	mohiddin	NOUN
amwa-13	165	5	sa	sa	NOUN
amwa-13	165	6	,	,	PUNCT
amwa-13	165	7	dimarco	dimarco	PROPN
amwa-13	165	8	a	a	PROPN
amwa-13	165	9	,	,	PUNCT
amwa-13	165	10	et	et	PROPN
amwa-13	165	11	al	al	PROPN
amwa-13	165	12	.	.	PUNCT
amwa-13	166	1	covid-19	covid-19	PROPN
amwa-13	166	2	and	and	CCONJ
amwa-13	166	3	the	the	DET
amwa-13	166	4	cardiovascular	cardiovascular	ADJ
amwa-13	166	5	system	system	NOUN
amwa-13	166	6	:	:	PUNCT
amwa-13	166	7	implications	implication	NOUN
amwa-13	166	8	for	for	ADP
amwa-13	166	9	risk	risk	NOUN
amwa-13	166	10	assessment	assessment	NOUN
amwa-13	166	11	,	,	PUNCT
amwa-13	166	12	diagnosis	diagnosis	NOUN
amwa-13	166	13	,	,	PUNCT
amwa-13	166	14	and	and	CCONJ
amwa-13	166	15	treatment	treatment	NOUN
amwa-13	166	16	options	option	NOUN
amwa-13	166	17	.	.	PUNCT
amwa-13	167	1	cardiovasc	cardiovasc	PROPN
amwa-13	167	2	res	re	NOUN
amwa-13	167	3	.	.	PUNCT
amwa-13	168	1	2020;116(10):1666	2020;116(10):1666	NUM
amwa-13	168	2	-	-	NUM
amwa-13	168	3	1687	1687	NUM
amwa-13	168	4	.	.	PUNCT
amwa-13	169	1	doi:10.1093/	doi:10.1093/	VERB
amwa-13	169	2	cvr	cvr	NOUN
amwa-13	169	3	/	/	SYM
amwa-13	169	4	cvaa106	cvaa106	PROPN
amwa-13	169	5	18	18	NUM
amwa-13	169	6	.	.	PUNCT
amwa-13	170	1	wang	wang	PROPN
amwa-13	170	2	d	d	PROPN
amwa-13	170	3	,	,	PUNCT
amwa-13	170	4	hu	hu	PROPN
amwa-13	170	5	b	b	PROPN
amwa-13	170	6	,	,	PUNCT
amwa-13	170	7	hu	hu	PROPN
amwa-13	171	1	c	c	X
amwa-13	171	2	,	,	PUNCT
amwa-13	171	3	et	et	PROPN
amwa-13	171	4	al	al	PROPN
amwa-13	171	5	.	.	PROPN
amwa-13	172	1	clinical	clinical	ADJ
amwa-13	172	2	characteristics	characteristic	NOUN
amwa-13	172	3	of	of	ADP
amwa-13	172	4	138	138	NUM
amwa-13	172	5	hospitalized	hospitalize	VERB
amwa-13	172	6	patients	patient	NOUN
amwa-13	172	7	with	with	ADP
amwa-13	172	8	2019	2019	NUM
amwa-13	172	9	novel	novel	ADJ
amwa-13	172	10	coronavirus	coronavirus	NOUN
amwa-13	172	11	–	–	PUNCT
amwa-13	172	12	infected	infected	ADJ
amwa-13	172	13	pneumonia	pneumonia	NOUN
amwa-13	172	14	in	in	ADP
amwa-13	172	15	wuhan	wuhan	PROPN
amwa-13	172	16	,	,	PUNCT
amwa-13	172	17	china	china	PROPN
amwa-13	172	18	.	.	PUNCT
amwa-13	173	1	jama	jama	PROPN
amwa-13	173	2	.	.	PUNCT
amwa-13	174	1	2020;323(11):1061	2020;323(11):1061	NUM
amwa-13	174	2	-	-	SYM
amwa-13	174	3	1069	1069	NUM
amwa-13	174	4	.	.	PUNCT
amwa-13	175	1	doi:10.1001	doi:10.1001	PROPN
amwa-13	175	2	/	/	SYM
amwa-13	175	3	jama.2020.1585	jama.2020.1585	PROPN
amwa-13	175	4	19	19	NUM
amwa-13	175	5	.	.	PUNCT
amwa-13	176	1	lala	lala	PROPN
amwa-13	176	2	a	a	PROPN
amwa-13	176	3	,	,	PUNCT
amwa-13	176	4	johnson	johnson	PROPN
amwa-13	176	5	kw	kw	PROPN
amwa-13	176	6	,	,	PUNCT
amwa-13	176	7	januzzi	januzzi	ADJ
amwa-13	176	8	jl	jl	PROPN
amwa-13	176	9	,	,	PUNCT
amwa-13	176	10	et	et	PROPN
amwa-13	176	11	al	al	PROPN
amwa-13	176	12	.	.	PUNCT
amwa-13	177	1	prevalence	prevalence	NOUN
amwa-13	177	2	and	and	CCONJ
amwa-13	177	3	impact	impact	NOUN
amwa-13	177	4	of	of	ADP
amwa-13	177	5	myocardial	myocardial	ADJ
amwa-13	177	6	injury	injury	NOUN
amwa-13	177	7	in	in	ADP
amwa-13	177	8	patients	patient	NOUN
amwa-13	177	9	hospitalized	hospitalize	VERB
amwa-13	177	10	with	with	ADP
amwa-13	177	11	covid-19	covid-19	PROPN
amwa-13	177	12	infection	infection	NOUN
amwa-13	177	13	.	.	PUNCT
amwa-13	178	1	j	j	PROPN
amwa-13	178	2	am	be	AUX
amwa-13	178	3	coll	coll	PROPN
amwa-13	178	4	cardiol	cardiol	NOUN
amwa-13	178	5	.	.	PUNCT
amwa-13	179	1	2020;76(5):533	2020;76(5):533	NUM
amwa-13	179	2	-	-	SYM
amwa-13	179	3	546	546	NUM
amwa-13	179	4	.	.	PUNCT
amwa-13	180	1	doi:10.1016	doi:10.1016	PROPN
amwa-13	180	2	/	/	SYM
amwa-13	180	3	j.jacc.2020.06.007	j.jacc.2020.06.007	PROPN
amwa-13	180	4	20	20	NUM
amwa-13	180	5	.	.	PUNCT
amwa-13	181	1	casas	casas	PROPN
amwa-13	181	2	-	-	PUNCT
amwa-13	181	3	rojo	rojo	PROPN
amwa-13	181	4	jm	jm	PROPN
amwa-13	181	5	,	,	PUNCT
amwa-13	181	6	antón	antón	PROPN
amwa-13	181	7	-	-	PUNCT
amwa-13	181	8	santos	santos	PROPN
amwa-13	181	9	jm	jm	PROPN
amwa-13	181	10	,	,	PUNCT
amwa-13	181	11	millán	millán	NOUN
amwa-13	181	12	-	-	PUNCT
amwa-13	181	13	núñez	núñez	NOUN
amwa-13	181	14	-	-	PUNCT
amwa-13	181	15	cortés	cortés	NOUN
amwa-13	181	16	j	j	PROPN
amwa-13	181	17	,	,	PUNCT
amwa-13	181	18	et	et	PROPN
amwa-13	181	19	al	al	PROPN
amwa-13	181	20	.	.	PROPN
amwa-13	182	1	clinical	clinical	ADJ
amwa-13	182	2	characteristics	characteristic	NOUN
amwa-13	182	3	of	of	ADP
amwa-13	182	4	patients	patient	NOUN
amwa-13	182	5	hospitalized	hospitalize	VERB
amwa-13	182	6	with	with	ADP
amwa-13	182	7	covid-19	covid-19	PROPN
amwa-13	182	8	in	in	ADP
amwa-13	182	9	spain	spain	PROPN
amwa-13	182	10	:	:	PUNCT
amwa-13	182	11	results	result	NOUN
amwa-13	182	12	from	from	ADP
amwa-13	182	13	the	the	DET
amwa-13	182	14	semi	semi	ADJ
amwa-13	182	15	-	-	ADJ
amwa-13	182	16	covid-19	covid-19	ADJ
amwa-13	182	17	registry	registry	NOUN
amwa-13	182	18	.	.	PUNCT
amwa-13	183	1	rev	rev	PROPN
amwa-13	183	2	clínica	clínica	PROPN
amwa-13	183	3	esp	esp	PROPN
amwa-13	183	4	engl	engl	PROPN
amwa-13	183	5	ed	ed	PROPN
amwa-13	183	6	.	.	PUNCT
amwa-13	184	1	2020;220(8):480	2020;220(8):480	PROPN
amwa-13	184	2	-	-	PUNCT
amwa-13	184	3	494	494	NUM
amwa-13	184	4	.	.	PUNCT
amwa-13	185	1	doi:10.1016	doi:10.1016	PROPN
amwa-13	185	2	/	/	SYM
amwa-13	185	3	j.rceng.2020.07.003	j.rceng.2020.07.003	PROPN
amwa-13	185	4	21	21	NUM
amwa-13	185	5	.	.	PUNCT
amwa-13	186	1	inciardi	inciardi	PROPN
amwa-13	186	2	rm	rm	PROPN
amwa-13	186	3	,	,	PUNCT
amwa-13	186	4	lupi	lupi	PROPN
amwa-13	186	5	l	l	PROPN
amwa-13	186	6	,	,	PUNCT
amwa-13	186	7	zaccone	zaccone	NOUN
amwa-13	186	8	g	g	NOUN
amwa-13	186	9	,	,	PUNCT
amwa-13	186	10	et	et	PROPN
amwa-13	186	11	al	al	PROPN
amwa-13	186	12	.	.	PUNCT
amwa-13	186	13	cardiac	cardiac	ADJ
amwa-13	186	14	involvement	involvement	NOUN
amwa-13	186	15	in	in	ADP
amwa-13	186	16	a	a	DET
amwa-13	186	17	patient	patient	NOUN
amwa-13	186	18	with	with	ADP
amwa-13	186	19	coronavirus	coronavirus	NOUN
amwa-13	186	20	disease	disease	NOUN
amwa-13	186	21	2019	2019	NUM
amwa-13	186	22	(	(	PUNCT
amwa-13	186	23	covid-19	covid-19	PROPN
amwa-13	186	24	)	)	PUNCT
amwa-13	186	25	.	.	PUNCT
amwa-13	187	1	jama	jama	PROPN
amwa-13	187	2	cardiol	cardiol	PROPN
amwa-13	187	3	.	.	PUNCT
amwa-13	188	1	2020;5(7):819824	2020;5(7):819824	X
amwa-13	188	2	.	.	PUNCT
amwa-13	188	3	doi:10.1001	doi:10.1001	PROPN
amwa-13	188	4	/	/	SYM
amwa-13	188	5	jamacardio.2020.1096	jamacardio.2020.1096	NOUN
amwa-13	188	6	22	22	NUM
amwa-13	188	7	.	.	PUNCT
amwa-13	189	1	robinson	robinson	PROPN
amwa-13	189	2	fa	fa	PROPN
amwa-13	189	3	,	,	PUNCT
amwa-13	189	4	mihealsick	mihealsick	NOUN
amwa-13	189	5	ryanp	ryanp	PROPN
amwa-13	189	6	,	,	PUNCT
amwa-13	189	7	wagener	wagener	PROPN
amwa-13	189	8	bm	bm	PROPN
amwa-13	189	9	,	,	PUNCT
amwa-13	189	10	et	et	PROPN
amwa-13	189	11	al	al	PROPN
amwa-13	189	12	.	.	PUNCT
amwa-13	189	13	role	role	NOUN
amwa-13	189	14	of	of	ADP
amwa-13	189	15	angiotensinconverting	angiotensinconverte	VERB
amwa-13	189	16	enzyme	enzyme	NOUN
amwa-13	189	17	2	2	NUM
amwa-13	189	18	and	and	CCONJ
amwa-13	189	19	pericytes	pericyte	NOUN
amwa-13	189	20	in	in	ADP
amwa-13	189	21	cardiac	cardiac	ADJ
amwa-13	189	22	complications	complication	NOUN
amwa-13	189	23	of	of	ADP
amwa-13	189	24	covid-19	covid-19	PROPN
amwa-13	189	25	infection	infection	NOUN
amwa-13	189	26	.	.	PUNCT
amwa-13	190	1	am	be	AUX
amwa-13	190	2	j	j	PROPN
amwa-13	190	3	physiol	physiol	PROPN
amwa-13	190	4	-	-	PUNCT
amwa-13	190	5	heart	heart	PROPN
amwa-13	190	6	circ	circ	PROPN
amwa-13	190	7	physiol	physiol	PROPN
amwa-13	190	8	.	.	PUNCT
amwa-13	191	1	2020;319(5):h1059	2020;319(5):h1059	NUM
amwa-13	191	2	-	-	SYM
amwa-13	191	3	h1068	h1068	NOUN
amwa-13	191	4	.	.	PUNCT
amwa-13	191	5	doi:10.1152	doi:10.1152	PROPN
amwa-13	191	6	/	/	SYM
amwa-13	191	7	ajpheart.00681.2020	ajpheart.00681.2020	PROPN
amwa-13	191	8	23	23	NUM
amwa-13	191	9	.	.	PUNCT
amwa-13	192	1	long	long	ADJ
amwa-13	192	2	h	h	NOUN
amwa-13	192	3	,	,	PUNCT
amwa-13	192	4	nie	nie	PROPN
amwa-13	192	5	l	l	PROPN
amwa-13	192	6	,	,	PUNCT
amwa-13	192	7	xiang	xiang	PROPN
amwa-13	192	8	x	x	PROPN
amwa-13	192	9	,	,	PUNCT
amwa-13	192	10	et	et	PROPN
amwa-13	192	11	al	al	PROPN
amwa-13	192	12	.	.	PUNCT
amwa-13	193	1	d	d	X
amwa-13	193	2	-	-	PUNCT
amwa-13	193	3	dimer	dimer	NOUN
amwa-13	193	4	and	and	CCONJ
amwa-13	193	5	prothrombin	prothrombin	ADJ
amwa-13	193	6	time	time	NOUN
amwa-13	193	7	are	be	AUX
amwa-13	193	8	the	the	DET
amwa-13	193	9	significant	significant	ADJ
amwa-13	193	10	indicators	indicator	NOUN
amwa-13	193	11	of	of	ADP
amwa-13	193	12	severe	severe	ADJ
amwa-13	193	13	covid-19	covid-19	PROPN
amwa-13	193	14	and	and	CCONJ
amwa-13	193	15	poor	poor	ADJ
amwa-13	193	16	prognosis	prognosis	NOUN
amwa-13	193	17	.	.	PUNCT
amwa-13	194	1	biomed	biome	VERB
amwa-13	194	2	res	re	NOUN
amwa-13	194	3	int	int	NOUN
amwa-13	194	4	.	.	PUNCT
amwa-13	195	1	2020;2020:1	2020;2020:1	PROPN
amwa-13	195	2	-	-	SYM
amwa-13	195	3	10	10	NUM
amwa-13	195	4	.	.	PUNCT
amwa-13	196	1	doi:10.1155/2020/6159720	doi:10.1155/2020/6159720	PROPN
amwa-13	196	2	24	24	NUM
amwa-13	196	3	.	.	PUNCT
amwa-13	197	1	chan	chan	PROPN
amwa-13	197	2	nc	nc	PROPN
amwa-13	197	3	,	,	PUNCT
amwa-13	197	4	weitz	weitz	PROPN
amwa-13	198	1	ji	ji	PROPN
amwa-13	198	2	.	.	PUNCT
amwa-13	199	1	covid-19	covid-19	PROPN
amwa-13	199	2	coagulopathy	coagulopathy	ADJ
amwa-13	199	3	,	,	PUNCT
amwa-13	199	4	thrombosis	thrombosis	NOUN
amwa-13	199	5	,	,	PUNCT
amwa-13	199	6	and	and	CCONJ
amwa-13	199	7	bleeding	bleeding	NOUN
amwa-13	199	8	.	.	PUNCT
amwa-13	200	1	blood	blood	NOUN
amwa-13	200	2	.	.	PUNCT
amwa-13	201	1	2020;136(4):381	2020;136(4):381	NUM
amwa-13	201	2	-	-	SYM
amwa-13	201	3	383	383	NUM
amwa-13	201	4	.	.	PUNCT
amwa-13	202	1	doi:10.1182	doi:10.1182	PROPN
amwa-13	202	2	/	/	SYM
amwa-13	202	3	blood.2020007335	blood.2020007335	PROPN
amwa-13	202	4	25	25	NUM
amwa-13	202	5	.	.	PUNCT
amwa-13	203	1	al	al	PROPN
amwa-13	203	2	-	-	PUNCT
amwa-13	203	3	samkari	samkari	PROPN
amwa-13	203	4	h	h	PROPN
amwa-13	203	5	,	,	PUNCT
amwa-13	203	6	karp	karp	ADJ
amwa-13	203	7	leaf	leaf	NOUN
amwa-13	203	8	rs	rs	NOUN
amwa-13	203	9	,	,	PUNCT
amwa-13	203	10	dzik	dzik	NOUN
amwa-13	203	11	wh	wh	PROPN
amwa-13	203	12	,	,	PUNCT
amwa-13	203	13	et	et	PROPN
amwa-13	203	14	al	al	PROPN
amwa-13	203	15	.	.	PUNCT
amwa-13	204	1	covid-19	covid-19	PROPN
amwa-13	204	2	and	and	CCONJ
amwa-13	204	3	coagulation	coagulation	NOUN
amwa-13	204	4	:	:	PUNCT
amwa-13	204	5	bleeding	bleed	VERB
amwa-13	204	6	and	and	CCONJ
amwa-13	204	7	thrombotic	thrombotic	ADJ
amwa-13	204	8	manifestations	manifestation	NOUN
amwa-13	204	9	of	of	ADP
amwa-13	204	10	sars	sar	NOUN
amwa-13	204	11	-	-	PUNCT
amwa-13	204	12	cov-2	cov-2	NOUN
amwa-13	204	13	infection	infection	NOUN
amwa-13	204	14	.	.	PUNCT
amwa-13	205	1	blood	blood	NOUN
amwa-13	205	2	.	.	PUNCT
amwa-13	206	1	2020;136(4):489	2020;136(4):489	NUM
amwa-13	206	2	-	-	SYM
amwa-13	206	3	500	500	NUM
amwa-13	206	4	.	.	PUNCT
amwa-13	207	1	doi:10.1182	doi:10.1182	PROPN
amwa-13	207	2	/	/	SYM
amwa-13	207	3	blood.2020006520	blood.2020006520	PROPN
amwa-13	207	4	26	26	NUM
amwa-13	207	5	.	.	PUNCT
amwa-13	208	1	tedeschi	tedeschi	PROPN
amwa-13	208	2	d	d	PROPN
amwa-13	208	3	,	,	PUNCT
amwa-13	208	4	rizzi	rizzi	PROPN
amwa-13	208	5	a	a	PRON
amwa-13	208	6	,	,	PUNCT
amwa-13	208	7	biscaglia	biscaglia	NOUN
amwa-13	208	8	s	s	PART
amwa-13	208	9	,	,	PUNCT
amwa-13	208	10	tumscitz	tumscitz	PROPN
amwa-13	208	11	c.	c.	PROPN
amwa-13	208	12	acute	acute	PROPN
amwa-13	208	13	myocardial	myocardial	ADJ
amwa-13	208	14	infarction	infarction	NOUN
amwa-13	208	15	and	and	CCONJ
amwa-13	208	16	large	large	ADJ
amwa-13	208	17	coronary	coronary	ADJ
amwa-13	208	18	thrombosis	thrombosis	NOUN
amwa-13	208	19	in	in	ADP
amwa-13	208	20	a	a	DET
amwa-13	208	21	patient	patient	NOUN
amwa-13	208	22	with	with	ADP
amwa-13	208	23	covid-19	covid-19	PROPN
amwa-13	208	24	.	.	PUNCT
amwa-13	208	25	catheter	catheter	PROPN
amwa-13	208	26	cardiovasc	cardiovasc	PROPN
amwa-13	208	27	interv	interv	VERB
amwa-13	208	28	.	.	PUNCT
amwa-13	209	1	2021;97(2):272	2021;97(2):272	NUM
amwa-13	209	2	-	-	PUNCT
amwa-13	209	3	277	277	NUM
amwa-13	209	4	.	.	PUNCT
amwa-13	210	1	doi:10.1002	doi:10.1002	NOUN
amwa-13	210	2	/	/	SYM
amwa-13	210	3	ccd.29179	ccd.29179	SYM
amwa-13	210	4	27	27	NUM
amwa-13	210	5	.	.	PUNCT
amwa-13	211	1	guagliumi	guagliumi	ADJ
amwa-13	211	2	g	g	NOUN
amwa-13	211	3	,	,	PUNCT
amwa-13	211	4	sonzogni	sonzogni	VERB
amwa-13	211	5	a	a	DET
amwa-13	211	6	,	,	PUNCT
amwa-13	211	7	pescetelli	pescetelli	NOUN
amwa-13	211	8	i	i	PROPN
amwa-13	211	9	,	,	PUNCT
amwa-13	211	10	pellegrini	pellegrini	PROPN
amwa-13	211	11	d	d	PROPN
amwa-13	211	12	,	,	PUNCT
amwa-13	211	13	finn	finn	PROPN
amwa-13	211	14	av	av	PROPN
amwa-13	211	15	.	.	PROPN
amwa-13	211	16	microthrombi	microthrombi	PROPN
amwa-13	211	17	and	and	CCONJ
amwa-13	211	18	st	st	NOUN
amwa-13	211	19	-	-	PUNCT
amwa-13	211	20	segment	segment	NOUN
amwa-13	211	21	–	–	PUNCT
amwa-13	211	22	elevation	elevation	NOUN
amwa-13	211	23	myocardial	myocardial	ADJ
amwa-13	211	24	infarction	infarction	NOUN
amwa-13	211	25	in	in	ADP
amwa-13	211	26	covid-19	covid-19	PROPN
amwa-13	211	27	.	.	PUNCT
amwa-13	211	28	circulation	circulation	NOUN
amwa-13	211	29	.	.	PUNCT
amwa-13	212	1	2020;142(8):804	2020;142(8):804	NUM
amwa-13	212	2	-	-	SYM
amwa-13	212	3	809	809	NUM
amwa-13	212	4	.	.	PUNCT
amwa-13	213	1	doi:10.1161/	doi:10.1161/	NOUN
amwa-13	213	2	circulationaha.120.049294	circulationaha.120.049294	NOUN
amwa-13	213	3	28	28	NUM
amwa-13	213	4	.	.	PUNCT
amwa-13	214	1	stafanini	stafanini	PROPN
amwa-13	214	2	gg	gg	PROPN
amwa-13	214	3	,	,	PUNCT
amwa-13	214	4	montorfano	montorfano	PROPN
amwa-13	214	5	m	m	PROPN
amwa-13	214	6	,	,	PUNCT
amwa-13	214	7	trabattoni	trabattoni	ADJ
amwa-13	214	8	d	d	NOUN
amwa-13	214	9	,	,	PUNCT
amwa-13	214	10	et	et	PROPN
amwa-13	214	11	al	al	PROPN
amwa-13	214	12	.	.	PROPN
amwa-13	214	13	st	st	PROPN
amwa-13	214	14	-	-	PUNCT
amwa-13	214	15	elevation	elevation	NOUN
amwa-13	214	16	myocardial	myocardial	ADJ
amwa-13	214	17	infarction	infarction	NOUN
amwa-13	214	18	in	in	ADP
amwa-13	214	19	patients	patient	NOUN
amwa-13	214	20	with	with	ADP
amwa-13	214	21	covid-19	covid-19	PROPN
amwa-13	214	22	.	.	PUNCT
amwa-13	214	23	circulation	circulation	NOUN
amwa-13	214	24	.	.	PUNCT
amwa-13	215	1	2020;141(25):2113	2020;141(25):2113	NUM
amwa-13	215	2	-	-	SYM
amwa-13	215	3	2116	2116	NUM
amwa-13	215	4	.	.	PUNCT
amwa-13	216	1	doi:10.1161	doi:10.1161	ADJ
amwa-13	216	2	/	/	SYM
amwa-13	216	3	circulationaha.120.047525	circulationaha.120.047525	PROPN
amwa-13	216	4	29	29	NUM
amwa-13	216	5	.	.	PUNCT
amwa-13	217	1	driggin	driggin	PROPN
amwa-13	217	2	e	e	PROPN
amwa-13	217	3	,	,	PUNCT
amwa-13	217	4	madhavan	madhavan	PROPN
amwa-13	217	5	mv	mv	PROPN
amwa-13	217	6	,	,	PUNCT
amwa-13	217	7	bikdeli	bikdeli	PROPN
amwa-13	217	8	b	b	NUM
amwa-13	217	9	,	,	PUNCT
amwa-13	217	10	et	et	PROPN
amwa-13	217	11	al	al	PROPN
amwa-13	217	12	.	.	PUNCT
amwa-13	218	1	cardiovascular	cardiovascular	ADJ
amwa-13	218	2	considerations	consideration	NOUN
amwa-13	218	3	for	for	ADP
amwa-13	218	4	patients	patient	NOUN
amwa-13	218	5	,	,	PUNCT
amwa-13	218	6	health	health	NOUN
amwa-13	218	7	care	care	NOUN
amwa-13	218	8	workers	worker	NOUN
amwa-13	218	9	,	,	PUNCT
amwa-13	218	10	and	and	CCONJ
amwa-13	218	11	health	health	NOUN
amwa-13	218	12	systems	system	NOUN
amwa-13	218	13	during	during	ADP
amwa-13	218	14	the	the	DET
amwa-13	218	15	covid-19	covid-19	PROPN
amwa-13	218	16	pandemic	pandemic	NOUN
amwa-13	218	17	.	.	PUNCT
amwa-13	219	1	j	j	PROPN
amwa-13	219	2	am	be	AUX
amwa-13	219	3	coll	coll	PROPN
amwa-13	219	4	cardiol	cardiol	NOUN
amwa-13	219	5	.	.	PUNCT
amwa-13	220	1	2020;75(18):2352	2020;75(18):2352	NUM
amwa-13	220	2	-	-	SYM
amwa-13	220	3	2371	2371	NUM
amwa-13	220	4	.	.	PUNCT
amwa-13	221	1	doi:10.1016	doi:10.1016	PROPN
amwa-13	221	2	/	/	SYM
amwa-13	221	3	j.	j.	PROPN
amwa-13	221	4	jacc.2020.03.031	jacc.2020.03.031	PROPN
amwa-13	222	1	30	30	NUM
amwa-13	222	2	.	.	PUNCT
amwa-13	223	1	crackower	crackower	PROPN
amwa-13	223	2	ma	ma	PROPN
amwa-13	223	3	,	,	PUNCT
amwa-13	223	4	sarao	sarao	NOUN
amwa-13	223	5	r	r	NOUN
amwa-13	223	6	,	,	PUNCT
amwa-13	223	7	oudit	oudit	NOUN
amwa-13	223	8	gy	gy	NOUN
amwa-13	223	9	,	,	PUNCT
amwa-13	223	10	et	et	PROPN
amwa-13	223	11	al	al	PROPN
amwa-13	223	12	.	.	PUNCT
amwa-13	223	13	angiotensin	angiotensin	NOUN
amwa-13	223	14	-	-	PUNCT
amwa-13	223	15	converting	convert	VERB
amwa-13	223	16	enzyme	enzyme	NOUN
amwa-13	223	17	2	2	NUM
amwa-13	223	18	is	be	AUX
amwa-13	223	19	an	an	DET
amwa-13	223	20	essential	essential	ADJ
amwa-13	223	21	regulator	regulator	NOUN
amwa-13	223	22	of	of	ADP
amwa-13	223	23	heart	heart	NOUN
amwa-13	223	24	function	function	NOUN
amwa-13	223	25	.	.	PUNCT
amwa-13	224	1	nature	nature	NOUN
amwa-13	224	2	.	.	PUNCT
amwa-13	225	1	2002;417(6891):822828	2002;417(6891):822828	NUM
amwa-13	225	2	.	.	PUNCT
amwa-13	226	1	doi:10.1038	doi:10.1038	NOUN
amwa-13	226	2	/	/	SYM
amwa-13	226	3	nature00786	nature00786	PROPN
amwa-13	226	4	mailto:jennifer.busch@wheaton.edu	mailto:jennifer.busch@wheaton.edu	NOUN
amwa-13	226	5	https://doi.org/10.1155/2020/6159720	https://doi.org/10.1155/2020/6159720	PROPN
amwa-13	226	6	https://doi.org/10.1002/ccd.29179	https://doi.org/10.1002/ccd.29179	VERB
amwa-13	227	1	amwa	amwa	PROPN
amwa-13	227	2	journal	journal	PROPN
amwa-13	227	3	/	/	SYM
amwa-13	227	4	v36	v36	PROPN
amwa-13	227	5	n2	n2	PROPN
amwa-13	227	6	/	/	SYM
amwa-13	227	7	2021	2021	NUM
amwa-13	227	8	/	/	SYM
amwa-13	227	9	amwa.org	amwa.org	PROPN
amwa-13	227	10	77	77	NUM
amwa-13	227	11	31	31	NUM
amwa-13	227	12	.	.	PUNCT
amwa-13	228	1	kuba	kuba	PROPN
amwa-13	228	2	k	k	PROPN
amwa-13	228	3	,	,	PUNCT
amwa-13	228	4	imai	imai	PROPN
amwa-13	228	5	y	y	PROPN
amwa-13	228	6	,	,	PUNCT
amwa-13	228	7	rao	rao	PROPN
amwa-13	228	8	s	s	PROPN
amwa-13	228	9	,	,	PUNCT
amwa-13	228	10	et	et	PROPN
amwa-13	228	11	al	al	PROPN
amwa-13	228	12	.	.	PUNCT
amwa-13	229	1	a	a	DET
amwa-13	229	2	crucial	crucial	ADJ
amwa-13	229	3	role	role	NOUN
amwa-13	229	4	of	of	ADP
amwa-13	229	5	angiotensin	angiotensin	NOUN
amwa-13	229	6	converting	convert	VERB
amwa-13	229	7	enzyme	enzyme	NOUN
amwa-13	229	8	2	2	NUM
amwa-13	229	9	(	(	PUNCT
amwa-13	229	10	ace2	ace2	PROPN
amwa-13	229	11	)	)	PUNCT
amwa-13	229	12	in	in	ADP
amwa-13	229	13	sars	sars	PROPN
amwa-13	229	14	coronavirus	coronavirus	PROPN
amwa-13	229	15	–	–	PUNCT
amwa-13	229	16	induced	induced	ADJ
amwa-13	229	17	lung	lung	NOUN
amwa-13	229	18	injury	injury	NOUN
amwa-13	229	19	.	.	PUNCT
amwa-13	230	1	nat	nat	PROPN
amwa-13	230	2	med	me	VERB
amwa-13	230	3	.	.	PUNCT
amwa-13	231	1	2005;11(8):875	2005;11(8):875	NUM
amwa-13	231	2	-	-	PUNCT
amwa-13	231	3	879	879	NUM
amwa-13	231	4	.	.	PUNCT
amwa-13	231	5	doi:10.1038	doi:10.1038	NOUN
amwa-13	231	6	/	/	SYM
amwa-13	231	7	nm1267	nm1267	NOUN
amwa-13	231	8	32	32	NUM
amwa-13	231	9	.	.	PUNCT
amwa-13	232	1	wang	wang	PROPN
amwa-13	232	2	h	h	PROPN
amwa-13	232	3	,	,	PUNCT
amwa-13	232	4	yang	yang	PROPN
amwa-13	232	5	p	p	PROPN
amwa-13	232	6	,	,	PUNCT
amwa-13	232	7	liu	liu	PROPN
amwa-13	232	8	k	k	PROPN
amwa-13	232	9	,	,	PUNCT
amwa-13	232	10	et	et	PROPN
amwa-13	232	11	al	al	PROPN
amwa-13	232	12	.	.	PROPN
amwa-13	233	1	sars	sars	PROPN
amwa-13	233	2	coronavirus	coronavirus	PROPN
amwa-13	233	3	entry	entry	NOUN
amwa-13	233	4	into	into	ADP
amwa-13	233	5	host	host	NOUN
amwa-13	233	6	cells	cell	NOUN
amwa-13	233	7	through	through	ADP
amwa-13	233	8	a	a	DET
amwa-13	233	9	novel	novel	NOUN
amwa-13	233	10	clathrinand	clathrinand	NOUN
amwa-13	233	11	caveolae	caveolae	NOUN
amwa-13	233	12	-	-	PUNCT
amwa-13	233	13	independent	independent	ADJ
amwa-13	233	14	endocytic	endocytic	ADJ
amwa-13	233	15	pathway	pathway	NOUN
amwa-13	233	16	.	.	PUNCT
amwa-13	234	1	cell	cell	NOUN
amwa-13	234	2	res	re	NOUN
amwa-13	234	3	.	.	PUNCT
amwa-13	235	1	2008;18(2):290	2008;18(2):290	NUM
amwa-13	235	2	-	-	PUNCT
amwa-13	235	3	301	301	NUM
amwa-13	235	4	.	.	PUNCT
amwa-13	235	5	doi:10.1038	doi:10.1038	PROPN
amwa-13	235	6	/	/	SYM
amwa-13	235	7	cr.2008.15	cr.2008.15	NOUN
amwa-13	235	8	33	33	NUM
amwa-13	235	9	.	.	PUNCT
amwa-13	236	1	gheblawi	gheblawi	PROPN
amwa-13	236	2	m	m	PROPN
amwa-13	236	3	,	,	PUNCT
amwa-13	236	4	wang	wang	PROPN
amwa-13	236	5	k	k	PROPN
amwa-13	236	6	,	,	PUNCT
amwa-13	236	7	viveiros	viveiro	NOUN
amwa-13	236	8	a	a	PRON
amwa-13	236	9	,	,	PUNCT
amwa-13	236	10	et	et	PROPN
amwa-13	236	11	al	al	PROPN
amwa-13	236	12	.	.	PUNCT
amwa-13	236	13	angiotensin	angiotensin	NOUN
amwa-13	236	14	-	-	PUNCT
amwa-13	236	15	converting	convert	VERB
amwa-13	236	16	enzyme	enzyme	NOUN
amwa-13	236	17	2	2	NUM
amwa-13	236	18	:	:	PUNCT
amwa-13	236	19	sars	sar	NOUN
amwa-13	236	20	-	-	PUNCT
amwa-13	236	21	cov-2	cov-2	NOUN
amwa-13	236	22	receptor	receptor	NOUN
amwa-13	236	23	and	and	CCONJ
amwa-13	236	24	regulator	regulator	NOUN
amwa-13	236	25	of	of	ADP
amwa-13	236	26	the	the	DET
amwa-13	236	27	renin	renin	ADJ
amwa-13	236	28	-	-	PUNCT
amwa-13	236	29	angiotensin	angiotensin	NOUN
amwa-13	236	30	system	system	NOUN
amwa-13	236	31	.	.	PUNCT
amwa-13	237	1	circ	circ	PROPN
amwa-13	237	2	res	re	NOUN
amwa-13	237	3	.	.	PUNCT
amwa-13	238	1	2020;126(10):1456	2020;126(10):1456	PRON
amwa-13	238	2	-	-	SYM
amwa-13	238	3	1474	1474	NUM
amwa-13	238	4	.	.	PUNCT
amwa-13	239	1	doi:10.1161	doi:10.1161	NOUN
amwa-13	239	2	/	/	SYM
amwa-13	239	3	circresaha.120.317015	circresaha.120.317015	PROPN
amwa-13	239	4	34	34	NUM
amwa-13	239	5	.	.	PUNCT
amwa-13	240	1	armulik	armulik	PROPN
amwa-13	240	2	a	a	PRON
amwa-13	240	3	,	,	PUNCT
amwa-13	240	4	genové	genové	NOUN
amwa-13	240	5	g	g	NOUN
amwa-13	240	6	,	,	PUNCT
amwa-13	240	7	betsholtz	betsholtz	PROPN
amwa-13	240	8	c.	c.	NOUN
amwa-13	240	9	pericytes	pericyte	NOUN
amwa-13	240	10	:	:	PUNCT
amwa-13	240	11	developmental	developmental	ADJ
amwa-13	240	12	,	,	PUNCT
amwa-13	240	13	physiological	physiological	ADJ
amwa-13	240	14	,	,	PUNCT
amwa-13	240	15	and	and	CCONJ
amwa-13	240	16	pathological	pathological	ADJ
amwa-13	240	17	perspectives	perspective	NOUN
amwa-13	240	18	,	,	PUNCT
amwa-13	240	19	problems	problem	NOUN
amwa-13	240	20	,	,	PUNCT
amwa-13	240	21	and	and	CCONJ
amwa-13	240	22	promises	promise	NOUN
amwa-13	240	23	.	.	PUNCT
amwa-13	241	1	dev	dev	NOUN
amwa-13	241	2	cell	cell	NOUN
amwa-13	241	3	.	.	PUNCT
amwa-13	242	1	2011;21(2):193	2011;21(2):193	NUM
amwa-13	242	2	-	-	SYM
amwa-13	242	3	215	215	NUM
amwa-13	242	4	.	.	PUNCT
amwa-13	242	5	doi:10.1016	doi:10.1016	PROPN
amwa-13	242	6	/	/	SYM
amwa-13	242	7	j.devcel.2011.07.001	j.devcel.2011.07.001	PROPN
amwa-13	242	8	35	35	NUM
amwa-13	242	9	.	.	PUNCT
amwa-13	243	1	lee	lee	PROPN
amwa-13	243	2	ll	ll	AUX
amwa-13	243	3	,	,	PUNCT
amwa-13	243	4	chintalgattu	chintalgattu	ADV
amwa-13	243	5	v.	v.	ADP
amwa-13	243	6	pericytes	pericyte	NOUN
amwa-13	243	7	in	in	ADP
amwa-13	243	8	the	the	DET
amwa-13	243	9	heart	heart	NOUN
amwa-13	243	10	.	.	PUNCT
amwa-13	244	1	in	in	ADP
amwa-13	244	2	:	:	PUNCT
amwa-13	244	3	birbrair	birbrair	VERB
amwa-13	244	4	a	a	PRON
amwa-13	244	5	,	,	PUNCT
amwa-13	244	6	ed	ed	NOUN
amwa-13	244	7	.	.	PUNCT
amwa-13	244	8	pericyte	pericyte	NOUN
amwa-13	244	9	biology	biology	NOUN
amwa-13	244	10	in	in	ADP
amwa-13	244	11	different	different	ADJ
amwa-13	244	12	organs	organ	NOUN
amwa-13	244	13	.	.	PUNCT
amwa-13	245	1	adv	adv	PROPN
amwa-13	245	2	exp	exp	NOUN
amwa-13	245	3	med	med	ADJ
amwa-13	245	4	biol	biol	PROPN
amwa-13	245	5	.	.	PUNCT
amwa-13	246	1	springer	springer	NOUN
amwa-13	246	2	;	;	PUNCT
amwa-13	246	3	2019:187	2019:187	NUM
amwa-13	246	4	-	-	SYM
amwa-13	246	5	210	210	NUM
amwa-13	246	6	.	.	PUNCT
amwa-13	247	1	doi:10.1007/978	doi:10.1007/978	NOUN
amwa-13	247	2	-	-	PUNCT
amwa-13	247	3	3	3	NUM
amwa-13	247	4	-	-	PUNCT
amwa-13	247	5	030	030	NUM
amwa-13	247	6	-	-	PUNCT
amwa-13	247	7	11093	11093	NUM
amwa-13	247	8	-	-	PUNCT
amwa-13	247	9	2_11	2_11	NUM
amwa-13	247	10	36	36	NUM
amwa-13	247	11	.	.	PUNCT
amwa-13	248	1	hashitani	hashitani	PROPN
amwa-13	248	2	h	h	PROPN
amwa-13	248	3	,	,	PUNCT
amwa-13	248	4	mitsui	mitsui	PROPN
amwa-13	248	5	r.	r.	PROPN
amwa-13	248	6	role	role	NOUN
amwa-13	248	7	of	of	ADP
amwa-13	248	8	pericytes	pericyte	NOUN
amwa-13	248	9	in	in	ADP
amwa-13	248	10	the	the	DET
amwa-13	248	11	initiation	initiation	NOUN
amwa-13	248	12	and	and	CCONJ
amwa-13	248	13	propagation	propagation	NOUN
amwa-13	248	14	of	of	ADP
amwa-13	248	15	spontaneous	spontaneous	ADJ
amwa-13	248	16	activity	activity	NOUN
amwa-13	248	17	in	in	ADP
amwa-13	248	18	the	the	DET
amwa-13	248	19	microvasculature	microvasculature	NOUN
amwa-13	248	20	.	.	PUNCT
amwa-13	249	1	in	in	ADP
amwa-13	249	2	:	:	PUNCT
amwa-13	249	3	hashitani	hashitani	PROPN
amwa-13	249	4	h	h	PROPN
amwa-13	249	5	,	,	PUNCT
amwa-13	249	6	lang	lang	PROPN
amwa-13	249	7	rj	rj	PROPN
amwa-13	249	8	,	,	PUNCT
amwa-13	249	9	eds	eds	PROPN
amwa-13	249	10	.	.	PROPN
amwa-13	249	11	smooth	smooth	ADJ
amwa-13	249	12	muscle	muscle	NOUN
amwa-13	249	13	spontaneous	spontaneous	ADJ
amwa-13	249	14	activity	activity	NOUN
amwa-13	249	15	:	:	PUNCT
amwa-13	249	16	physiological	physiological	ADJ
amwa-13	249	17	and	and	CCONJ
amwa-13	249	18	pathological	pathological	ADJ
amwa-13	249	19	modulation	modulation	NOUN
amwa-13	249	20	.	.	PUNCT
amwa-13	250	1	adv	adv	PROPN
amwa-13	250	2	exp	exp	NOUN
amwa-13	250	3	med	med	ADJ
amwa-13	250	4	biol	biol	PROPN
amwa-13	250	5	.	.	PUNCT
amwa-13	251	1	springer	springer	NOUN
amwa-13	251	2	;	;	PUNCT
amwa-13	251	3	2019:329	2019:329	NUM
amwa-13	251	4	-	-	PUNCT
amwa-13	251	5	356	356	NUM
amwa-13	251	6	.	.	PUNCT
amwa-13	252	1	doi:10.1007/978	doi:10.1007/978	PROPN
amwa-13	252	2	-	-	PUNCT
amwa-13	252	3	981	981	NUM
amwa-13	252	4	-	-	PUNCT
amwa-13	252	5	13	13	NUM
amwa-13	252	6	-	-	PUNCT
amwa-13	252	7	5895	5895	NUM
amwa-13	252	8	-	-	PUNCT
amwa-13	252	9	1_14	1_14	NUM
amwa-13	252	10	37	37	NUM
amwa-13	252	11	.	.	PUNCT
amwa-13	253	1	ards	ard	VERB
amwa-13	253	2	symptoms	symptom	NOUN
amwa-13	253	3	and	and	CCONJ
amwa-13	253	4	causes	cause	NOUN
amwa-13	253	5	.	.	PUNCT
amwa-13	254	1	mayo	mayo	PROPN
amwa-13	254	2	clinic	clinic	PROPN
amwa-13	254	3	.	.	PUNCT
amwa-13	255	1	accessed	access	VERB
amwa-13	255	2	january	january	PROPN
amwa-13	255	3	10	10	NUM
amwa-13	255	4	,	,	PUNCT
amwa-13	255	5	2021	2021	NUM
amwa-13	255	6	.	.	PUNCT
amwa-13	256	1	https://www.mayoclinic.org/diseases-conditions/ards/symptomscauses/syc-20355576	https://www.mayoclinic.org/diseases-conditions/ards/symptomscauses/syc-20355576	PROPN
amwa-13	256	2	38	38	NUM
amwa-13	256	3	.	.	PUNCT
amwa-13	257	1	zhang	zhang	PROPN
amwa-13	257	2	j	j	PROPN
amwa-13	257	3	,	,	PUNCT
amwa-13	257	4	tecson	tecson	NOUN
amwa-13	257	5	km	km	PROPN
amwa-13	257	6	,	,	PUNCT
amwa-13	257	7	mccullough	mccullough	PROPN
amwa-13	257	8	pa	pa	PROPN
amwa-13	257	9	.	.	PUNCT
amwa-13	257	10	endothelial	endothelial	ADJ
amwa-13	257	11	dysfunction	dysfunction	NOUN
amwa-13	257	12	contributes	contribute	VERB
amwa-13	257	13	to	to	ADP
amwa-13	257	14	covid-19	covid-19	PROPN
amwa-13	257	15	-	-	PUNCT
amwa-13	257	16	associated	associate	VERB
amwa-13	257	17	vascular	vascular	ADJ
amwa-13	257	18	inflammation	inflammation	NOUN
amwa-13	257	19	and	and	CCONJ
amwa-13	257	20	coagulopathy	coagulopathy	ADJ
amwa-13	257	21	.	.	PUNCT
amwa-13	258	1	rev	rev	AUX
amwa-13	258	2	cardiovasc	cardiovasc	PROPN
amwa-13	258	3	med	me	VERB
amwa-13	258	4	.	.	PUNCT
amwa-13	259	1	2020;21(3):315	2020;21(3):315	PROPN
amwa-13	259	2	-	-	SYM
amwa-13	259	3	319	319	NUM
amwa-13	259	4	.	.	PUNCT
amwa-13	260	1	doi:10.31083	doi:10.31083	PROPN
amwa-13	260	2	/	/	SYM
amwa-13	260	3	j.	j.	PROPN
amwa-13	260	4	rcm.2020.03.126	rcm.2020.03.126	PROPN
amwa-13	260	5	39	39	NUM
amwa-13	260	6	.	.	PUNCT
amwa-13	261	1	jose	jose	PROPN
amwa-13	261	2	rj	rj	PROPN
amwa-13	261	3	,	,	PUNCT
amwa-13	261	4	manuel	manuel	PROPN
amwa-13	261	5	a.	a.	PROPN
amwa-13	261	6	covid-19	covid-19	PROPN
amwa-13	261	7	cytokine	cytokine	NOUN
amwa-13	261	8	storm	storm	NOUN
amwa-13	261	9	:	:	PUNCT
amwa-13	261	10	the	the	DET
amwa-13	261	11	interplay	interplay	NOUN
amwa-13	261	12	between	between	ADP
amwa-13	261	13	inflammation	inflammation	NOUN
amwa-13	261	14	and	and	CCONJ
amwa-13	261	15	coagulation	coagulation	NOUN
amwa-13	261	16	.	.	PUNCT
amwa-13	262	1	lancet	lancet	PROPN
amwa-13	262	2	respir	respir	VERB
amwa-13	262	3	med	med	ADJ
amwa-13	262	4	.	.	PUNCT
amwa-13	263	1	2020;8(6):e46	2020;8(6):e46	PROPN
amwa-13	263	2	-	-	PUNCT
amwa-13	263	3	e47	e47	PROPN
amwa-13	263	4	.	.	PUNCT
amwa-13	264	1	doi:10.1016	doi:10.1016	PROPN
amwa-13	264	2	/	/	SYM
amwa-13	264	3	s2213	s2213	PROPN
amwa-13	264	4	-	-	PUNCT
amwa-13	264	5	2600(20)30216	2600(20)30216	NUM
amwa-13	264	6	-	-	SYM
amwa-13	264	7	2	2	NUM
amwa-13	264	8	40	40	NUM
amwa-13	264	9	.	.	PUNCT
amwa-13	265	1	zhou	zhou	PROPN
amwa-13	265	2	f	f	PROPN
amwa-13	265	3	,	,	PUNCT
amwa-13	265	4	yu	yu	PROPN
amwa-13	265	5	t	t	PROPN
amwa-13	265	6	,	,	PUNCT
amwa-13	265	7	du	du	PROPN
amwa-13	265	8	r	r	PROPN
amwa-13	265	9	,	,	PUNCT
amwa-13	265	10	et	et	PROPN
amwa-13	265	11	al	al	PROPN
amwa-13	265	12	.	.	PUNCT
amwa-13	266	1	clinical	clinical	ADJ
amwa-13	266	2	course	course	NOUN
amwa-13	266	3	and	and	CCONJ
amwa-13	266	4	risk	risk	NOUN
amwa-13	266	5	factors	factor	NOUN
amwa-13	266	6	for	for	ADP
amwa-13	266	7	mortality	mortality	NOUN
amwa-13	266	8	of	of	ADP
amwa-13	266	9	adult	adult	NOUN
amwa-13	266	10	inpatients	inpatient	NOUN
amwa-13	266	11	with	with	ADP
amwa-13	266	12	covid-19	covid-19	PROPN
amwa-13	266	13	in	in	ADP
amwa-13	266	14	wuhan	wuhan	PROPN
amwa-13	266	15	,	,	PUNCT
amwa-13	266	16	china	china	PROPN
amwa-13	266	17	:	:	PUNCT
amwa-13	266	18	a	a	DET
amwa-13	266	19	retrospective	retrospective	ADJ
amwa-13	266	20	cohort	cohort	NOUN
amwa-13	266	21	study	study	NOUN
amwa-13	266	22	.	.	PUNCT
amwa-13	267	1	lancet	lancet	PROPN
amwa-13	267	2	.	.	PUNCT
amwa-13	268	1	2020;395(10229):1054	2020;395(10229):1054	NUM
amwa-13	268	2	-	-	SYM
amwa-13	268	3	1062	1062	NUM
amwa-13	268	4	.	.	PUNCT
amwa-13	269	1	doi:10.1016/	doi:10.1016/	NOUN
amwa-13	269	2	s0140	s0140	PROPN
amwa-13	269	3	-	-	PUNCT
amwa-13	269	4	6736(20)30566	6736(20)30566	ADP
amwa-13	269	5	-	-	PUNCT
amwa-13	269	6	3	3	NUM
amwa-13	269	7	41	41	NUM
amwa-13	269	8	.	.	PUNCT
amwa-13	270	1	gold	gold	PROPN
amwa-13	270	2	jaw	jaw	PROPN
amwa-13	270	3	,	,	PUNCT
amwa-13	270	4	wong	wong	PROPN
amwa-13	270	5	kk	kk	PROPN
amwa-13	270	6	,	,	PUNCT
amwa-13	270	7	szablewski	szablewski	ADJ
amwa-13	270	8	cm	cm	PROPN
amwa-13	270	9	,	,	PUNCT
amwa-13	270	10	et	et	PROPN
amwa-13	270	11	al	al	PROPN
amwa-13	270	12	.	.	PROPN
amwa-13	270	13	characteristics	characteristic	NOUN
amwa-13	270	14	and	and	CCONJ
amwa-13	270	15	clinical	clinical	ADJ
amwa-13	270	16	outcomes	outcome	NOUN
amwa-13	270	17	of	of	ADP
amwa-13	270	18	adult	adult	NOUN
amwa-13	270	19	patients	patient	NOUN
amwa-13	270	20	hospitalized	hospitalize	VERB
amwa-13	270	21	with	with	ADP
amwa-13	270	22	covid-19	covid-19	PROPN
amwa-13	270	23	—	—	PUNCT
amwa-13	270	24	georgia	georgia	PROPN
amwa-13	270	25	,	,	PUNCT
amwa-13	270	26	march	march	PROPN
amwa-13	270	27	2020	2020	NUM
amwa-13	270	28	.	.	PUNCT
amwa-13	271	1	mmwr	mmwr	ADJ
amwa-13	271	2	morb	morb	NOUN
amwa-13	271	3	mortal	mortal	ADJ
amwa-13	271	4	wkly	wkly	PROPN
amwa-13	271	5	rep	rep	PROPN
amwa-13	271	6	.	.	PROPN
amwa-13	271	7	2020;69	2020;69	NUM
amwa-13	271	8	.	.	PUNCT
amwa-13	272	1	doi:10.15585/	doi:10.15585/	PROPN
amwa-13	272	2	mmwr.mm6918e1	mmwr.mm6918e1	VERB
amwa-13	272	3	42	42	NUM
amwa-13	272	4	.	.	PUNCT
amwa-13	273	1	raised	raise	VERB
amwa-13	273	2	blood	blood	NOUN
amwa-13	273	3	pressure	pressure	NOUN
amwa-13	273	4	(	(	PUNCT
amwa-13	273	5	sbp>=140	sbp>=140	ADJ
amwa-13	273	6	or	or	CCONJ
amwa-13	273	7	dbp>=90	dbp>=90	NOUN
amwa-13	273	8	)	)	PUNCT
amwa-13	273	9	(	(	PUNCT
amwa-13	273	10	age	age	NOUN
amwa-13	273	11	-	-	PUNCT
amwa-13	273	12	standardized	standardize	VERB
amwa-13	273	13	estimate	estimate	NOUN
amwa-13	273	14	)	)	PUNCT
amwa-13	273	15	.	.	PUNCT
amwa-13	274	1	the	the	DET
amwa-13	274	2	global	global	ADJ
amwa-13	274	3	health	health	PROPN
amwa-13	274	4	observatory	observatory	NOUN
amwa-13	274	5	.	.	PUNCT
amwa-13	275	1	published	publish	VERB
amwa-13	275	2	2021	2021	NUM
amwa-13	275	3	.	.	PUNCT
amwa-13	276	1	accessed	access	VERB
amwa-13	276	2	january	january	PROPN
amwa-13	276	3	9	9	NUM
amwa-13	276	4	,	,	PUNCT
amwa-13	276	5	2021	2021	NUM
amwa-13	276	6	.	.	PUNCT
amwa-13	277	1	https://www.who.int/data/gho/data/indicators/	https://www.who.int/data/gho/data/indicators/	ADJ
amwa-13	277	2	indicator	indicator	NOUN
amwa-13	277	3	-	-	PUNCT
amwa-13	277	4	details	detail	NOUN
amwa-13	277	5	/	/	SYM
amwa-13	277	6	gho	gho	PROPN
amwa-13	277	7	/	/	SYM
amwa-13	277	8	raised	raise	VERB
amwa-13	277	9	-	-	PUNCT
amwa-13	277	10	blood	blood	NOUN
amwa-13	277	11	-	-	PUNCT
amwa-13	277	12	pressure-(sbp-=140	pressure-(sbp-=140	NUM
amwa-13	277	13	-	-	PUNCT
amwa-13	277	14	or	or	CCONJ
amwa-13	277	15	-	-	PUNCT
amwa-13	277	16	dbp-=90)(age	dbp-=90)(age	NOUN
amwa-13	277	17	-	-	PUNCT
amwa-13	277	18	standardized	standardize	VERB
amwa-13	277	19	-	-	PUNCT
amwa-13	277	20	estimate	estimate	NOUN
amwa-13	277	21	)	)	PUNCT
amwa-13	277	22	43	43	NUM
amwa-13	277	23	.	.	PUNCT
amwa-13	278	1	centers	center	NOUN
amwa-13	278	2	for	for	ADP
amwa-13	278	3	disease	disease	NOUN
amwa-13	278	4	control	control	NOUN
amwa-13	278	5	and	and	CCONJ
amwa-13	278	6	prevention	prevention	NOUN
amwa-13	278	7	.	.	PUNCT
amwa-13	279	1	heart	heart	NOUN
amwa-13	279	2	disease	disease	NOUN
amwa-13	279	3	facts	fact	VERB
amwa-13	279	4	.	.	PUNCT
amwa-13	280	1	centers	center	NOUN
amwa-13	280	2	for	for	ADP
amwa-13	280	3	disease	disease	NOUN
amwa-13	280	4	control	control	NOUN
amwa-13	280	5	and	and	CCONJ
amwa-13	280	6	prevention	prevention	NOUN
amwa-13	280	7	.	.	PUNCT
amwa-13	281	1	published	publish	VERB
amwa-13	281	2	september	september	PROPN
amwa-13	281	3	8	8	NUM
amwa-13	281	4	,	,	PUNCT
amwa-13	281	5	2020	2020	NUM
amwa-13	281	6	.	.	PUNCT
amwa-13	282	1	accessed	access	VERB
amwa-13	282	2	january	january	PROPN
amwa-13	282	3	9	9	NUM
amwa-13	282	4	,	,	PUNCT
amwa-13	282	5	2021	2021	NUM
amwa-13	282	6	.	.	PUNCT
amwa-13	283	1	https://www.cdc.gov/heartdisease/facts.htm	https://www.cdc.gov/heartdisease/facts.htm	PRON
amwa-13	283	2	44	44	NUM
amwa-13	283	3	.	.	PUNCT
amwa-13	284	1	bean	bean	PROPN
amwa-13	284	2	dm	dm	PROPN
amwa-13	284	3	,	,	PUNCT
amwa-13	284	4	kraljevic	kraljevic	PROPN
amwa-13	284	5	z	z	PROPN
amwa-13	284	6	,	,	PUNCT
amwa-13	284	7	searle	searle	PROPN
amwa-13	284	8	t	t	PROPN
amwa-13	284	9	,	,	PUNCT
amwa-13	284	10	et	et	PROPN
amwa-13	284	11	al	al	PROPN
amwa-13	284	12	.	.	PUNCT
amwa-13	284	13	angiotensin	angiotensin	NOUN
amwa-13	284	14	-	-	PUNCT
amwa-13	284	15	converting	convert	VERB
amwa-13	284	16	enzyme	enzyme	NOUN
amwa-13	284	17	inhibitors	inhibitor	NOUN
amwa-13	284	18	and	and	CCONJ
amwa-13	284	19	angiotensin	angiotensin	NOUN
amwa-13	284	20	ii	ii	PROPN
amwa-13	284	21	receptor	receptor	NOUN
amwa-13	284	22	blockers	blocker	NOUN
amwa-13	284	23	are	be	AUX
amwa-13	284	24	not	not	PART
amwa-13	284	25	associated	associate	VERB
amwa-13	284	26	with	with	ADP
amwa-13	284	27	severe	severe	ADJ
amwa-13	284	28	covid-19	covid-19	PROPN
amwa-13	284	29	infection	infection	NOUN
amwa-13	284	30	in	in	ADP
amwa-13	284	31	a	a	DET
amwa-13	284	32	multi	multi	ADJ
amwa-13	284	33	-	-	ADJ
amwa-13	284	34	site	site	ADJ
amwa-13	284	35	uk	uk	PROPN
amwa-13	284	36	acute	acute	PROPN
amwa-13	284	37	hospital	hospital	PROPN
amwa-13	284	38	trust	trust	PROPN
amwa-13	284	39	.	.	PUNCT
amwa-13	285	1	eur	eur	PROPN
amwa-13	285	2	j	j	PROPN
amwa-13	285	3	heart	heart	NOUN
amwa-13	285	4	fail	fail	VERB
amwa-13	285	5	.	.	PUNCT
amwa-13	286	1	2020;22(6):967	2020;22(6):967	PROPN
amwa-13	286	2	-	-	PUNCT
amwa-13	286	3	974	974	NUM
amwa-13	286	4	.	.	PUNCT
amwa-13	287	1	doi:10.1002	doi:10.1002	NOUN
amwa-13	287	2	/	/	SYM
amwa-13	288	1	ejhf.1924	ejhf.1924	PROPN
amwa-13	288	2	45	45	NUM
amwa-13	288	3	.	.	PUNCT
amwa-13	289	1	fryar	fryar	PROPN
amwa-13	289	2	cd	cd	PROPN
amwa-13	289	3	,	,	PUNCT
amwa-13	289	4	ostchega	ostchega	PROPN
amwa-13	289	5	y	y	PROPN
amwa-13	289	6	,	,	PUNCT
amwa-13	289	7	hales	hales	PROPN
amwa-13	289	8	cm	cm	PROPN
amwa-13	289	9	,	,	PUNCT
amwa-13	289	10	zhang	zhang	PROPN
amwa-13	289	11	g	g	PROPN
amwa-13	289	12	,	,	PUNCT
amwa-13	289	13	kruszon	kruszon	PROPN
amwa-13	289	14	-	-	PUNCT
amwa-13	289	15	moran	moran	PROPN
amwa-13	289	16	d.	d.	PROPN
amwa-13	289	17	hypertension	hypertension	PROPN
amwa-13	289	18	prevalence	prevalence	NOUN
amwa-13	289	19	and	and	CCONJ
amwa-13	289	20	control	control	NOUN
amwa-13	289	21	among	among	ADP
amwa-13	289	22	adults	adult	NOUN
amwa-13	289	23	:	:	PUNCT
amwa-13	289	24	united	united	PROPN
amwa-13	289	25	states	states	PROPN
amwa-13	289	26	,	,	PUNCT
amwa-13	289	27	2015–2016	2015–2016	NUM
amwa-13	289	28	.	.	PUNCT
amwa-13	290	1	cdc.gov	cdc.gov	PROPN
amwa-13	290	2	.	.	PUNCT
amwa-13	290	3	published	publish	VERB
amwa-13	290	4	october	october	PROPN
amwa-13	290	5	2017	2017	NUM
amwa-13	290	6	.	.	PUNCT
amwa-13	291	1	accessed	access	VERB
amwa-13	291	2	april	april	PROPN
amwa-13	291	3	8	8	NUM
amwa-13	291	4	,	,	PUNCT
amwa-13	291	5	2021	2021	NUM
amwa-13	291	6	.	.	PUNCT
amwa-13	292	1	https://www.cdc.gov/nchs/products/databriefs/db289.htm	https://www.cdc.gov/nchs/products/databriefs/db289.htm	NUM
amwa-13	292	2	46	46	NUM
amwa-13	292	3	.	.	PUNCT
amwa-13	293	1	american	american	PROPN
amwa-13	293	2	heart	heart	PROPN
amwa-13	293	3	association	association	PROPN
amwa-13	293	4	news	news	PROPN
amwa-13	293	5	.	.	PUNCT
amwa-13	294	1	is	be	AUX
amwa-13	294	2	high	high	ADJ
amwa-13	294	3	blood	blood	NOUN
amwa-13	294	4	pressure	pressure	NOUN
amwa-13	294	5	inevitable	inevitable	ADJ
amwa-13	294	6	?	?	PUNCT
amwa-13	295	1	here	here	ADV
amwa-13	295	2	’s	’	VERB
amwa-13	295	3	how	how	SCONJ
amwa-13	295	4	to	to	PART
amwa-13	295	5	keep	keep	VERB
amwa-13	295	6	it	it	PRON
amwa-13	295	7	in	in	ADP
amwa-13	295	8	check	check	NOUN
amwa-13	295	9	.	.	PUNCT
amwa-13	296	1	www.heart.org	www.heart.org	PROPN
amwa-13	296	2	.	.	PROPN
amwa-13	296	3	published	publish	VERB
amwa-13	296	4	may	may	PROPN
amwa-13	296	5	18	18	NUM
amwa-13	296	6	,	,	PUNCT
amwa-13	296	7	2020	2020	NUM
amwa-13	296	8	.	.	PUNCT
amwa-13	297	1	accessed	access	VERB
amwa-13	297	2	january	january	PROPN
amwa-13	297	3	9	9	NUM
amwa-13	297	4	,	,	PUNCT
amwa-13	297	5	2021	2021	NUM
amwa-13	297	6	.	.	PUNCT
amwa-13	298	1	https://www.heart.org/en/news/2020/05/18/	https://www.heart.org/en/news/2020/05/18/	PROPN
amwa-13	298	2	is	be	AUX
amwa-13	298	3	-	-	PUNCT
amwa-13	298	4	high	high	ADJ
amwa-13	298	5	-	-	PUNCT
amwa-13	298	6	blood	blood	NOUN
amwa-13	298	7	-	-	PUNCT
amwa-13	298	8	pressure	pressure	NOUN
amwa-13	298	9	-	-	PUNCT
amwa-13	298	10	inevitable	inevitable	ADJ
amwa-13	298	11	-	-	PUNCT
amwa-13	298	12	heres	here	NOUN
amwa-13	298	13	-	-	PUNCT
amwa-13	298	14	how	how	NOUN
amwa-13	298	15	-	-	PUNCT
amwa-13	298	16	to	to	ADP
amwa-13	298	17	-	-	PUNCT
amwa-13	298	18	keep	keep	VERB
amwa-13	298	19	-	-	PUNCT
amwa-13	298	20	it	it	PRON
amwa-13	298	21	-	-	PUNCT
amwa-13	298	22	in	in	ADP
amwa-13	298	23	-	-	PUNCT
amwa-13	298	24	check	check	NOUN
amwa-13	298	25	47	47	NUM
amwa-13	298	26	.	.	PUNCT
amwa-13	299	1	vaduganathan	vaduganathan	PROPN
amwa-13	299	2	m	m	PROPN
amwa-13	299	3	,	,	PUNCT
amwa-13	299	4	vardeny	vardeny	PROPN
amwa-13	299	5	o	o	PROPN
amwa-13	299	6	,	,	PUNCT
amwa-13	299	7	michel	michel	PROPN
amwa-13	299	8	t	t	PROPN
amwa-13	299	9	,	,	PUNCT
amwa-13	299	10	mcmurray	mcmurray	PROPN
amwa-13	299	11	jjv	jjv	PROPN
amwa-13	299	12	,	,	PUNCT
amwa-13	299	13	pfeffer	pfeffer	PROPN
amwa-13	299	14	ma	ma	PROPN
amwa-13	299	15	,	,	PUNCT
amwa-13	299	16	solomon	solomon	PROPN
amwa-13	299	17	sd	sd	PROPN
amwa-13	299	18	.	.	PUNCT
amwa-13	300	1	renin	renin	ADJ
amwa-13	300	2	–	–	PUNCT
amwa-13	300	3	angiotensin	angiotensin	NOUN
amwa-13	300	4	–	–	PUNCT
amwa-13	300	5	aldosterone	aldosterone	NOUN
amwa-13	300	6	system	system	NOUN
amwa-13	300	7	inhibitors	inhibitor	NOUN
amwa-13	300	8	in	in	ADP
amwa-13	300	9	patients	patient	NOUN
amwa-13	300	10	with	with	ADP
amwa-13	300	11	covid-19	covid-19	PROPN
amwa-13	300	12	.	.	PUNCT
amwa-13	301	1	n	n	PROPN
amwa-13	301	2	engl	engl	PROPN
amwa-13	301	3	j	j	PROPN
amwa-13	301	4	med	med	PROPN
amwa-13	301	5	.	.	PUNCT
amwa-13	302	1	2020;382:1653	2020;382:1653	NUM
amwa-13	302	2	-	-	SYM
amwa-13	302	3	1659	1659	NUM
amwa-13	302	4	.	.	PUNCT
amwa-13	303	1	doi:10.1056/	doi:10.1056/	PROPN
amwa-13	303	2	nejmsr2005760	nejmsr2005760	PROPN
amwa-13	303	3	48	48	NUM
amwa-13	303	4	.	.	PUNCT
amwa-13	304	1	ferrario	ferrario	PROPN
amwa-13	304	2	cm	cm	PROPN
amwa-13	304	3	,	,	PUNCT
amwa-13	304	4	jessup	jessup	PROPN
amwa-13	304	5	j	j	PROPN
amwa-13	304	6	,	,	PUNCT
amwa-13	304	7	chappell	chappell	PROPN
amwa-13	304	8	mc	mc	PROPN
amwa-13	304	9	,	,	PUNCT
amwa-13	304	10	et	et	PROPN
amwa-13	304	11	al	al	PROPN
amwa-13	304	12	.	.	PROPN
amwa-13	304	13	effect	effect	NOUN
amwa-13	304	14	of	of	ADP
amwa-13	304	15	angiotensinconverting	angiotensinconverte	VERB
amwa-13	304	16	enzyme	enzyme	NOUN
amwa-13	304	17	inhibition	inhibition	NOUN
amwa-13	304	18	and	and	CCONJ
amwa-13	304	19	angiotensin	angiotensin	NOUN
amwa-13	304	20	ii	ii	PROPN
amwa-13	304	21	receptor	receptor	NOUN
amwa-13	304	22	blockers	blocker	NOUN
amwa-13	304	23	on	on	ADP
amwa-13	304	24	cardiac	cardiac	ADJ
amwa-13	304	25	angiotensin	angiotensin	NOUN
amwa-13	304	26	-	-	PUNCT
amwa-13	304	27	converting	convert	VERB
amwa-13	304	28	enzyme	enzyme	NOUN
amwa-13	304	29	2	2	NUM
amwa-13	304	30	.	.	PUNCT
amwa-13	304	31	circulation	circulation	NOUN
amwa-13	304	32	.	.	PUNCT
amwa-13	305	1	2005;111(20):2605	2005;111(20):2605	NUM
amwa-13	305	2	-	-	SYM
amwa-13	305	3	2610	2610	NUM
amwa-13	305	4	.	.	PUNCT
amwa-13	306	1	doi:10.1161	doi:10.1161	ADJ
amwa-13	306	2	/	/	SYM
amwa-13	306	3	circulationaha.104.510461	circulationaha.104.510461	NOUN
amwa-13	306	4	49	49	NUM
amwa-13	306	5	.	.	PUNCT
amwa-13	307	1	igase	igase	VERB
amwa-13	307	2	m	m	PROPN
amwa-13	307	3	,	,	PUNCT
amwa-13	307	4	strawn	strawn	PROPN
amwa-13	307	5	wb	wb	PROPN
amwa-13	307	6	,	,	PUNCT
amwa-13	307	7	gallagher	gallagher	PROPN
amwa-13	307	8	pe	pe	PROPN
amwa-13	307	9	,	,	PUNCT
amwa-13	307	10	geary	geary	PROPN
amwa-13	307	11	rl	rl	PROPN
amwa-13	307	12	,	,	PUNCT
amwa-13	307	13	ferrario	ferrario	PROPN
amwa-13	307	14	cm	cm	PROPN
amwa-13	307	15	.	.	PUNCT
amwa-13	308	1	angiotensin	angiotensin	PROPN
amwa-13	308	2	ii	ii	PROPN
amwa-13	308	3	at1	at1	PROPN
amwa-13	308	4	receptors	receptor	NOUN
amwa-13	308	5	regulate	regulate	VERB
amwa-13	308	6	ace2	ace2	NOUN
amwa-13	308	7	and	and	CCONJ
amwa-13	308	8	angiotensin-(1–7	angiotensin-(1–7	NOUN
amwa-13	308	9	)	)	PUNCT
amwa-13	308	10	expression	expression	NOUN
amwa-13	308	11	in	in	ADP
amwa-13	308	12	the	the	DET
amwa-13	308	13	aorta	aorta	NOUN
amwa-13	308	14	of	of	ADP
amwa-13	308	15	spontaneously	spontaneously	ADV
amwa-13	308	16	hypertensive	hypertensive	ADJ
amwa-13	308	17	rats	rat	NOUN
amwa-13	308	18	.	.	PUNCT
amwa-13	309	1	am	be	AUX
amwa-13	309	2	j	j	PROPN
amwa-13	309	3	physiol	physiol	PROPN
amwa-13	309	4	-	-	PUNCT
amwa-13	309	5	heart	heart	PROPN
amwa-13	309	6	circ	circ	PROPN
amwa-13	309	7	physiol	physiol	PROPN
amwa-13	309	8	.	.	PUNCT
amwa-13	310	1	2005;289(3):h1013	2005;289(3):h1013	NUM
amwa-13	310	2	-	-	PUNCT
amwa-13	310	3	h1019	h1019	PROPN
amwa-13	310	4	.	.	PUNCT
amwa-13	310	5	doi:10.1152	doi:10.1152	PROPN
amwa-13	310	6	/	/	SYM
amwa-13	310	7	ajpheart.00068.2005	ajpheart.00068.2005	VERB
amwa-13	310	8	50	50	NUM
amwa-13	310	9	.	.	PUNCT
amwa-13	311	1	mackey	mackey	PROPN
amwa-13	311	2	k	k	PROPN
amwa-13	311	3	,	,	PUNCT
amwa-13	311	4	king	king	PROPN
amwa-13	311	5	vj	vj	PROPN
amwa-13	311	6	,	,	PUNCT
amwa-13	311	7	gurley	gurley	PROPN
amwa-13	311	8	s	s	PROPN
amwa-13	311	9	,	,	PUNCT
amwa-13	311	10	et	et	PROPN
amwa-13	311	11	al	al	PROPN
amwa-13	311	12	.	.	PROPN
amwa-13	311	13	risks	risk	NOUN
amwa-13	311	14	and	and	CCONJ
amwa-13	311	15	impact	impact	NOUN
amwa-13	311	16	of	of	ADP
amwa-13	311	17	angiotensinconverting	angiotensinconverte	VERB
amwa-13	311	18	enzyme	enzyme	NOUN
amwa-13	311	19	inhibitors	inhibitor	NOUN
amwa-13	311	20	or	or	CCONJ
amwa-13	311	21	angiotensin	angiotensin	NOUN
amwa-13	311	22	-	-	PUNCT
amwa-13	311	23	receptor	receptor	NOUN
amwa-13	311	24	blockers	blocker	NOUN
amwa-13	311	25	on	on	ADP
amwa-13	311	26	sars	sar	NOUN
amwa-13	311	27	-	-	PUNCT
amwa-13	311	28	cov-2	cov-2	PART
amwa-13	311	29	infection	infection	NOUN
amwa-13	311	30	in	in	ADP
amwa-13	311	31	adults	adult	NOUN
amwa-13	311	32	.	.	PUNCT
amwa-13	312	1	ann	ann	PROPN
amwa-13	312	2	intern	intern	PROPN
amwa-13	312	3	med	me	VERB
amwa-13	312	4	.	.	PUNCT
amwa-13	313	1	2020;173(3):195	2020;173(3):195	NUM
amwa-13	313	2	-	-	PUNCT
amwa-13	313	3	203	203	NUM
amwa-13	313	4	.	.	PUNCT
amwa-13	313	5	doi:10.7326	doi:10.7326	NOUN
amwa-13	313	6	/	/	SYM
amwa-13	313	7	m20	m20	PROPN
amwa-13	313	8	-	-	PUNCT
amwa-13	313	9	1515	1515	NUM
amwa-13	313	10	51	51	NUM
amwa-13	313	11	.	.	PUNCT
amwa-13	314	1	dublin	dublin	PROPN
amwa-13	314	2	s	s	PROPN
amwa-13	314	3	,	,	PUNCT
amwa-13	314	4	walker	walker	PROPN
amwa-13	314	5	r	r	PROPN
amwa-13	314	6	,	,	PUNCT
amwa-13	314	7	floyd	floyd	PROPN
amwa-13	314	8	js	js	PROPN
amwa-13	314	9	,	,	PUNCT
amwa-13	314	10	et	et	PROPN
amwa-13	314	11	al	al	PROPN
amwa-13	314	12	.	.	PUNCT
amwa-13	315	1	renin	renin	ADJ
amwa-13	315	2	-	-	PUNCT
amwa-13	315	3	angiotensin	angiotensin	NOUN
amwa-13	315	4	-	-	PUNCT
amwa-13	315	5	aldosterone	aldosterone	NOUN
amwa-13	315	6	system	system	NOUN
amwa-13	315	7	inhibitors	inhibitor	NOUN
amwa-13	315	8	and	and	CCONJ
amwa-13	315	9	covid-19	covid-19	PROPN
amwa-13	315	10	infection	infection	NOUN
amwa-13	315	11	or	or	CCONJ
amwa-13	315	12	hospitalization	hospitalization	NOUN
amwa-13	315	13	:	:	PUNCT
amwa-13	315	14	a	a	DET
amwa-13	315	15	cohort	cohort	NOUN
amwa-13	315	16	study	study	NOUN
amwa-13	315	17	.	.	PUNCT
amwa-13	316	1	am	be	AUX
amwa-13	316	2	j	j	PROPN
amwa-13	316	3	hypertens	hyperten	NOUN
amwa-13	316	4	.	.	PUNCT
amwa-13	317	1	published	publish	VERB
amwa-13	317	2	online	online	ADJ
amwa-13	317	3	october	october	PROPN
amwa-13	317	4	13	13	NUM
amwa-13	317	5	,	,	PUNCT
amwa-13	317	6	2020	2020	NUM
amwa-13	317	7	.	.	PUNCT
amwa-13	318	1	doi:10.1093/	doi:10.1093/	VERB
amwa-13	318	2	ajh	ajh	PROPN
amwa-13	318	3	/	/	SYM
amwa-13	318	4	hpaa168	hpaa168	PROPN
amwa-13	318	5	52	52	NUM
amwa-13	318	6	.	.	PUNCT
amwa-13	319	1	palazzuoli	palazzuoli	PROPN
amwa-13	319	2	a	a	PRON
amwa-13	319	3	,	,	PUNCT
amwa-13	319	4	mancone	mancone	PROPN
amwa-13	319	5	m	m	PROPN
amwa-13	319	6	,	,	PUNCT
amwa-13	319	7	ferrari	ferrari	PROPN
amwa-13	319	8	gm	gm	PROPN
amwa-13	319	9	,	,	PUNCT
amwa-13	319	10	et	et	PROPN
amwa-13	319	11	al	al	PROPN
amwa-13	319	12	.	.	PROPN
amwa-13	319	13	antecedent	antecedent	PROPN
amwa-13	319	14	administration	administration	NOUN
amwa-13	319	15	of	of	ADP
amwa-13	319	16	angiotensin	angiotensin	NOUN
amwa-13	319	17	-	-	PUNCT
amwa-13	319	18	converting	convert	VERB
amwa-13	319	19	-	-	PUNCT
amwa-13	319	20	enzyme	enzyme	NOUN
amwa-13	319	21	inhibitors	inhibitor	NOUN
amwa-13	319	22	or	or	CCONJ
amwa-13	319	23	angiotensin	angiotensin	NOUN
amwa-13	319	24	ii	ii	NOUN
amwa-13	319	25	receptor	receptor	NOUN
amwa-13	319	26	antagonists	antagonist	NOUN
amwa-13	319	27	and	and	CCONJ
amwa-13	319	28	survival	survival	NOUN
amwa-13	319	29	after	after	ADP
amwa-13	319	30	hospitalization	hospitalization	NOUN
amwa-13	319	31	for	for	ADP
amwa-13	319	32	covid-19	covid-19	PROPN
amwa-13	319	33	syndrome	syndrome	NOUN
amwa-13	319	34	.	.	PUNCT
amwa-13	320	1	j	j	PROPN
amwa-13	320	2	am	be	AUX
amwa-13	320	3	heart	heart	NOUN
amwa-13	320	4	assoc	assoc	NOUN
amwa-13	320	5	.	.	PUNCT
amwa-13	321	1	2020;9(22):e017364	2020;9(22):e017364	X
amwa-13	321	2	.	.	PUNCT
amwa-13	322	1	doi:10.1161	doi:10.1161	ADJ
amwa-13	322	2	/	/	SYM
amwa-13	322	3	jaha.120.017364	jaha.120.017364	NOUN
amwa-13	322	4	53	53	NUM
amwa-13	322	5	.	.	PUNCT
amwa-13	323	1	xu	xu	PROPN
amwa-13	323	2	j	j	PROPN
amwa-13	323	3	,	,	PUNCT
amwa-13	323	4	huang	huang	PROPN
amwa-13	323	5	c	c	PROPN
amwa-13	323	6	,	,	PUNCT
amwa-13	323	7	fan	fan	NOUN
amwa-13	323	8	g	g	NOUN
amwa-13	323	9	,	,	PUNCT
amwa-13	323	10	et	et	PROPN
amwa-13	323	11	al	al	PROPN
amwa-13	323	12	.	.	PUNCT
amwa-13	323	13	use	use	NOUN
amwa-13	323	14	of	of	ADP
amwa-13	323	15	angiotensin	angiotensin	NOUN
amwa-13	323	16	-	-	PUNCT
amwa-13	323	17	converting	convert	VERB
amwa-13	323	18	enzyme	enzyme	NOUN
amwa-13	323	19	inhibitors	inhibitor	NOUN
amwa-13	323	20	and	and	CCONJ
amwa-13	323	21	angiotensin	angiotensin	NOUN
amwa-13	323	22	ii	ii	PROPN
amwa-13	323	23	receptor	receptor	NOUN
amwa-13	323	24	blockers	blocker	NOUN
amwa-13	323	25	in	in	ADP
amwa-13	323	26	context	context	NOUN
amwa-13	323	27	of	of	ADP
amwa-13	323	28	covid19	covid19	NOUN
amwa-13	323	29	outbreak	outbreak	NOUN
amwa-13	323	30	:	:	PUNCT
amwa-13	323	31	a	a	DET
amwa-13	323	32	retrospective	retrospective	ADJ
amwa-13	323	33	analysis	analysis	NOUN
amwa-13	323	34	.	.	PUNCT
amwa-13	324	1	front	front	NOUN
amwa-13	324	2	med	med	PROPN
amwa-13	324	3	.	.	PUNCT
amwa-13	325	1	2020;14(5):601	2020;14(5):601	NUM
amwa-13	325	2	-	-	PUNCT
amwa-13	325	3	612	612	NUM
amwa-13	325	4	.	.	PUNCT
amwa-13	325	5	doi:10.1007	doi:10.1007	VERB
amwa-13	325	6	/	/	SYM
amwa-13	325	7	s11684	s11684	NOUN
amwa-13	325	8	-	-	PUNCT
amwa-13	325	9	020	020	NUM
amwa-13	325	10	-	-	PUNCT
amwa-13	325	11	0800	0800	NUM
amwa-13	325	12	-	-	PUNCT
amwa-13	325	13	y	y	PROPN
amwa-13	325	14	54	54	NUM
amwa-13	325	15	.	.	PUNCT
amwa-13	326	1	zhang	zhang	PROPN
amwa-13	326	2	p	p	PROPN
amwa-13	326	3	,	,	PUNCT
amwa-13	326	4	zhu	zhu	PROPN
amwa-13	326	5	l	l	PROPN
amwa-13	326	6	,	,	PUNCT
amwa-13	326	7	cai	cai	PROPN
amwa-13	326	8	j	j	PROPN
amwa-13	326	9	,	,	PUNCT
amwa-13	326	10	et	et	PROPN
amwa-13	326	11	al	al	PROPN
amwa-13	326	12	.	.	PROPN
amwa-13	326	13	association	association	PROPN
amwa-13	326	14	of	of	ADP
amwa-13	326	15	inpatient	inpatient	PROPN
amwa-13	326	16	use	use	NOUN
amwa-13	326	17	of	of	ADP
amwa-13	326	18	angiotensinconverting	angiotensinconverte	VERB
amwa-13	326	19	enzyme	enzyme	NOUN
amwa-13	326	20	inhibitors	inhibitor	NOUN
amwa-13	326	21	and	and	CCONJ
amwa-13	326	22	angiotensin	angiotensin	NOUN
amwa-13	326	23	ii	ii	PROPN
amwa-13	326	24	receptor	receptor	NOUN
amwa-13	326	25	blockers	blocker	NOUN
amwa-13	326	26	with	with	ADP
amwa-13	326	27	mortality	mortality	NOUN
amwa-13	326	28	among	among	ADP
amwa-13	326	29	patients	patient	NOUN
amwa-13	326	30	with	with	ADP
amwa-13	326	31	hypertension	hypertension	NOUN
amwa-13	326	32	hospitalized	hospitalize	VERB
amwa-13	326	33	with	with	ADP
amwa-13	326	34	covid-19	covid-19	PROPN
amwa-13	326	35	.	.	PUNCT
amwa-13	327	1	circ	circ	PROPN
amwa-13	327	2	res	re	NOUN
amwa-13	327	3	.	.	PUNCT
amwa-13	328	1	2020;126(12):1671	2020;126(12):1671	NUM
amwa-13	328	2	-	-	SYM
amwa-13	328	3	1681	1681	NUM
amwa-13	328	4	.	.	PUNCT
amwa-13	329	1	doi:10.1161/	doi:10.1161/	PROPN
amwa-13	329	2	circresaha.120.317134	circresaha.120.317134	PROPN
amwa-13	329	3	55	55	NUM
amwa-13	329	4	.	.	PUNCT
amwa-13	330	1	reynolds	reynolds	PROPN
amwa-13	330	2	hr	hr	PROPN
amwa-13	330	3	,	,	PUNCT
amwa-13	330	4	adhikari	adhikari	PROPN
amwa-13	330	5	s	s	PROPN
amwa-13	330	6	,	,	PUNCT
amwa-13	330	7	pulgarin	pulgarin	NOUN
amwa-13	330	8	c	c	NOUN
amwa-13	330	9	,	,	PUNCT
amwa-13	330	10	et	et	PROPN
amwa-13	330	11	al	al	PROPN
amwa-13	330	12	.	.	PUNCT
amwa-13	331	1	renin	renin	ADJ
amwa-13	331	2	–	–	PUNCT
amwa-13	331	3	angiotensin	angiotensin	NOUN
amwa-13	331	4	–	–	PUNCT
amwa-13	331	5	aldosterone	aldosterone	NOUN
amwa-13	331	6	system	system	NOUN
amwa-13	331	7	inhibitors	inhibitor	NOUN
amwa-13	331	8	and	and	CCONJ
amwa-13	331	9	risk	risk	NOUN
amwa-13	331	10	of	of	ADP
amwa-13	331	11	covid-19	covid-19	PROPN
amwa-13	331	12	.	.	PUNCT
amwa-13	332	1	n	n	PROPN
amwa-13	332	2	engl	engl	PROPN
amwa-13	332	3	j	j	PROPN
amwa-13	332	4	med	med	PROPN
amwa-13	332	5	.	.	PUNCT
amwa-13	333	1	2020;382(25):2441	2020;382(25):2441	NUM
amwa-13	333	2	-	-	PUNCT
amwa-13	333	3	2448	2448	NUM
amwa-13	333	4	.	.	PUNCT
amwa-13	334	1	doi:10.1056	doi:10.1056	PROPN
amwa-13	334	2	/	/	SYM
amwa-13	334	3	nejmoa2008975	nejmoa2008975	PROPN
amwa-13	334	4	56	56	NUM
amwa-13	334	5	.	.	PUNCT
amwa-13	335	1	fernández	fernández	PROPN
amwa-13	335	2	-	-	PUNCT
amwa-13	335	3	ruiz	ruiz	PROPN
amwa-13	335	4	i.	i.	PROPN
amwa-13	335	5	raas	raas	PROPN
amwa-13	335	6	inhibitors	inhibitor	NOUN
amwa-13	335	7	do	do	AUX
amwa-13	335	8	not	not	PART
amwa-13	335	9	increase	increase	VERB
amwa-13	335	10	the	the	DET
amwa-13	335	11	risk	risk	NOUN
amwa-13	335	12	of	of	ADP
amwa-13	335	13	covid-19	covid-19	PROPN
amwa-13	335	14	.	.	PUNCT
amwa-13	336	1	nat	nat	PROPN
amwa-13	336	2	rev	rev	PROPN
amwa-13	336	3	cardiol	cardiol	NOUN
amwa-13	336	4	.	.	PUNCT
amwa-13	337	1	2020;17(7):383	2020;17(7):383	NUM
amwa-13	337	2	-	-	PUNCT
amwa-13	337	3	383	383	NUM
amwa-13	337	4	.	.	PUNCT
amwa-13	338	1	doi:10.1038	doi:10.1038	NOUN
amwa-13	338	2	/	/	SYM
amwa-13	338	3	s41569	s41569	PROPN
amwa-13	338	4	-	-	PUNCT
amwa-13	338	5	020	020	NUM
amwa-13	338	6	-	-	PUNCT
amwa-13	338	7	0401	0401	NUM
amwa-13	338	8	-	-	SYM
amwa-13	338	9	0	0	NUM
amwa-13	338	10	57	57	NUM
amwa-13	338	11	.	.	PUNCT
amwa-13	338	12	centers	center	NOUN
amwa-13	338	13	for	for	ADP
amwa-13	338	14	disease	disease	NOUN
amwa-13	338	15	control	control	NOUN
amwa-13	338	16	and	and	CCONJ
amwa-13	338	17	prevention	prevention	NOUN
amwa-13	338	18	.	.	PUNCT
amwa-13	339	1	covid-19	covid-19	PROPN
amwa-13	339	2	and	and	CCONJ
amwa-13	339	3	your	your	PRON
amwa-13	339	4	health	health	NOUN
amwa-13	339	5	:	:	PUNCT
amwa-13	339	6	people	people	NOUN
amwa-13	339	7	with	with	ADP
amwa-13	339	8	certain	certain	ADJ
amwa-13	339	9	medical	medical	ADJ
amwa-13	339	10	conditions	condition	NOUN
amwa-13	339	11	.	.	PUNCT
amwa-13	340	1	centers	center	NOUN
amwa-13	340	2	for	for	ADP
amwa-13	340	3	disease	disease	NOUN
amwa-13	340	4	control	control	NOUN
amwa-13	340	5	and	and	CCONJ
amwa-13	340	6	prevention	prevention	NOUN
amwa-13	340	7	.	.	PUNCT
amwa-13	341	1	published	publish	VERB
amwa-13	341	2	february	february	PROPN
amwa-13	341	3	11	11	NUM
amwa-13	341	4	,	,	PUNCT
amwa-13	341	5	2020	2020	NUM
amwa-13	341	6	.	.	PUNCT
amwa-13	342	1	accessed	access	VERB
amwa-13	342	2	january	january	PROPN
amwa-13	342	3	2	2	NUM
amwa-13	342	4	,	,	PUNCT
amwa-13	342	5	2021	2021	NUM
amwa-13	342	6	.	.	PUNCT
amwa-13	343	1	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/	PRON
amwa-13	343	2	people-with-medical-conditions.html	people-with-medical-conditions.html	VERB
amwa-13	343	3	58	58	NUM
amwa-13	343	4	.	.	PUNCT
amwa-13	344	1	patients	patient	NOUN
amwa-13	344	2	taking	take	VERB
amwa-13	344	3	ace	ace	NOUN
amwa-13	344	4	-	-	PUNCT
amwa-13	344	5	i	i	PRON
amwa-13	344	6	and	and	CCONJ
amwa-13	344	7	arbs	arb	NOUN
amwa-13	344	8	who	who	PRON
amwa-13	344	9	contract	contract	VERB
amwa-13	344	10	covid-19	covid-19	PROPN
amwa-13	344	11	should	should	AUX
amwa-13	344	12	continue	continue	VERB
amwa-13	344	13	treatment	treatment	NOUN
amwa-13	344	14	,	,	PUNCT
amwa-13	344	15	unless	unless	SCONJ
amwa-13	344	16	otherwise	otherwise	ADV
amwa-13	344	17	advised	advise	VERB
amwa-13	344	18	by	by	ADP
amwa-13	344	19	their	their	PRON
amwa-13	344	20	physician	physician	NOUN
amwa-13	344	21	.	.	PUNCT
amwa-13	345	1	american	american	ADJ
amwa-13	345	2	heart	heart	PROPN
amwa-13	345	3	association	association	PROPN
amwa-13	345	4	.	.	PUNCT
amwa-13	346	1	published	publish	VERB
amwa-13	346	2	march	march	PROPN
amwa-13	346	3	17	17	NUM
amwa-13	346	4	,	,	PUNCT
amwa-13	346	5	2020	2020	NUM
amwa-13	346	6	.	.	PUNCT
amwa-13	347	1	accessed	access	VERB
amwa-13	347	2	january	january	PROPN
amwa-13	347	3	2	2	NUM
amwa-13	347	4	,	,	PUNCT
amwa-13	347	5	2021	2021	NUM
amwa-13	347	6	.	.	PUNCT
amwa-13	348	1	https://newsroom.heart.org/news/patients-taking-acei-and-arbs-who-contract-covid-19-should-continue-treatment-unlessotherwise-advised-by-their-physician	https://newsroom.heart.org/news/patients-taking-acei-and-arbs-who-contract-covid-19-should-continue-treatment-unlessotherwise-advised-by-their-physician	PROPN
amwa-13	348	2	59	59	NUM
amwa-13	348	3	.	.	PUNCT
amwa-13	349	1	search	search	NOUN
amwa-13	349	2	of	of	ADP
amwa-13	349	3	:	:	PUNCT
amwa-13	349	4	covid-19	covid-19	PROPN
amwa-13	349	5	,	,	PUNCT
amwa-13	349	6	ace	ace	NOUN
amwa-13	349	7	,	,	PUNCT
amwa-13	349	8	arb	arb	PROPN
amwa-13	349	9	.	.	PUNCT
amwa-13	350	1	clinicaltrials.gov	clinicaltrials.gov	X
amwa-13	350	2	.	.	PROPN
amwa-13	350	3	published	publish	VERB
amwa-13	350	4	2021	2021	NUM
amwa-13	350	5	.	.	PUNCT
amwa-13	351	1	accessed	access	VERB
amwa-13	351	2	january	january	PROPN
amwa-13	351	3	11	11	NUM
amwa-13	351	4	,	,	PUNCT
amwa-13	351	5	2021	2021	NUM
amwa-13	351	6	.	.	PUNCT
amwa-13	352	1	https://clinicaltrials.gov/ct2/results?cond=	https://clinicaltrials.gov/ct2/results?cond=	NOUN
amwa-13	352	2	covid19&term	covid19&term	NOUN
amwa-13	352	3	=	=	SYM
amwa-13	352	4	ace%2c+arb&type=&rslt=&recrs	ace%2c+arb&type=&rslt=&recr	NOUN
amwa-13	352	5	=	=	NOUN
amwa-13	352	6	a&recrs	a&recr	NOUN
amwa-13	352	7	=	=	NOUN
amwa-13	352	8	f&recrs	f&recr	NOUN
amwa-13	352	9	=	=	SYM
amwa-13	352	10	d	d	NOUN
amwa-13	352	11	&	&	CCONJ
amwa-13	352	12	age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=	age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=	PROPN
amwa-13	352	13	&	&	CCONJ
amwa-13	352	14	city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd	city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd	NOUN
amwa-13	352	15	_	_	PUNCT
amwa-13	352	16	s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=	s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=	PROPN
amwa-13	353	1	60	60	NUM
amwa-13	353	2	.	.	PUNCT
amwa-13	354	1	santos	santos	PROPN
amwa-13	354	2	ra	ra	PROPN
amwa-13	354	3	.	.	PUNCT
amwa-13	355	1	angiotensin-(1	angiotensin-(1	PROPN
amwa-13	355	2	-	-	PUNCT
amwa-13	355	3	7	7	NUM
amwa-13	355	4	)	)	PUNCT
amwa-13	355	5	.	.	PUNCT
amwa-13	356	1	hypertension	hypertension	NOUN
amwa-13	356	2	.	.	PUNCT
amwa-13	357	1	2014;63(6):1138	2014;63(6):1138	PROPN
amwa-13	357	2	-	-	PUNCT
amwa-13	357	3	1147	1147	NUM
amwa-13	357	4	.	.	PUNCT
amwa-13	358	1	doi:10.1161	doi:10.1161	ADJ
amwa-13	358	2	/	/	SYM
amwa-13	358	3	hypertensionaha.113.01274	hypertensionaha.113.01274	NOUN
amwa-13	358	4	61	61	NUM
amwa-13	358	5	.	.	PUNCT
amwa-13	359	1	iusuf	iusuf	PROPN
amwa-13	359	2	d	d	PROPN
amwa-13	359	3	,	,	PUNCT
amwa-13	359	4	henning	henning	PROPN
amwa-13	359	5	rh	rh	PROPN
amwa-13	359	6	,	,	PUNCT
amwa-13	359	7	van	van	PROPN
amwa-13	359	8	gilst	gilst	PROPN
amwa-13	359	9	wh	wh	PROPN
amwa-13	359	10	,	,	PUNCT
amwa-13	359	11	roks	roks	PROPN
amwa-13	359	12	ajm	ajm	PROPN
amwa-13	359	13	.	.	PUNCT
amwa-13	359	14	angiotensin-(1–7	angiotensin-(1–7	PROPN
amwa-13	359	15	):	):	PUNCT
amwa-13	359	16	pharmacological	pharmacological	ADJ
amwa-13	359	17	properties	property	NOUN
amwa-13	359	18	and	and	CCONJ
amwa-13	359	19	pharmacotherapeutic	pharmacotherapeutic	ADJ
amwa-13	359	20	perspectives	perspective	NOUN
amwa-13	359	21	.	.	PUNCT
amwa-13	360	1	eur	eur	PROPN
amwa-13	360	2	j	j	PROPN
amwa-13	360	3	pharmacol	pharmacol	PROPN
amwa-13	360	4	.	.	PUNCT
amwa-13	361	1	2008;585(2	2008;585(2	NUM
amwa-13	361	2	-	-	PUNCT
amwa-13	361	3	3):303	3):303	NUM
amwa-13	361	4	-	-	SYM
amwa-13	361	5	312	312	NUM
amwa-13	361	6	.	.	PUNCT
amwa-13	361	7	doi:10.1016	doi:10.1016	PROPN
amwa-13	361	8	/	/	SYM
amwa-13	361	9	j.ejphar.2008.02.090	j.ejphar.2008.02.090	PROPN
amwa-13	361	10	62	62	NUM
amwa-13	361	11	.	.	PUNCT
amwa-13	362	1	vijayvargiya	vijayvargiya	PROPN
amwa-13	362	2	p	p	X
amwa-13	362	3	,	,	PUNCT
amwa-13	362	4	garrigos	garrigos	PROPN
amwa-13	362	5	ze	ze	PROPN
amwa-13	362	6	,	,	PUNCT
amwa-13	362	7	almeida	almeida	PROPN
amwa-13	362	8	nec	nec	PROPN
amwa-13	362	9	,	,	PUNCT
amwa-13	362	10	gurram	gurram	PROPN
amwa-13	362	11	pr	pr	PROPN
amwa-13	362	12	,	,	PUNCT
amwa-13	362	13	stevens	stevens	PROPN
amwa-13	362	14	rw	rw	PROPN
amwa-13	362	15	,	,	PUNCT
amwa-13	362	16	razonable	razonable	ADJ
amwa-13	362	17	rr	rr	PROPN
amwa-13	362	18	.	.	PUNCT
amwa-13	363	1	treatment	treatment	NOUN
amwa-13	363	2	considerations	consideration	NOUN
amwa-13	363	3	for	for	ADP
amwa-13	363	4	covid-19	covid-19	PROPN
amwa-13	363	5	.	.	PROPN
amwa-13	363	6	mayo	mayo	PROPN
amwa-13	363	7	clin	clin	PROPN
amwa-13	363	8	proc	proc	PROPN
amwa-13	363	9	.	.	PUNCT
amwa-13	364	1	2020	2020	NUM
amwa-13	364	2	;	;	PUNCT
amwa-13	364	3	95(7):1454	95(7):1454	NUM
amwa-13	364	4	-	-	SYM
amwa-13	364	5	1466	1466	NUM
amwa-13	364	6	.	.	PUNCT
amwa-13	365	1	63	63	NUM
amwa-13	365	2	.	.	PUNCT
amwa-13	366	1	who	who	PRON
amwa-13	366	2	solidarity	solidarity	VERB
amwa-13	366	3	trial	trial	NOUN
amwa-13	366	4	consortium	consortium	NOUN
amwa-13	366	5	.	.	PUNCT
amwa-13	367	1	repurposed	repurpose	VERB
amwa-13	367	2	antiviral	antiviral	ADJ
amwa-13	367	3	drugs	drug	NOUN
amwa-13	367	4	for	for	ADP
amwa-13	367	5	covid-19	covid-19	PROPN
amwa-13	367	6	—	—	PUNCT
amwa-13	367	7	interim	interim	ADJ
amwa-13	367	8	who	who	PRON
amwa-13	367	9	solidarity	solidarity	VERB
amwa-13	367	10	trial	trial	NOUN
amwa-13	367	11	results	result	NOUN
amwa-13	367	12	.	.	PUNCT
amwa-13	368	1	n	n	X
amwa-13	368	2	engl	engl	PROPN
amwa-13	368	3	j	j	PROPN
amwa-13	368	4	med	med	PROPN
amwa-13	368	5	.	.	PROPN
amwa-13	368	6	2021	2021	NUM
amwa-13	368	7	;	;	PUNCT
amwa-13	368	8	384(6):497	384(6):497	NUM
amwa-13	368	9	-	-	SYM
amwa-13	368	10	511	511	NUM
amwa-13	368	11	.	.	PUNCT
amwa-13	369	1	doi:10.1056	doi:10.1056	PROPN
amwa-13	369	2	/	/	SYM
amwa-13	369	3	nejmoa2023184	nejmoa2023184	PROPN
amwa-13	369	4	64	64	NUM
amwa-13	369	5	.	.	PUNCT
amwa-13	370	1	who	who	PRON
amwa-13	370	2	discontinues	discontinue	VERB
amwa-13	370	3	hydroxychloroquine	hydroxychloroquine	PROPN
amwa-13	370	4	and	and	CCONJ
amwa-13	370	5	lopinavir	lopinavir	PROPN
amwa-13	370	6	/	/	SYM
amwa-13	370	7	ritonavir	ritonavir	PROPN
amwa-13	370	8	treatment	treatment	NOUN
amwa-13	370	9	arms	arm	NOUN
amwa-13	370	10	for	for	ADP
amwa-13	370	11	covid-19	covid-19	PROPN
amwa-13	370	12	.	.	PUNCT
amwa-13	370	13	world	world	PROPN
amwa-13	370	14	health	health	PROPN
amwa-13	370	15	organization	organization	PROPN
amwa-13	370	16	.	.	PUNCT
amwa-13	371	1	published	publish	VERB
amwa-13	371	2	july	july	PROPN
amwa-13	371	3	4	4	NUM
amwa-13	371	4	,	,	PUNCT
amwa-13	371	5	2020	2020	NUM
amwa-13	371	6	.	.	PUNCT
amwa-13	372	1	accessed	access	VERB
amwa-13	372	2	april	april	PROPN
amwa-13	372	3	7	7	NUM
amwa-13	372	4	,	,	PUNCT
amwa-13	372	5	2021	2021	NUM
amwa-13	372	6	.	.	PUNCT
amwa-13	373	1	https://www.who.int/news/item/0407-2020-who-discontinues-hydroxychloroquine-and-lopinavirritonavir-treatment-arms-for-covid-19	https://www.who.int/news/item/0407-2020-who-discontinues-hydroxychloroquine-and-lopinavirritonavir-treatment-arms-for-covid-19	PROPN
amwa-13	373	2	https://www.mayoclinic.org/diseases-conditions/ards/symptoms-causes/syc-20355576	https://www.mayoclinic.org/diseases-conditions/ards/symptoms-causes/syc-20355576	PROPN
amwa-13	373	3	https://www.mayoclinic.org/diseases-conditions/ards/symptoms-causes/syc-20355576	https://www.mayoclinic.org/diseases-conditions/ards/symptoms-causes/syc-20355576	PROPN
amwa-13	373	4	https://www.who.int/data/gho/data/indicators/indicator-details/gho/raised-blood-pressure-(sbp-=140-or-dbp-=90)-(age-standardized-estimate	https://www.who.int/data/gho/data/indicators/indicator-details/gho/raised-blood-pressure-(sbp-=140-or-dbp-=90)-(age-standardized-estimate	NOUN
amwa-13	373	5	)	)	PUNCT
amwa-13	374	1	https://www.cdc.gov/heartdisease/facts.htm	https://www.cdc.gov/heartdisease/facts.htm	PRON
amwa-13	374	2	https://doi.org/10.1002/ejhf.1924	https://doi.org/10.1002/ejhf.1924	X
amwa-13	374	3	https://www.cdc.gov/nchs/products/databriefs/db289.htm	https://www.cdc.gov/nchs/products/databriefs/db289.htm	NUM
amwa-13	374	4	http://www.heart.org	http://www.heart.org	PROPN
amwa-13	374	5	https://www.heart.org/en/news/2020/05/18/is-high-blood-pressure-inevitable-heres-how-to-keep-it-in-check	https://www.heart.org/en/news/2020/05/18/is-high-blood-pressure-inevitable-heres-how-to-keep-it-in-check	PROPN
amwa-13	374	6	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html	PROPN
amwa-13	374	7	https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician	https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician	PROPN
amwa-13	374	8	https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician	https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician	PROPN
amwa-13	374	9	https://clinicaltrials.gov/ct2/results?cond=covid19&term=ace%2c+arb&type=&rslt=&recrs=a&recrs=f&recrs=d&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=	https://clinicaltrials.gov/ct2/results?cond=covid19&term=ace%2c+arb&type=&rslt=&recrs=a&recrs=f&recrs=d&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=	PROPN
amwa-13	374	10	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	PROPN
amwa-13	374	11	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	PROPN
amwa-13	374	12	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	PROPN
amwa-13	374	13	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19	ADV
amwa-13	374	14	78	78	NUM
amwa-13	374	15	amwa	amwa	PROPN
amwa-13	374	16	journal	journal	PROPN
amwa-13	374	17	/	/	SYM
amwa-13	374	18	v36	v36	PROPN
amwa-13	374	19	n2	n2	PROPN
amwa-13	374	20	/	/	SYM
amwa-13	374	21	2021	2021	NUM
amwa-13	374	22	/	/	SYM
amwa-13	374	23	amwa.org	amwa.org	PROPN
amwa-13	374	24	65	65	NUM
amwa-13	374	25	.	.	PUNCT
amwa-13	374	26	chloroquine	chloroquine	NOUN
amwa-13	374	27	or	or	CCONJ
amwa-13	374	28	hydroxychloroquine	hydroxychloroquine	VERB
amwa-13	374	29	with	with	ADP
amwa-13	374	30	or	or	CCONJ
amwa-13	374	31	without	without	ADP
amwa-13	374	32	azithromycin	azithromycin	NOUN
amwa-13	374	33	.	.	PUNCT
amwa-13	375	1	covid-19	covid-19	PROPN
amwa-13	375	2	treatment	treatment	NOUN
amwa-13	375	3	guidelines	guideline	NOUN
amwa-13	375	4	.	.	PUNCT
amwa-13	376	1	published	publish	VERB
amwa-13	376	2	october	october	PROPN
amwa-13	376	3	9	9	NUM
amwa-13	376	4	,	,	PUNCT
amwa-13	376	5	2020	2020	NUM
amwa-13	376	6	.	.	PUNCT
amwa-13	377	1	accessed	access	VERB
amwa-13	377	2	october	october	PROPN
amwa-13	377	3	31	31	NUM
amwa-13	377	4	,	,	PUNCT
amwa-13	377	5	2020	2020	NUM
amwa-13	377	6	.	.	PUNCT
amwa-13	378	1	https://www.covid19treatmentguidelines.nih.gov/	https://www.covid19treatmentguidelines.nih.gov/	PROPN
amwa-13	378	2	antiviral	antiviral	ADJ
amwa-13	378	3	-	-	PUNCT
amwa-13	378	4	therapy	therapy	NOUN
amwa-13	378	5	/	/	SYM
amwa-13	378	6	chloroquine	chloroquine	NOUN
amwa-13	378	7	-	-	PUNCT
amwa-13	378	8	or	or	CCONJ
amwa-13	378	9	-	-	PUNCT
amwa-13	378	10	hydroxychloroquine	hydroxychloroquine	NOUN
amwa-13	378	11	-	-	PUNCT
amwa-13	378	12	with	with	ADP
amwa-13	378	13	-	-	PUNCT
amwa-13	378	14	or	or	CCONJ
amwa-13	378	15	-	-	PUNCT
amwa-13	378	16	withoutazithromycin/	withoutazithromycin/	NUM
amwa-13	378	17	66	66	NUM
amwa-13	378	18	.	.	PUNCT
amwa-13	379	1	lopinavir	lopinavir	PROPN
amwa-13	379	2	/	/	SYM
amwa-13	379	3	ritonavir	ritonavir	PROPN
amwa-13	379	4	and	and	CCONJ
amwa-13	379	5	other	other	ADJ
amwa-13	379	6	hiv	hiv	PROPN
amwa-13	379	7	protease	protease	NOUN
amwa-13	379	8	inhibitors	inhibitor	NOUN
amwa-13	379	9	.	.	PUNCT
amwa-13	380	1	covid19	covid19	NOUN
amwa-13	380	2	treatment	treatment	NOUN
amwa-13	380	3	guidelines	guideline	NOUN
amwa-13	380	4	.	.	PUNCT
amwa-13	381	1	national	national	PROPN
amwa-13	381	2	institutes	institutes	PROPN
amwa-13	381	3	of	of	ADP
amwa-13	381	4	health	health	PROPN
amwa-13	381	5	.	.	PUNCT
amwa-13	382	1	published	publish	VERB
amwa-13	382	2	february	february	PROPN
amwa-13	382	3	11	11	NUM
amwa-13	382	4	,	,	PUNCT
amwa-13	382	5	2021	2021	NUM
amwa-13	382	6	.	.	PUNCT
amwa-13	383	1	accessed	access	VERB
amwa-13	383	2	april	april	PROPN
amwa-13	383	3	7	7	NUM
amwa-13	383	4	,	,	PUNCT
amwa-13	383	5	2021	2021	NUM
amwa-13	383	6	.	.	PUNCT
amwa-13	384	1	https://www	https://www	PROPN
amwa-13	384	2	.	.	PUNCT
amwa-13	384	3	covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavirritonavir-and-other-hiv-protease-inhibitors/	covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavirritonavir-and-other-hiv-protease-inhibitors/	VERB
amwa-13	384	4	67	67	NUM
amwa-13	384	5	.	.	PUNCT
amwa-13	385	1	naksuk	naksuk	PROPN
amwa-13	385	2	n	n	CCONJ
amwa-13	385	3	,	,	PUNCT
amwa-13	385	4	lazar	lazar	PROPN
amwa-13	385	5	s	s	PROPN
amwa-13	385	6	,	,	PUNCT
amwa-13	385	7	peeraphatdit	peeraphatdit	NOUN
amwa-13	385	8	tb	tb	NOUN
amwa-13	385	9	.	.	PUNCT
amwa-13	385	10	cardiac	cardiac	ADJ
amwa-13	385	11	safety	safety	NOUN
amwa-13	385	12	of	of	ADP
amwa-13	385	13	off	off	ADP
amwa-13	385	14	-	-	PUNCT
amwa-13	385	15	label	label	NOUN
amwa-13	385	16	covid-19	covid-19	PROPN
amwa-13	385	17	drug	drug	NOUN
amwa-13	385	18	therapy	therapy	NOUN
amwa-13	385	19	:	:	PUNCT
amwa-13	385	20	a	a	DET
amwa-13	385	21	review	review	NOUN
amwa-13	385	22	and	and	CCONJ
amwa-13	385	23	proposed	propose	VERB
amwa-13	385	24	monitoring	monitoring	NOUN
amwa-13	385	25	protocol	protocol	NOUN
amwa-13	385	26	.	.	PUNCT
amwa-13	386	1	eur	eur	PROPN
amwa-13	386	2	heart	heart	PROPN
amwa-13	386	3	j	j	PROPN
amwa-13	386	4	acute	acute	PROPN
amwa-13	386	5	cardiovasc	cardiovasc	PROPN
amwa-13	386	6	care	care	VERB
amwa-13	386	7	.	.	PUNCT
amwa-13	387	1	2020;9(3):215	2020;9(3):215	X
amwa-13	387	2	-	-	SYM
amwa-13	387	3	221	221	NUM
amwa-13	387	4	.	.	PUNCT
amwa-13	388	1	doi:10.1177/2048872620922784	doi:10.1177/2048872620922784	NOUN
amwa-13	388	2	68	68	NUM
amwa-13	388	3	.	.	PUNCT
amwa-13	389	1	hooks	hooks	PROPN
amwa-13	389	2	m	m	PROPN
amwa-13	389	3	,	,	PUNCT
amwa-13	389	4	bart	bart	PROPN
amwa-13	389	5	b	b	PROPN
amwa-13	389	6	,	,	PUNCT
amwa-13	389	7	vardeny	vardeny	PROPN
amwa-13	389	8	o	o	NOUN
amwa-13	389	9	,	,	PUNCT
amwa-13	389	10	westanmo	westanmo	PROPN
amwa-13	389	11	a	a	PRON
amwa-13	389	12	,	,	PUNCT
amwa-13	389	13	adabag	adabag	PROPN
amwa-13	389	14	s.	s.	PROPN
amwa-13	389	15	effects	effect	NOUN
amwa-13	389	16	of	of	ADP
amwa-13	389	17	hydroxychloroquine	hydroxychloroquine	ADJ
amwa-13	389	18	treatment	treatment	NOUN
amwa-13	389	19	on	on	ADP
amwa-13	389	20	qt	qt	NOUN
amwa-13	389	21	interval	interval	NOUN
amwa-13	389	22	.	.	PUNCT
amwa-13	390	1	heart	heart	NOUN
amwa-13	390	2	rhythm	rhythm	NOUN
amwa-13	390	3	.	.	PUNCT
amwa-13	391	1	2020;17(11):1930	2020;17(11):1930	NUM
amwa-13	391	2	-	-	SYM
amwa-13	391	3	1935	1935	NUM
amwa-13	391	4	.	.	PUNCT
amwa-13	392	1	doi:10.1016	doi:10.1016	PROPN
amwa-13	392	2	/	/	SYM
amwa-13	392	3	j.hrthm.2020.06.029	j.hrthm.2020.06.029	PROPN
amwa-13	392	4	69	69	NUM
amwa-13	392	5	.	.	PUNCT
amwa-13	393	1	costedoat	costedoat	PROPN
amwa-13	393	2	-	-	PUNCT
amwa-13	393	3	chalumeau	chalumeau	PROPN
amwa-13	393	4	n	n	CCONJ
amwa-13	393	5	,	,	PUNCT
amwa-13	393	6	hulot	hulot	NOUN
amwa-13	393	7	js	js	NOUN
amwa-13	393	8	,	,	PUNCT
amwa-13	393	9	amoura	amoura	NOUN
amwa-13	393	10	z	z	NOUN
amwa-13	393	11	,	,	PUNCT
amwa-13	393	12	et	et	PROPN
amwa-13	393	13	al	al	PROPN
amwa-13	393	14	.	.	PUNCT
amwa-13	394	1	heart	heart	NOUN
amwa-13	394	2	conduction	conduction	NOUN
amwa-13	394	3	disorders	disorder	NOUN
amwa-13	394	4	related	relate	VERB
amwa-13	394	5	to	to	ADP
amwa-13	394	6	antimalarials	antimalarial	NOUN
amwa-13	394	7	toxicity	toxicity	NOUN
amwa-13	394	8	:	:	PUNCT
amwa-13	394	9	an	an	DET
amwa-13	394	10	analysis	analysis	NOUN
amwa-13	394	11	of	of	ADP
amwa-13	394	12	electrocardiograms	electrocardiogram	NOUN
amwa-13	394	13	in	in	ADP
amwa-13	394	14	85	85	NUM
amwa-13	394	15	patients	patient	NOUN
amwa-13	394	16	treated	treat	VERB
amwa-13	394	17	with	with	ADP
amwa-13	394	18	hydroxychloroquine	hydroxychloroquine	NOUN
amwa-13	394	19	for	for	ADP
amwa-13	394	20	connective	connective	ADJ
amwa-13	394	21	tissue	tissue	NOUN
amwa-13	394	22	diseases	disease	NOUN
amwa-13	394	23	.	.	PUNCT
amwa-13	395	1	rheumatology	rheumatology	NOUN
amwa-13	395	2	.	.	PUNCT
amwa-13	396	1	2007;46(5):808	2007;46(5):808	NUM
amwa-13	396	2	-	-	PUNCT
amwa-13	396	3	810	810	NUM
amwa-13	396	4	.	.	PUNCT
amwa-13	397	1	doi:10.1093	doi:10.1093	NOUN
amwa-13	397	2	/	/	SYM
amwa-13	397	3	rheumatology	rheumatology	NOUN
amwa-13	397	4	/	/	SYM
amwa-13	397	5	kel402	kel402	PROPN
amwa-13	397	6	70	70	NUM
amwa-13	397	7	.	.	PUNCT
amwa-13	398	1	bavinger	bavinger	PROPN
amwa-13	398	2	c	c	PROPN
amwa-13	398	3	,	,	PUNCT
amwa-13	398	4	bendavid	bendavid	PROPN
amwa-13	398	5	e	e	NOUN
amwa-13	398	6	,	,	PUNCT
amwa-13	398	7	niehaus	niehaus	PROPN
amwa-13	398	8	k	k	PROPN
amwa-13	398	9	,	,	PUNCT
amwa-13	398	10	et	et	PROPN
amwa-13	398	11	al	al	PROPN
amwa-13	398	12	.	.	PROPN
amwa-13	398	13	risk	risk	NOUN
amwa-13	398	14	of	of	ADP
amwa-13	398	15	cardiovascular	cardiovascular	ADJ
amwa-13	398	16	disease	disease	NOUN
amwa-13	398	17	from	from	ADP
amwa-13	398	18	antiretroviral	antiretroviral	ADJ
amwa-13	398	19	therapy	therapy	NOUN
amwa-13	398	20	for	for	ADP
amwa-13	398	21	hiv	hiv	PROPN
amwa-13	398	22	:	:	PUNCT
amwa-13	398	23	a	a	DET
amwa-13	398	24	systematic	systematic	ADJ
amwa-13	398	25	review	review	NOUN
amwa-13	398	26	.	.	PUNCT
amwa-13	399	1	landay	landay	PROPN
amwa-13	399	2	a	a	PRON
amwa-13	399	3	,	,	PUNCT
amwa-13	399	4	ed	ed	NOUN
amwa-13	399	5	.	.	PUNCT
amwa-13	400	1	plos	plos	PROPN
amwa-13	400	2	one	one	NUM
amwa-13	400	3	.	.	PUNCT
amwa-13	401	1	2013;8(3):e59551	2013;8(3):e59551	X
amwa-13	401	2	.	.	PUNCT
amwa-13	401	3	doi:10.1371	doi:10.1371	PROPN
amwa-13	401	4	/	/	PUNCT
amwa-13	402	1	journal.pone.0059551	journal.pone.0059551	PROPN
amwa-13	402	2	71	71	NUM
amwa-13	402	3	.	.	PUNCT
amwa-13	403	1	kaletra	kaletra	ADJ
amwa-13	403	2	tablets	tablet	NOUN
amwa-13	403	3	and	and	CCONJ
amwa-13	403	4	oral	oral	ADJ
amwa-13	403	5	solution	solution	NOUN
amwa-13	403	6	.	.	PUNCT
amwa-13	404	1	abbvie	abbvie	PROPN
amwa-13	404	2	.	.	PUNCT
amwa-13	405	1	accessed	access	VERB
amwa-13	405	2	january	january	PROPN
amwa-13	405	3	9	9	NUM
amwa-13	405	4	,	,	PUNCT
amwa-13	405	5	2021	2021	NUM
amwa-13	405	6	.	.	PUNCT
amwa-13	406	1	https://www.rxabbvie.com/pdf/kaletratabpi.pdf	https://www.rxabbvie.com/pdf/kaletratabpi.pdf	NOUN
amwa-13	406	2	72	72	NUM
amwa-13	406	3	.	.	PUNCT
amwa-13	407	1	zhu	zhu	PROPN
amwa-13	407	2	n	n	CCONJ
amwa-13	407	3	,	,	PUNCT
amwa-13	407	4	zhang	zhang	PROPN
amwa-13	407	5	d	d	PROPN
amwa-13	407	6	,	,	PUNCT
amwa-13	407	7	wang	wang	PROPN
amwa-13	407	8	w	w	PROPN
amwa-13	407	9	,	,	PUNCT
amwa-13	407	10	et	et	PROPN
amwa-13	407	11	al	al	PROPN
amwa-13	407	12	.	.	PUNCT
amwa-13	408	1	a	a	DET
amwa-13	408	2	novel	novel	ADJ
amwa-13	408	3	coronavirus	coronavirus	NOUN
amwa-13	408	4	from	from	ADP
amwa-13	408	5	patients	patient	NOUN
amwa-13	408	6	with	with	ADP
amwa-13	408	7	pneumonia	pneumonia	NOUN
amwa-13	408	8	in	in	ADP
amwa-13	408	9	china	china	PROPN
amwa-13	408	10	,	,	PUNCT
amwa-13	408	11	2019	2019	NUM
amwa-13	408	12	.	.	PUNCT
amwa-13	409	1	n	n	X
amwa-13	409	2	engl	engl	PROPN
amwa-13	409	3	j	j	PROPN
amwa-13	409	4	med	med	PROPN
amwa-13	409	5	.	.	PUNCT
amwa-13	410	1	2020;382(8):727	2020;382(8):727	NUM
amwa-13	410	2	-	-	SYM
amwa-13	410	3	733	733	NUM
amwa-13	410	4	.	.	PUNCT
amwa-13	410	5	doi:10.1056	doi:10.1056	PROPN
amwa-13	410	6	/	/	SYM
amwa-13	410	7	nejmoa2001017	nejmoa2001017	PROPN
amwa-13	410	8	73	73	NUM
amwa-13	410	9	.	.	PUNCT
amwa-13	411	1	naming	name	VERB
amwa-13	411	2	the	the	DET
amwa-13	411	3	coronavirus	coronavirus	NOUN
amwa-13	411	4	disease	disease	NOUN
amwa-13	411	5	(	(	PUNCT
amwa-13	411	6	covid-19	covid-19	PROPN
amwa-13	411	7	)	)	PUNCT
amwa-13	411	8	and	and	CCONJ
amwa-13	411	9	the	the	DET
amwa-13	411	10	virus	virus	NOUN
amwa-13	411	11	that	that	PRON
amwa-13	411	12	causes	cause	VERB
amwa-13	411	13	it	it	PRON
amwa-13	411	14	.	.	PUNCT
amwa-13	412	1	world	world	NOUN
amwa-13	412	2	health	health	PROPN
amwa-13	412	3	organization	organization	PROPN
amwa-13	412	4	.	.	PUNCT
amwa-13	413	1	accessed	access	VERB
amwa-13	413	2	september	september	PROPN
amwa-13	413	3	10	10	NUM
amwa-13	413	4	,	,	PUNCT
amwa-13	413	5	2020	2020	NUM
amwa-13	413	6	.	.	PUNCT
amwa-13	414	1	https://	https://	PROPN
amwa-13	414	2	www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virusthat-causes-it	www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virusthat-causes-it	PROPN
amwa-13	414	3	74	74	NUM
amwa-13	414	4	.	.	PUNCT
amwa-13	415	1	office	office	NOUN
amwa-13	415	2	of	of	ADP
amwa-13	415	3	the	the	DET
amwa-13	415	4	commissioner	commissioner	NOUN
amwa-13	415	5	.	.	PUNCT
amwa-13	416	1	pfizer	pfizer	NOUN
amwa-13	416	2	-	-	PUNCT
amwa-13	416	3	biontech	biontech	PROPN
amwa-13	416	4	covid-19	covid-19	PROPN
amwa-13	416	5	vaccine	vaccine	NOUN
amwa-13	416	6	.	.	PUNCT
amwa-13	417	1	us	we	PRON
amwa-13	417	2	food	food	NOUN
amwa-13	417	3	and	and	CCONJ
amwa-13	417	4	drug	drug	PROPN
amwa-13	417	5	administration	administration	NOUN
amwa-13	417	6	.	.	PUNCT
amwa-13	418	1	published	publish	VERB
amwa-13	418	2	online	online	ADJ
amwa-13	418	3	january	january	PROPN
amwa-13	418	4	5	5	NUM
amwa-13	418	5	,	,	PUNCT
amwa-13	418	6	2021	2021	NUM
amwa-13	418	7	.	.	PUNCT
amwa-13	419	1	accessed	access	VERB
amwa-13	419	2	january	january	PROPN
amwa-13	419	3	11	11	NUM
amwa-13	419	4	,	,	PUNCT
amwa-13	419	5	2021	2021	NUM
amwa-13	419	6	.	.	PUNCT
amwa-13	420	1	https://www.fda.gov/emergencypreparedness-and-response/coronavirus-disease-2019-covid-19/pfizerbiontech-covid-19-vaccine	https://www.fda.gov/emergencypreparedness-and-response/coronavirus-disease-2019-covid-19/pfizerbiontech-covid-19-vaccine	NOUN
amwa-13	420	2	75	75	NUM
amwa-13	420	3	.	.	PUNCT
amwa-13	421	1	office	office	NOUN
amwa-13	421	2	of	of	ADP
amwa-13	421	3	the	the	DET
amwa-13	421	4	commissioner	commissioner	NOUN
amwa-13	421	5	.	.	PUNCT
amwa-13	422	1	moderna	moderna	PROPN
amwa-13	422	2	covid-19	covid-19	PROPN
amwa-13	422	3	vaccine	vaccine	NOUN
amwa-13	422	4	.	.	PUNCT
amwa-13	423	1	us	we	PRON
amwa-13	423	2	food	food	NOUN
amwa-13	423	3	and	and	CCONJ
amwa-13	423	4	drug	drug	PROPN
amwa-13	423	5	administration	administration	NOUN
amwa-13	423	6	.	.	PUNCT
amwa-13	424	1	published	publish	VERB
amwa-13	424	2	online	online	ADJ
amwa-13	424	3	january	january	PROPN
amwa-13	424	4	6	6	NUM
amwa-13	424	5	,	,	PUNCT
amwa-13	424	6	2021	2021	NUM
amwa-13	424	7	.	.	PUNCT
amwa-13	425	1	accessed	access	VERB
amwa-13	425	2	january	january	PROPN
amwa-13	425	3	11	11	NUM
amwa-13	425	4	,	,	PUNCT
amwa-13	425	5	2021	2021	NUM
amwa-13	425	6	.	.	PUNCT
amwa-13	426	1	https://www.fda.gov/emergency-preparedness-and-response/	https://www.fda.gov/emergency-preparedness-and-response/	NOUN
amwa-13	426	2	coronavirus	coronavirus	NOUN
amwa-13	426	3	-	-	PUNCT
amwa-13	426	4	disease-2019	disease-2019	NOUN
amwa-13	426	5	-	-	PUNCT
amwa-13	426	6	covid-19	covid-19	PROPN
amwa-13	426	7	/	/	SYM
amwa-13	426	8	moderna	moderna	PROPN
amwa-13	426	9	-	-	PUNCT
amwa-13	426	10	covid-19	covid-19	PROPN
amwa-13	426	11	-	-	PUNCT
amwa-13	426	12	vaccine	vaccine	NOUN
amwa-13	426	13	master	master	NOUN
amwa-13	426	14	essential	essential	ADJ
amwa-13	426	15	skills	skill	NOUN
amwa-13	426	16	in	in	ADP
amwa-13	426	17	medical	medical	ADJ
amwa-13	426	18	writing	writing	NOUN
amwa-13	426	19	learn	learn	NOUN
amwa-13	426	20	at	at	ADP
amwa-13	426	21	your	your	PRON
amwa-13	426	22	own	own	ADJ
amwa-13	426	23	pace	pace	NOUN
amwa-13	426	24	•	•	ADP
amwa-13	426	25	great	great	ADJ
amwa-13	426	26	reference	reference	NOUN
amwa-13	426	27	guides	guide	NOUN
amwa-13	426	28	es	es	AUX
amwa-13	426	29	express	express	VERB
amwa-13	426	30	everything	everything	PRON
amwa-13	426	31	you	you	PRON
amwa-13	426	32	need	need	VERB
amwa-13	426	33	to	to	PART
amwa-13	426	34	earn	earn	VERB
amwa-13	426	35	your	your	PRON
amwa-13	426	36	amwa	amwa	PROPN
amwa-13	426	37	essential	essential	ADJ
amwa-13	426	38	skills	skill	NOUN
amwa-13	426	39	certificate	certificate	NOUN
amwa-13	426	40	...	...	PUNCT
amwa-13	426	41	tied	tie	VERB
amwa-13	426	42	up	up	ADP
amwa-13	426	43	in	in	ADP
amwa-13	426	44	a	a	DET
amwa-13	426	45	bow	bow	NOUN
amwa-13	426	46	.	.	PUNCT
amwa-13	427	1	www.amwa.org/es_express	www.amwa.org/es_express	PROPN
amwa-13	427	2	https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine-with-or-without-azithromycin/	https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine-with-or-without-azithromycin/	PROPN
amwa-13	427	3	https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavir-ritonavir-and-other-hiv-protease-inhibitors/	https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavir-ritonavir-and-other-hiv-protease-inhibitors/	PROPN
amwa-13	427	4	https://www.rxabbvie.com/pdf/kaletratabpi.pdf	https://www.rxabbvie.com/pdf/kaletratabpi.pdf	PROPN
amwa-13	427	5	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it	PROPN
amwa-13	427	6	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine	PROPN
amwa-13	427	7	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine	X
amwa-13	428	1	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine	PROPN
amwa-13	428	2	http://www.amwa.org/es_express	http://www.amwa.org/es_express	NOUN